Index of /wp-content/uploads/2020/12

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1-1-bonus.pdf2025-05-06 14:19 25K 
[ ]1_Daily-Reporting_-26-03-2020.pdf2025-05-06 14:19 247K 
[ ]1_Ranbaxy_Drugs_Limited.pdf2025-05-06 14:19 659K 
[ ]1_Ranbaxy_Malaysia_Sdn_Bhd_Malaysia.pdf2025-05-06 14:19 1.0M 
[ ]2.-Sun-Pharmaceutical-Bangladesh-Limited_FS-for-website_FY20.pdf2025-05-06 14:19 629K 
[ ]2_Basics_GmbH_Germany-1.pdf2025-05-06 14:19 1.1M 
[ ]2_Basics_GmbH_Germany.pdf2025-05-06 14:19 1.1M 
[ ]2_Daily-Reporting_27-03-2020.pdf2025-05-06 14:19 247K 
[ ]2_Gufic_Pharma_Limited.pdf2025-05-06 14:19 548K 
[ ]3-Retoure_Sun-Pharmaceuticals-Germany-GmbH.pdf2025-05-06 14:19 324K 
[ ]3_Daily-Reporting_30-03-2020.pdf2025-05-06 14:19 247K 
[ ]3_Ranbaxy_GmbH_Germany.pdf2025-05-06 14:19 195K 
[ ]3_Vidyut_Investments_Limited.pdf2025-05-06 14:19 460K 
[ ]3rd-Quarter-2006-07-results-on-29-Jan-2007-call-on-30-Jan-at-0930-January-17-2007.pdf2025-05-06 14:19 24K 
[ ]4.-Sun-Farmaceutica-do-Brasil-Ltda._FS-for-website_FY20.pdf2025-05-06 14:19 815K 
[ ]4_Daily-Reporting_31-03-2020.pdf2025-05-06 14:19 247K 
[ ]4_Ranbaxy_S_A_Proprietory_South_Africa.pdf2025-05-06 14:19 598K 
[ ]5-Produkte.pdf2025-05-06 14:19 203K 
[ ]5.-Sun-Pharma-De-Mexico-S.A.-DE-C.V._FS-for-website_FY20.pdf2025-05-06 14:19 3.4M 
[ ]5_Daily-Reporting_01-04-2020.pdf2025-05-06 14:19 246K 
[ ]5_Sonke_Pharmaceuticals_Pty_Ltd_South_Africa.pdf2025-05-06 14:19 370K 
[ ]6.-Spil-De-Mexico-S.A.-De-C.V._FS-for-website_FY20.pdf2025-05-06 14:19 795K 
[ ]6_Daily-Reporting_03-04-2020.pdf2025-05-06 14:19 247K 
[ ]6_Ranbaxy_Egypt_L_L_C_Egypt.pdf2025-05-06 14:19 921K 
[ ]7-Haftungsausschluss-_-Datenschutzerkl„rung.pdf2025-05-06 14:19 594K 
[ ]7.-Sun-Pharmaceutical-Peru-S.A.C._FS-for-website_FY20-1.pdf2025-05-06 14:19 3.9M 
[ ]7.-Sun-Pharmaceutical-Peru-S.A.C._FS-for-website_FY20.pdf2025-05-06 14:19 3.9M 
[ ]7_Daily-Reporting-07-04-2020.pdf2025-05-06 14:19 246K 
[ ]7_Rexcel_Egypt_L_L_C_Egypt.pdf2025-05-06 14:19 830K 
[ ]8.-OOO-Sun-Pharmaceutical-Industries-Limited_FS-for-website_FY20.pdf2025-05-06 14:19 1.0M 
[ ]8_Daily-Reporting_08-04-2020.pdf2025-05-06 14:19 246K 
[ ]8_Ranbaxy_U_K_Ltd_United_Kingdom.pdf2025-05-06 14:19 344K 
[ ]9-AGB_SUN.pdf2025-05-06 14:19 93K 
[ ]9_Daily-Reporting_09-04-2020.pdf2025-05-06 14:19 247K 
[ ]9_Ranbaxy_Poland_S_P_Z_o_o_Poland.pdf2025-05-06 14:19 1.6M 
[ ]10_Daily-Reporting_13-04-2020.pdf2025-05-06 14:19 247K 
[ ]10_Ranbaxy_Nigeria_Ltd_Nigeria.pdf2025-05-06 14:19 1.0M 
[ ]11_Daily-Reporting_15-04-2020.pdf2025-05-06 14:19 246K 
[ ]11_Ranbaxy_Thailand_Company_Limited_Thailand.pdf2025-05-06 14:19 704K 
[ ]12.-Alkaloida-Chemical-Company-Zrt._FS-for-website_FY20.pdf2025-05-06 14:19 2.9M 
[ ]12_Daily-Reporting_16-04-2020.pdf2025-05-06 14:19 247K 
[ ]12_Ranbaxy_Pharmaceuticals_Ukraine_LLC_Ukraine.pdf2025-05-06 14:19 1.0M 
[ ]13.-Sun-Pharmaceutical-Industries-Australia-Pty-Limited-FS-for-website_FY20.pdf2025-05-06 14:19 9.0M 
[ ]13_Daily-Reporting_17-04-2020.pdf2025-05-06 14:19 246K 
[ ]13_Ranbaxy_Morocco_LLC_Morocco.pdf2025-05-06 14:20 415K 
[ ]14_Daily-Reporting_20-04-2020.pdf2025-05-06 14:19 28K 
[ ]14_Ranbaxy_Farmaceutica_Ltda_Brazil.pdf2025-05-06 14:19 945K 
[ ]15.-Sun-Pharmaceutical-Industries-Europe-B.V._FS-for-website_FY20.pdf2025-05-06 14:19 2.2M 
[ ]15_Daily-Reporting_21-04-2020.pdf2025-05-06 14:19 246K 
[ ]15_Ranbaxy_PRP_Peru_S_A_C_Peru.pdf2025-05-06 14:19 850K 
[ ]16_Daily-Reporting_22-04-2020.pdf2025-05-06 14:19 246K 
[ ]16_Ranbaxy_Europe_Ltd_United_Kingdom.pdf2025-05-06 14:19 246K 
[ ]16th-AGM-Chairman-Speech-Sep-2008.pdf2025-05-06 14:19 47K 
[ ]17_Daily-Reporting_23-04-2020.pdf2025-05-06 14:19 107K 
[ ]17_RINC_Consol_31_March_14_Final.pdf2025-05-06 14:19 877K 
[ ]17th-AGM-Chairman-Speech-Sep-2009.pdf2025-05-06 14:19 69K 
[ ]18.-Sun-Pharma-Global-FZE_FS-for-website_FY20.pdf2025-05-06 14:19 3.9M 
[ ]18_Daily-Reporting_24-04-2020.pdf2025-05-06 14:19 306K 
[ ]18_Ranbaxy_Pharmaceutical_Inc_USA.pdf2025-05-06 14:19 437K 
[ ]18th-AGM-Chairman-Speech-Sep-2010-1.pdf2025-05-06 14:19 33K 
[ ]18th-AGM-Chairman-Speech-Sep-2010.pdf2025-05-06 14:19 33K 
[ ]19_Daily-Reporting_27-04-2020.pdf2025-05-06 14:19 306K 
[ ]19_Ranbaxy_USA_Inc_USA.pdf2025-05-06 14:19 366K 
[ ]20.-Sun-Laboratories-FZE_FS-for-website_FY20.pdf2025-05-06 14:19 3.8M 
[ ]20_Daily-Reporting_28-04-2020.pdf2025-05-06 14:19 306K 
[ ]20_Ohm_Laboratories_Inc_USA.pdf2025-05-06 14:19 409K 
[ ]21-AGM-Chairman-Speech-Sep-2013.pdf2025-05-06 14:19 53K 
[ ]21_Daily-Reporting_29-04-2020.pdf2025-05-06 14:19 306K 
[ ]21_Ranbaxy_Laboratories_Inc_USA.pdf2025-05-06 14:19 414K 
[ ]22.-Sun-Pharma-Philippines-Inc.-FS-for-website_FY20.pdf2025-05-06 14:19 559K 
[ ]22_Daily-Reporting_30-04-2020.pdf2025-05-06 14:19 306K 
[ ]22_Ranbaxy_Signature_LLC_USA1.pdf2025-05-06 14:19 204K 
[ ]22th-AGM-Chairman-Speech-Sep-2014_0-1.pdf2025-05-06 14:19 116K 
[ ]22th-AGM-Chairman-Speech-Sep-2014_0.pdf2025-05-06 14:19 116K 
[ ]23_Daily-Reporting_04-05-2020.pdf2025-05-06 14:19 306K 
[ ]23_Ranbaxy_Netherlands_B_V_RNBV_The_Netherlands.pdf2025-05-06 14:19 936K 
[ ]23rd-AGM-Chairman-Speech-31Oct-2015.pdf2025-05-06 14:19 116K 
[ ]24_Daily-Reporting_05-05-2020.pdf2025-05-06 14:19 306K 
[ ]24_RHUKL_PDF.pdf2025-05-06 14:19 158K 
[ ]24th-AGM-Speech-Sept-2016.pdf2025-05-06 14:19 105K 
[ ]25_Daily-Reporting_06-05-2020.pdf2025-05-06 14:19 306K 
[ ]25_Ranbaxy_Ireland_Ltd_Ireland.pdf2025-05-06 14:19 435K 
[ ]26_Daily-Reporting_07-05-2020.pdf2025-05-06 14:19 306K 
[ ]26_ZAO_Ranbaxy_Russia.pdf2025-05-06 14:19 1.5M 
[ ]27_Daily-Reporting_08-05-2020.pdf2025-05-06 14:19 306K 
[ ]27_Ranbaxy_Pharmacie_Generiques_SAS_France.pdf2025-05-06 14:19 1.0M 
[ ]27thAGMSpeech.pdf2025-05-06 14:19 91K 
[ ]28_Daily-Reporting_11-05-2020.pdf2025-05-06 14:19 306K 
[ ]28_Ranbaxy_Portugal_Com_E_Desenvolv_De_Prod_Farmaceuticos_Unipessoal_Lda_Portugal.pdf2025-05-06 14:19 1.1M 
[ ]28th-AGM-Speech.pdf2025-05-06 14:19 96K 
[ ]29_Daily-Reporting_12-05-2020.pdf2025-05-06 14:19 306K 
[ ]29_Laboratorios_Ranbaxy_S_L_Spain.pdf2025-05-06 14:19 1.6M 
[ ]30_Daily-Reporting_13-05-2020.pdf2025-05-06 14:19 306K 
[ ]30_Office_Pharmaceutique_Industriel_Et_Hospitalier_SARL_OPIH-SARL_France.pdf2025-05-06 14:19 752K 
[ ]31-Taro-Pharmaceuticals-Europe-B.V.-FS-for-website_FY20.pdf2025-05-06 14:19 36K 
[ ]31_Daily-Reporting_14-05-2020.pdf2025-05-06 14:19 306K 
[ ]31_Ranbaxy_Australia_Pty_Ltd_Australia.pdf2025-05-06 14:19 576K 
[ ]32_Daily-Reporting_15-05-2020.pdf2025-05-06 14:19 306K 
[ ]32_Ranbaxy_Pharmaceuticals_Canada_Inc_Canada.pdf2025-05-06 14:19 611K 
[ ]33_Daily-Reporting_18-05-2020.pdf2025-05-06 14:19 306K 
[ ]33_Ranbaxy_Italia_S_p_A_Italy.pdf2025-05-06 14:19 3.4M 
[ ]34_Daily-Reporting_19-05-2020.pdf2025-05-06 14:19 306K 
[ ]34_Terapia_S_A_Romania.pdf2025-05-06 14:19 1.8M 
[ ]35_Daily-Reporting_20-05-2020.pdf2025-05-06 14:19 306K 
[ ]35_Ranbaxy_Belgium_N_V_Belgium.pdf2025-05-06 14:19 1.5M 
[ ]36_Be_Tabs_Investments_Proprietary_Ltd_South_Africa.pdf2025-05-06 14:20 624K 
[ ]36_Daily-Reporting_21-05-2020.pdf2025-05-06 14:19 306K 
[ ]37_Be_Tabs_Pharmaceuticals_Proprietary_Ltd_South_Africa.pdf2025-05-06 14:19 1.1M 
[ ]37_Daily-Reporting_22-05-2020.pdf2025-05-06 14:19 306K 
[ ]38_Daily-Reporting_26-05-2020.pdf2025-05-06 14:20 306K 
[ ]39_Daily-Reporting_27-05-2020.pdf2025-05-06 14:19 306K 
[ ]40_Daily-Reporting_28-05-2020.pdf2025-05-06 14:19 306K 
[ ]41.-Sun-Pharma-Switzerland-Ltd._FS-for-website_FY20.pdf2025-05-06 14:19 234K 
[ ]41_Daily-Reporting_29-05-2020.pdf2025-05-06 14:19 306K 
[ ]42.-Sun-Pharma-Holding_FS-for-website_FY20.pdf2025-05-06 14:19 1.0M 
[ ]42_Daily-Reporting_01-06-2020.pdf2025-05-06 14:19 306K 
[ ]43_Daily-Reporting_02-06-2020.pdf2025-05-06 14:19 306K 
[ ]44_Daily-Reporting_03-06-2020.pdf2025-05-06 14:19 306K 
[ ]45.-Sun-Pharma-East-Africa-Limited_FS-for-website_FY20.pdf2025-05-06 14:20 309K 
[ ]45_Daily-Reporting_04-06-2020.pdf2025-05-06 14:19 306K 
[ ]46.-Basics-GmbH_FS-for-website_FY20.pdf2025-05-06 14:19 1.1M 
[ ]46_Daily-Reporting_05-06-2020.pdf2025-05-06 14:19 306K 
[ ]47_Daily-Reporting_08-06-2020.pdf2025-05-06 14:19 306K 
[ ]48.-Sun-Pharmaceuticals-Morocco-LLC_FS-for-website_FY20.pdf2025-05-06 14:19 195K 
[ ]48_Daily-Reporting_09-06-2020.pdf2025-05-06 14:19 306K 
[ ]49_Daily-Reporting_10-06-2020.pdf2025-05-06 14:19 306K 
[ ]50.-Ranbaxy-Holdings-U.K.-Limited_FS-for-website_FY20.pdf2025-05-06 14:19 623K 
[ ]50_Daily-Reporting_11-06-2020.pdf2025-05-06 14:19 306K 
[ ]51.-Sun-Pharma-France-Formerly-known-as-Ranbaxy-Pharmacie-Generiques_FS-for-website_FY20.pdf2025-05-06 14:19 1.1M 
[ ]51_Daily-Reporting_12-06-2020.pdf2025-05-06 14:19 306K 
[ ]52_Daily-Reporting_15-06-2020.pdf2025-05-06 14:19 306K 
[ ]53.-Ranbaxy-Italia-S.P.A._FS-for-website_FY20.pdf2025-05-06 14:19 2.5M 
[ ]53_Daily-Reporting_16-06-2020.pdf2025-05-06 14:19 306K 
[ ]54_Daily-Reporting_17-06-2020.pdf2025-05-06 14:19 307K 
[ ]55_Daily-Reporting_18-06-2020.pdf2025-05-06 14:19 307K 
[ ]56_Daily-Reporting_19-06-2020.pdf2025-05-06 14:20 307K 
[ ]57_Daily-Reporting_22-06-2020.pdf2025-05-06 14:19 307K 
[ ]58_Daily-Reporting_23-06-2020.pdf2025-05-06 14:19 307K 
[ ]59_Daily-Reporting_24-06-2020.pdf2025-05-06 14:19 307K 
[ ]60_Daily-Reporting_25-06-2020.pdf2025-05-06 14:19 307K 
[ ]61_Daily-Reporting_26-06-2020.pdf2025-05-06 14:19 307K 
[ ]62-63-64-74.-Rabnaxy-Inc-and-its-subsidiaries_FS-for-website_FY20.pdf2025-05-06 14:19 426K 
[ ]62.-Ranbaxy-Thailand-Co.-Ltd._FS-for-website_FY20.pdf2025-05-06 14:19 1.1M 
[ ]62_Daily-Reporting_29-06-2020.pdf2025-05-06 14:19 307K 
[ ]63_Daily-Reporting_30-06-2020.pdf2025-05-06 14:19 307K 
[ ]64_Daily-Reporting_01-07-2020.pdf2025-05-06 14:19 306K 
[ ]65_Daily-Reporting_02-07-2020.pdf2025-05-06 14:19 307K 
[ ]66_Daily-Reporting_03-07-2020.pdf2025-05-06 14:19 307K 
[ ]67.-AO-Ranbaxy_FS-for-website_FY20-1.pdf2025-05-06 14:19 1.3M 
[ ]67.-AO-Ranbaxy_FS-for-website_FY20.pdf2025-05-06 14:19 1.3M 
[ ]67_Daily-Reporting_06-07-2020.pdf2025-05-06 14:19 307K 
[ ]68.-Sun-Pharma-Laboratorios-S.L.U-formerly-Laboratorios-Ranbaxy-S.L.U._FS-for-website_FY20.pdf2025-05-06 14:19 5.2M 
[ ]68_Daily-Reporting_07-07-2020.pdf2025-05-06 14:19 307K 
[ ]69.-Ranbaxy-Malaysia-SDN.-BHD.-_FS-for-website_FY20.pdf2025-05-06 14:19 1.0M 
[ ]69_Daily-Reporting_08-07-2020.pdf2025-05-06 14:19 306K 
[ ]70.-Ranbaxy-Farmaceutica-Ltda._FS-for-website_FY20.pdf2025-05-06 14:19 580K 
[ ]70_Daily-Reporting_09-07-2020.pdf2025-05-06 14:19 307K 
[ ]71.-Sun-Pharma-ANZ-Pty-Ltd_FS-for-website_FY20.pdf2025-05-06 14:19 1.2M 
[ ]71_Daily-Reporting_10-07-2020.pdf2025-05-06 14:19 307K 
[ ]72.-Sun-Pharma-Canada-Inc._FS-for-website_FY20.pdf2025-05-06 14:19 127K 
[ ]72_Daily-Reporting_13-07-2020-1.pdf2025-05-06 14:19 307K 
[ ]72_Daily-Reporting_13-07-2020.pdf2025-05-06 14:19 307K 
[ ]73.-Terapia-SA_FS-for-website_FY20.pdf2025-05-06 14:19 3.1M 
[ ]73_Daily-Reporting_14-07-2020.pdf2025-05-06 14:19 307K 
[ ]74_Daily-Reporting_15-07-2020.pdf2025-05-06 14:19 307K 
[ ]75_Daily-Reporting_16-07-2020.pdf2025-05-06 14:19 307K 
[ ]76.-JSC-Biosintez_FS-for-website_FY20.pdf2025-05-06 14:19 1.9M 
[ ]76_Daily-Reporting_17-07-2020.pdf2025-05-06 14:19 307K 
[ ]77.-Sun-Pharmaceutical-Holdings-USA-Inc.-and-Subsidiaries_FS-for-website_FY20.pdf2025-05-06 14:19 502K 
[ ]77_Daily-Reporting_20-07-2020.pdf2025-05-06 14:19 307K 
[ ]78_Daily-Reporting_21-07-2020.pdf2025-05-06 14:19 481K 
[ ]79_Daily-Reporting_22-07-2020.pdf2025-05-06 14:19 307K 
[ ]80_Daily-Reporting_23-07-2020.pdf2025-05-06 14:19 307K 
[ ]81_Daily-Reporting_24-07-2020.pdf2025-05-06 14:19 307K 
[ ]82.-Kayaku-Co.-Ltd._FS-for-website_FY20.pdf2025-05-06 14:19 892K 
[ ]82_Daily-Reporting_27-07-2020.pdf2025-05-06 14:19 307K 
[ ]83_Daily-Reporting_28-07-2020.pdf2025-05-06 14:19 307K 
[ ]84_Daily-Reporting_29-07-2020.pdf2025-05-06 14:19 307K 
[ ]85_Daily-Reporting_30-07-2020.pdf2025-05-06 14:19 307K 
[ ]86_Daily-Reporting_31-07-2020.pdf2025-05-06 14:19 307K 
[ ]87_Daily-Reporting_03-08-2020.pdf2025-05-06 14:19 307K 
[ ]88_Daily-Reporting_04-08-2020.pdf2025-05-06 14:19 307K 
[ ]89_Daily-Reporting_05-08-2020.pdf2025-05-06 14:19 307K 
[ ]90_Daily-Reporting_06-08-2020.pdf2025-05-06 14:19 307K 
[ ]91_Daily-Reporting_07-08-2020.pdf2025-05-06 14:19 307K 
[ ]92_Daily-Reporting_10-08-2020.pdf2025-05-06 14:20 307K 
[ ]93_Daily-Reporting_11-08-2020.pdf2025-05-06 14:19 307K 
[ ]94_Daily-Reporting_12-08-2020.pdf2025-05-06 14:19 307K 
[ ]95_Daily-Reporting_13-08-2020.pdf2025-05-06 14:19 307K 
[ ]96_Daily-Reporting_14-08-2020.pdf2025-05-06 14:19 307K 
[ ]97_Daily-Reporting_17-08-2020.pdf2025-05-06 14:19 307K 
[ ]98_Daily-Reporting_18-08-2020.pdf2025-05-06 14:19 307K 
[ ]99_Daily_Reporting_19-08-2020.pdf2025-05-06 14:19 307K 
[ ]100_Daily-Reporting_20-08-2020.pdf2025-05-06 14:19 307K 
[ ]101_Daily-Reporting_21-08-2020.pdf2025-05-06 14:19 307K 
[ ]102_Daily_Reporting_24-08-2020.pdf2025-05-06 14:19 307K 
[ ]103_Daily-Reporting_25-08-2020.pdf2025-05-06 14:19 307K 
[ ]104_Daily-Reporting_26-08-2020.pdf2025-05-06 14:19 307K 
[ ]105_Daily-Reporting_27-08-2020.pdf2025-05-06 14:19 307K 
[ ]106_Daily-Reporting_28-08-2020.pdf2025-05-06 14:19 307K 
[ ]107_Daily-Reporting_31-08-2020.pdf2025-05-06 14:19 309K 
[ ]108_Daily-Reporting_01-09-2020.pdf2025-05-06 14:19 309K 
[ ]109_Daily-Reporting_02-09-2020.pdf2025-05-06 14:19 309K 
[ ]110_Daily-Reporting_03-09-2020.pdf2025-05-06 14:19 309K 
[ ]111_Daily-Reporting_04-09-2020.pdf2025-05-06 14:19 309K 
[ ]112_Daily-Reporting_07-09-2020.pdf2025-05-06 14:19 309K 
[ ]113_Daily-Reporting_08-09-2020.pdf2025-05-06 14:19 309K 
[ ]114_Daily-Reporting_09-09-2020.pdf2025-05-06 14:19 309K 
[ ]115_Daily-Reporting_10-09-2020.pdf2025-05-06 14:19 309K 
[ ]116_Daily-Reporting_11-09-2020.pdf2025-05-06 14:19 309K 
[ ]117_Daily-Reporting_14-09-2020.pdf2025-05-06 14:19 309K 
[ ]118_Daily-Reporting_15-09-2020.pdf2025-05-06 14:19 309K 
[ ]119_Daily-Reporting_16-09-2020.pdf2025-05-06 14:19 309K 
[ ]120_Daily-Reporting_17-09-2020.pdf2025-05-06 14:19 309K 
[ ]121_Daily-Reporting_18-09-2020.pdf2025-05-06 14:19 309K 
[ ]122_Daily-Reporting_21-09-2020.pdf2025-05-06 14:19 309K 
[ ]123_Daily-Reporting_22-09-2020.pdf2025-05-06 14:19 309K 
[ ]124_Daily-Reporting_23-09-2020.pdf2025-05-06 14:19 309K 
[ ]125_Daily-Reporting_24-09-2020.pdf2025-05-06 14:19 309K 
[ ]126_Daily-Reporting_25-09-2020.pdf2025-05-06 14:19 309K 
[ ]448.pdf2025-05-06 14:19 28K 
[ ]449.pdf2025-05-06 14:19 26K 
[ ]450.pdf2025-05-06 14:19 34K 
[ ]452.pdf2025-05-06 14:19 38K 
[ ]457.pdf2025-05-06 14:19 25K 
[ ]458.pdf2025-05-06 14:19 25K 
[ ]459-1.pdf2025-05-06 14:19 23K 
[ ]459.pdf2025-05-06 14:19 23K 
[ ]460.pdf2025-05-06 14:19 22K 
[ ]462.pdf2025-05-06 14:19 22K 
[ ]463.pdf2025-05-06 14:19 34K 
[ ]467.pdf2025-05-06 14:19 22K 
[ ]468.pdf2025-05-06 14:19 22K 
[ ]469.pdf2025-05-06 14:19 73K 
[ ]470.pdf2025-05-06 14:19 22K 
[ ]627.pdf2025-05-06 14:19 60K 
[ ]629.pdf2025-05-06 14:19 22K 
[ ]630.pdf2025-05-06 14:19 22K 
[ ]631.pdf2025-05-06 14:19 22K 
[ ]100929-Expiration-of-Offering.pdf2025-05-06 14:19 42K 
[ ]100929-Rosuvastatin-tentative-approval.pdf2025-05-06 14:19 22K 
[ ]101001-CLE-tentative-approval.pdf2025-05-06 14:19 23K 
[ ]101118-Desloratidine-approal.pdf2025-05-06 14:19 24K 
[ ]101118-DiltiazemER-approal-Nov.pdf2025-05-06 14:19 22K 
[ ]101124-Duloxetine-HCL-tentative.pdf2025-05-06 14:19 22K 
[ ]101130-Donepezil-HCL-tentative.pdf2025-05-06 14:19 22K 
[ ]101230-Ibandronate-Injection-tentative-1.pdf2025-05-06 14:19 22K 
[ ]101230-Ibandronate-Injection-tentative.pdf2025-05-06 14:19 22K 
[ ]110118-Q3-FY11-results-on-31-01-10.pdf2025-05-06 14:19 23K 
[ ]110203-Galantamine-Hydrobromide-ER.pdf2025-05-06 14:19 22K 
[ ]110411-Merck-and-Sun-Pharma-Joint-Venture-2.pdf2025-05-06 14:19 27K 
[ ]110420-Call-transcript-Sun-Merck-JV.pdf2025-05-06 14:19 126K 
[ ]110504-NDA-Docetaxel-approval.pdf2025-05-06 14:19 22K 
[ ]110514-Q4-FY11-results-on-28-05-11.pdf2025-05-06 14:19 25K 
[ ]110620-Sumatriptan-Injection-Approval.pdf2025-05-06 14:19 23K 
[ ]110719-Alfuzosin-Tablets-Approval.pdf2025-05-06 14:19 23K 
[ ]110720-Q1-FY12-results-on-28-07-11.pdf2025-05-06 14:19 25K 
[ ]110729-Clopidogrel-TabletsTentative-Approval.pdf2025-05-06 14:19 22K 
[ ]110919-Sun-Pharma-subsidiary-resolves-USFDA-warning-letter-1.pdf2025-05-06 14:19 22K 
[ ]110919-Sun-Pharma-subsidiary-resolves-USFDA-warning-letter.pdf2025-05-06 14:19 22K 
[ ]111031-Diltiazem-HCL-ER-Cap-Subsidiary-Approval.pdf2025-05-06 14:19 22K 
[ ]111103-Q2-FY12-results-on-13-11-11-1.pdf2025-05-06 14:19 24K 
[ ]111103-Q2-FY12-results-on-13-11-11.pdf2025-05-06 14:19 24K 
[ ]111209-Tramadol-HCL-ER-Tab-Subsidiary-Approval.pdf2025-05-06 14:19 21K 
[ ]120131-Q3-FY12-results-on-13-02-12.pdf2025-05-06 14:19 23K 
[ ]120215-Protonix-Litigation-Update-Feb-2012.pdf2025-05-06 14:19 22K 
[ ]120328-Quetiapine-Fumarate-Tab-Approval-.pdf2025-05-06 14:19 19K 
[ ]120424-Olanzapine-Tab.-USP-Approval-24-April-2012.pdf2025-05-06 14:19 18K 
[ ]120515-Q4-FY12-results-on-29-05-12.pdf2025-05-06 14:19 21K 
[ ]120524-Azelastine-HCL-Nasal-Spray-Approval.pdf2025-05-06 14:19 18K 
[ ]120529-Appointment-of-Chairman-on-Sun-Board.pdf2025-05-06 14:19 22K 
[ ]120730-Q1-FY13-results-on-10-08-12.pdf2025-05-06 14:19 21K 
[ ]120813-Sun-Pharma-to-Take-Taro-Private.pdf2025-05-06 14:19 25K 
[ ]121022-Q2-FY13-results-on-08-11-12.pdf2025-05-06 14:19 21K 
[ ]130125-Q3-FY13-results-on-08-02-13-1.pdf2025-05-06 14:19 27K 
[ ]20080320-Allotment-of-Equity-Shares-against-conversion-of-further-FCCBs.pdf2025-05-06 14:19 9.3K 
[ ]20080412-Quarterly-compliance-report-of-the-Corp.-Gov.-31-03-2008.pdf2025-05-06 14:19 23K 
[ ]20080808-Form-of-Waiverforgoing-the-Right-to-receive-the-dividend-31-03-2008.pdf2025-05-06 14:19 62K 
[ ]20080827-Notice-of-Sixteenth-Annual-General-Meeting.pdf2025-05-06 14:20 1.4M 
[ ]20081003-Quarterly-compliance-report-of-the-Corp.-Gov.-30-09-2008.pdf2025-05-06 14:19 11K 
[ ]20090116-Notice-of-Board-Meeting-for-quarter-end-31-12-2008.pdf2025-05-06 14:19 7.8K 
[ ]20090210-Security-pledge-revocation-letter-Pledged-.pdf2025-05-06 14:19 767K 
[ ]20090313-Security-pledge-revocation-letter-Revoked.pdf2025-05-06 14:19 13K 
[ ]20090407-Quarterly-compliance-report-of-the-Corp.-Gov.-31-03-2009.pdf2025-05-06 14:19 12K 
[ ]20090420-Details-of-share-holding-in-terms-of-Regulation-83-31-03-2009.pdf2025-05-06 14:19 17K 
[ ]20090530-Outcome-of-Board-meeting-31-03-2009.pdf2025-05-06 14:19 8.5K 
[ ]20090702-Quarterly-compliance-report-of-the-Corp.-Gov.-30-06-2009.pdf2025-05-06 14:19 18K 
[ ]20090711-Notice-of-Seventeenth-Annual-General-Meeting.pdf2025-05-06 14:19 62K 
[ ]20090731-Form-of-Waiverforgoing-the-Right-to-receive-the-dividend-31-03-2009.pdf2025-05-06 14:19 62K 
[ ]20090810-Security-pledge-revocation-letter-Revoked-_-Pledged.pdf2025-05-06 14:19 14K 
[ ]20090912-Acquisition-of-Shares-_-Takeovers-code-intimation.pdf2025-05-06 14:19 20K 
[ ]20090912-Notice-of-Proceedings-17th-AGM.pdf2025-05-06 14:19 21K 
[ ]20090914-Notice-for-expiry-of-HSR-waiting-period-in-U.S.-for-Taro-Tender-Offer.pdf2025-05-06 14:19 71K 
[ ]20091010-Notice-of-Board-Meeting-for-quarter-end-30-09-2009.pdf2025-05-06 14:19 8.6K 
[ ]20091020-Security-pledge-revocation-letter-Revoked-_-Pledged-1.pdf2025-05-06 14:19 15K 
[ ]20091020-Security-pledge-revocation-letter-Revoked-_-Pledged.pdf2025-05-06 14:19 15K 
[ ]20091218-Security-pledge-revocation-letter-Revoked.pdf2025-05-06 14:19 34K 
[ ]20100104-Quarterly-compliance-report-of-the-Corp.-Gov.-31-12-2009.pdf2025-05-06 14:19 13K 
[ ]20100326-Security-pledge-revocation-letter-Revoked.pdf2025-05-06 14:19 17K 
[ ]20100402-appointed-Shri.-Kal-Sundaram-as-an-additional-Director-on-the-Board.pdf2025-05-06 14:19 8.0K 
[ ]20100507-Notice-of-Board-Meeting-for-quarter-end-31-03-2010.pdf2025-05-06 14:19 8.1K 
[ ]20100614-Notice-of-Eighteenth-Annual-General-Meeting.pdf2025-05-06 14:19 41K 
[ ]20100810-Fixation-of-Book-Closure-Date-for-payment-of-Dividend..pdf2025-05-06 14:19 18K 
[ ]20100819-Form-of-Waiverforgoing-the-Right-to-receive-the-dividend-31-03-2010.pdf2025-05-06 14:19 63K 
[ ]20100901-Security-pledge-revocation-letter-Revoked.pdf2025-05-06 14:19 14K 
[ ]20100901-Security-pledge-revocation-letter-Revoked1.pdf2025-05-06 14:19 14K 
[ ]20100907-Security-pledge-revocation-letter-Revoked-_-Pledged.pdf2025-05-06 14:19 14K 
[ ]20100915-Expiration-of-Tender-Offer.pdf2025-05-06 14:19 24K 
[ ]20100923-Security-pledge-revocation-letter-Revoked-_-Pledged.pdf2025-05-06 14:19 14K 
[ ]20100924-Notice-Split-of-Shares-fro-Rs.5-to-Re.1-per-share.pdf2025-05-06 14:19 56K 
[ ]20100924-Notice-of-Proceedings-18th-AGM.pdf2025-05-06 14:20 141K 
[ ]20101111-Security-pledge-revocation-letter-Pledged-.pdf2025-05-06 14:19 13K 
[ ]20101112-Result-of-the-Postal-Ballot.pdf2025-05-06 14:19 49K 
[ ]20110128-Security-pledge-revocation-letter-Pledged-.pdf2025-05-06 14:19 14K 
[ ]20110218-Security-pledge-revocation-letter-Revoked.pdf2025-05-06 14:19 14K 
[ ]20110330-Security-pledge-revocation-letter-Revoked.pdf2025-05-06 14:19 13K 
[ ]20110511-Security-pledge-revocation-letter-Pledged-.pdf2025-05-06 14:19 14K 
[ ]20110511-Security-pledge-revocation-letter-Revoked-_-Pledged.pdf2025-05-06 14:19 14K 
[ ]20110705-Security-pledge-revocation-letter-Revoked-_-Pledged.pdf2025-05-06 14:19 14K 
[ ]20110715-Security-pledge-revocation-letter-Revoked.pdf2025-05-06 14:19 14K 
[ ]20110819-Notice-of-Nineteenth-Annual-General-Meeting.pdf2025-05-06 14:19 95K 
[ ]20110819-SPIL-Proxy-Form-_-Attendance-Slip.pdf2025-05-06 14:19 82K 
[ ]20110905-Form-of-Waiverforgoing-the-Right-to-receive-the-dividend-31-03-2011.pdf2025-05-06 14:19 52K 
[ ]20110919-Security-pledge-revocation-letter-Pledged-.pdf2025-05-06 14:19 14K 
[ ]20110927-Acquisition-of-Shares-_-Takeovers-code-intimation.pdf2025-05-06 14:19 23K 
[ ]20111013-Security-pledge-revocation-letter-Revoked-_-Pledged.pdf2025-05-06 14:19 14K 
[ ]20111018-Notice-of-Board-Meeting-for-quarter-end-30-09-2011.pdf2025-05-06 14:19 7.9K 
[ ]20120111-Quarterly-compliance-report-of-the-Corp.-Gov.31-12-2010.pdf2025-05-06 14:19 12K 
[ ]20120130-Notice-of-Board-Meeting-for-quarter-end-31-12-2011.pdf2025-05-06 14:19 8.1K 
[ ]20120229-Olanzapine-ODT-Approval-28-Feb-2012.pdf2025-05-06 14:19 21K 
[ ]20120403-Quarterly-compliance-report-of-the-Corp.-Gov.31-03-2012.pdf2025-05-06 14:19 17K 
[ ]20120416-Clause-47-c-of-the-Listing-Agreement.pdf2025-05-06 14:19 340K 
[ ]20120703-Quarterly-compliance-report-of-the-Corp.-Gov.30-06-2012.pdf2025-05-06 14:19 12K 
[ ]20120807-Intimation-Restructuring-Interim-Dividend-_-Record-Date-SPIL-3-8-12.pdf2025-05-06 14:19 14K 
[ ]20120811-Notice-of-Adjourned-Twentieth-Annual-General-Meeting.pdf2025-05-06 14:19 84K 
[ ]20120811-Notice-of-Twentieth-Annual-General-Meeting.pdf2025-05-06 14:19 121K 
[ ]20120811-SPIL-Proxy-Form-_-Attendance-Slip.pdf2025-05-06 14:19 338K 
[ ]20120813-Form-of-Waiverforgoing-the-Right-to-receive-the-dividend-31-03-2012..pdf2025-05-06 14:19 55K 
[ ]20120927-Disclosure-UR-13-6-of-the-SEBI-Prohibition-of-Insider-Trading.pdf2025-05-06 14:19 17K 
[ ]20121003-Rising-Funds-_-Fixation-of-Book-Closure-Date.pdf2025-05-06 14:19 20K 
[ ]20121004-Disclosure-UR-13-6-of-the-SEBI-Prohibition-of-Insider-Trading.pdf2025-05-06 14:19 20K 
[ ]20121010-Disclosure-UR-13-6-of-the-SEBI-Prohibition-of-Insider-Trading.pdf2025-05-06 14:19 15K 
[ ]20121011-Notice-for-20th-Annual-General-Meeting.pdf2025-05-06 14:19 21K 
[ ]20121012-Disclosure-UR-13-6-of-the-SEBI-Prohibition-of-Insider-Trading.pdf2025-05-06 14:19 18K 
[ ]20121015-Quarterly-compliance-report-of-the-Corp.-Gov.30-09-2012.pdf2025-05-06 14:19 13K 
[ ]20121022-Notice-of-Board-Meeting-for-quarter-end-30-09-2012.pdf2025-05-06 14:19 17K 
[ ]20121108-Sun-Pharma-to-Acquire-DUSA-.pdf2025-05-06 14:19 46K 
[ ]20121108-Sun-Pharma-to-Acquire-DUSA-1.pdf2025-05-06 14:19 46K 
[ ]20121217-Sun-Pharma-to-Acquire-URL-.pdf2025-05-06 14:19 19K 
[ ]20130108-Notice-of-Convening-the-meeting-of-Equity-Shareholders.pdf2025-05-06 14:19 373K 
[ ]20130109-Quarterly-compliance-report-of-the-Corp.-Gov.31-12-2012.pdf2025-05-06 14:19 12K 
[ ]20130123-Notice-of-Board-Meeting-for-quarter-end-31-12-2012.pdf2025-05-06 14:19 16K 
[ ]20130205-Generic-Doxil-Approval-1.pdf2025-05-06 14:19 24K 
[ ]20130208-Sun-pharma-and-Taro-announces-termination-of-proposed-transaction-1.pdf2025-05-06 14:19 31K 
[ ]20130401-Quarterly-compliance-report-of-the-Corp.-Gov.31-03-2013.pdf2025-05-06 14:19 17K 
[ ]20130612-Press-Release-Sun-Pharma-settles-generic-Protonix®-litigation-1.pdf2025-05-06 14:19 18K 
[ ]20130703-Quarterly-compliance-report-of-the-Corp.-Gov.30-06-2013.pdf2025-05-06 14:19 20K 
[ ]20130715-Postal-Ballot-Result-.pdf2025-05-06 14:19 174K 
[ ]20130718-Intimation-regarding-Record-Date-Stock-Exchanges_0.pdf2025-05-06 14:19 48K 
[ ]20130805-Disclosure-UR-13-6-of-the-SEBI-Prohibition-of-Insider-Trading.pdf2025-05-06 14:19 26K 
[ ]20130904-Form-for-waiver-forgoing-right-to-receive-Dividend-for-Y.E.-31-03-2013.pdf2025-05-06 14:19 57K 
[ ]20130905-Notice-of-Twenty-first-Annual-General-Meeting.pdf2025-05-06 14:19 123K 
[ ]20130905-SPIL-Proxy-Form-_-Attendance-Slip..pdf2025-05-06 14:19 570K 
[ ]20140509-Proceedings-of-Court-convened-Meeting-of-Equity-Shareholders-held-on-May-05-2014-1.pdf2025-05-06 14:19 135K 
[ ]20140509-Proceedings-of-Court-convened-Meeting-of-Equity-Shareholders-held-on-May-05-2014.pdf2025-05-06 14:19 135K 
[ ]20150202-Sun-Pharma-receives-US-FTC-clearance-for-acquisition.pdf2025-05-06 14:19 59K 
[ ]20151028-Press-Release-Sun-Pharma-InSite-Vision-tender-offer-update.pdf2025-05-06 14:19 81K 
[ ]20151102-Report-on-Proceedings-of-23rd-AGM-with-Scrutinizer-report-_-voting-results.pdf2025-05-06 14:19 4.0M 
[ ]AGM-approves-bonus-preference.-August-28-2002.pdf2025-05-06 14:19 16K 
[ ]AO-Ranbaxy-1.pdf2025-05-06 14:19 7.6M 
[ ]AO-Ranbaxy-2.pdf2025-05-06 14:19 2.6M 
[ ]AO-Ranbaxy-Formerly-known-as-ZAO-Ranbaxy.pdf2025-05-06 14:19 1.7M 
[ ]AO-Ranbaxy.pdf2025-05-06 14:19 1.9M 
[IMG]API-banner-image-150x150.jpg2025-05-06 14:19 5.4K 
[IMG]API-banner-image-300x200.jpg2025-05-06 14:19 12K 
[IMG]API-banner-image-400x250.jpg2025-05-06 14:19 19K 
[IMG]API-banner-image-400x284.jpg2025-05-06 14:19 21K 
[IMG]API-banner-image-400x516.jpg2025-05-06 14:19 28K 
[IMG]API-banner-image-480x320.jpg2025-05-06 14:19 26K 
[IMG]API-banner-image-510x382.jpg2025-05-06 14:19 32K 
[IMG]API-banner-image-768x512.jpg2025-05-06 14:19 57K 
[IMG]API-banner-image-980x653.jpg2025-05-06 14:19 86K 
[IMG]API-banner-image-1024x683.jpg2025-05-06 14:19 92K 
[IMG]API-banner-image-1080x675.jpg2025-05-06 14:19 95K 
[IMG]API-banner-image-1080x720.jpg2025-05-06 14:19 99K 
[IMG]API-banner-image-1280x853.jpg2025-05-06 14:19 131K 
[IMG]API-banner-image-1536x1024.jpg2025-05-06 14:19 176K 
[IMG]API-banner-image-2048x1365.jpg2025-05-06 14:19 286K 
[IMG]API-banner-image.jpg2025-05-06 14:19 568K 
[IMG]ARV-banner-image-150x150.jpg2025-05-06 14:19 3.8K 
[IMG]ARV-banner-image-300x200.jpg2025-05-06 14:19 8.4K 
[IMG]ARV-banner-image-400x250.jpg2025-05-06 14:19 12K 
[IMG]ARV-banner-image-400x284.jpg2025-05-06 14:19 13K 
[IMG]ARV-banner-image-400x516.jpg2025-05-06 14:19 20K 
[IMG]ARV-banner-image-480x320.jpg2025-05-06 14:19 17K 
[IMG]ARV-banner-image-510x382.jpg2025-05-06 14:19 20K 
[IMG]ARV-banner-image-768x512.jpg2025-05-06 14:19 34K 
[IMG]ARV-banner-image-980x653.jpg2025-05-06 14:19 50K 
[IMG]ARV-banner-image-1024x683.jpg2025-05-06 14:19 53K 
[IMG]ARV-banner-image-1080x675.jpg2025-05-06 14:19 55K 
[IMG]ARV-banner-image-1080x720.jpg2025-05-06 14:19 57K 
[IMG]ARV-banner-image-1280x853.jpg2025-05-06 14:19 75K 
[IMG]ARV-banner-image-1536x1024.jpg2025-05-06 14:19 102K 
[IMG]ARV-banner-image-2048x1365.jpg2025-05-06 14:19 176K 
[IMG]ARV-banner-image.jpg2025-05-06 14:19 413K 
[IMG]About-us_Banner-image-150x150.jpg2025-05-06 14:19 3.6K 
[IMG]About-us_Banner-image-300x200.jpg2025-05-06 14:19 6.9K 
[IMG]About-us_Banner-image-400x250.jpg2025-05-06 14:19 9.9K 
[IMG]About-us_Banner-image-400x284.jpg2025-05-06 14:19 11K 
[IMG]About-us_Banner-image-400x516.jpg2025-05-06 14:19 15K 
[IMG]About-us_Banner-image-480x320.jpg2025-05-06 14:19 13K 
[IMG]About-us_Banner-image-510x382.jpg2025-05-06 14:19 16K 
[IMG]About-us_Banner-image-768x512.jpg2025-05-06 14:19 26K 
[IMG]About-us_Banner-image-980x653.jpg2025-05-06 14:20 36K 
[IMG]About-us_Banner-image-1024x683.jpg2025-05-06 14:19 39K 
[IMG]About-us_Banner-image-1080x675.jpg2025-05-06 14:19 40K 
[IMG]About-us_Banner-image-1080x720.jpg2025-05-06 14:19 41K 
[IMG]About-us_Banner-image-1280x853.jpg2025-05-06 14:19 54K 
[IMG]About-us_Banner-image-1536x1024.jpg2025-05-06 14:19 70K 
[IMG]About-us_Banner-image.jpg2025-05-06 14:19 163K 
[ ]Abridged-Annual-Report.pdf2025-05-06 14:19 2.5M 
[ ]Absorica-Press-Release.pdf2025-05-06 14:20 364K 
[ ]Acquires-Controlling-Stake-in-Taro-22-09-10.pdf2025-05-06 14:19 26K 
[ ]Acquisition-of-Thallion-Pharmaceuticals-Inc..pdf2025-05-06 14:19 145K 
[ ]Additional-details-for-OAI-classification-for-Halol-facility.pdf2025-05-06 14:19 237K 
[ ]Aditya-Acquisition-Company-Limited-1.pdf2025-05-06 14:19 508K 
[ ]Aditya-Acquisition-Company-Ltd.-1.pdf2025-05-06 14:19 266K 
[ ]Aditya-Acquisition-Company-Ltd.-2.pdf2025-05-06 14:19 282K 
[ ]Aditya-Acquisition-Company-Ltd..pdf2025-05-06 14:19 433K 
[ ]Aditya-Acquisition-Company-Ltd.pdf2025-05-06 14:19 259K 
[ ]Aditya-Pharma-Private-Limited-1.pdf2025-05-06 14:19 1.0M 
[ ]Aditya-Pharma-Private-Limited.pdf2025-05-06 14:19 1.0M 
[IMG]Africa-150x150.png2025-05-06 14:19 13K 
[IMG]Africa-264x300.png2025-05-06 14:19 26K 
[IMG]Africa-310x250.png2025-05-06 14:19 17K 
[IMG]Africa-310x284.png2025-05-06 14:19 19K 
[IMG]Africa.png2025-05-06 14:19 20K 
[ ]Alkaloida-Chemical-Company-Zrt-1.pdf2025-05-06 14:19 1.5M 
[ ]Alkaloida-Chemical-Company-Zrt-2.pdf2025-05-06 14:19 873K 
[ ]Alkaloida-Chemical-Company-Zrt-3.pdf2025-05-06 14:19 1.2M 
[ ]Alkaloida-Chemical-Company-Zrt.-1.pdf2025-05-06 14:19 1.5M 
[ ]Alkaloida-Chemical-Company-Zrt..pdf2025-05-06 14:19 1.5M 
[ ]Alkaloida-Chemical-Company-Zrt.pdf2025-05-06 14:19 2.8M 
[ ]Alkaloida-Sweden-AB-1.pdf2025-05-06 14:19 8.3M 
[ ]Alkaloida-Sweden-AB-2.pdf2025-05-06 14:19 387K 
[ ]Alkaloida-Sweden-AB-3.pdf2025-05-06 14:19 3.1M 
[ ]Alkaloida-Sweden-AB.pdf2025-05-06 14:19 2.9M 
[ ]Allotment-of-Equity-Shares-under-SUN-ESOS-2015-–-February-14-2018.pdf2025-05-06 14:19 457K 
[ ]AllotmentofEquityshares.pdf2025-05-06 14:19 457K 
[ ]Allottment-Commitee-Meeting-Outcome-of-Meeting-February-14-2-2017.pdf2025-05-06 14:19 2.2M 
[ ]Allottment-Commitee-Meeting_Outcome-of-Meeting.pdf2025-05-06 14:19 36K 
[ ]AlprazolamJun10.pdf2025-05-06 14:19 22K 
[ ]Announcement-of-a-management-presentation-on-NCE-and-NDDS-March-12-2007.pdf2025-05-06 14:19 24K 
[ ]Announcement.pdf2025-05-06 14:19 44K 
[ ]Annual-Report-1.pdf2025-05-06 14:19 4.6M 
[ ]Annual-Report-2.pdf2025-05-06 14:19 23M 
[ ]Annual-Report-3.pdf2025-05-06 14:19 11M 
[ ]Annual-Report-4.pdf2025-05-06 14:19 3.8M 
[ ]Annual-Report-5.pdf2025-05-06 14:19 7.4M 
[ ]Annual-Report-6.pdf2025-05-06 14:19 13M 
[ ]Annual-Report-7.pdf2025-05-06 14:19 13M 
[ ]Annual-Report-2009.pdf2025-05-06 14:19 4.1M 
[ ]Annual-Report.pdf2025-05-06 14:19 3.8M 
[ ]Annual-Return-MGT-9-1.pdf2025-05-06 14:19 197K 
[ ]Annual-Return-MGT-9.pdf2025-05-06 14:19 794K 
[ ]Apportionment-of-cost-between-SPIL-and-SPARC-May-14-2007.pdf2025-05-06 14:19 41K 
[ ]Approval-Strattera-31-08-10.pdf2025-05-06 14:19 22K 
[ ]Archival-Policy.pdf2025-05-06 14:19 270K 
[IMG]Asia-150x150.png2025-05-06 14:19 15K 
[IMG]Asia-300x274.png2025-05-06 14:19 34K 
[IMG]Asia-400x250.png2025-05-06 14:19 39K 
[IMG]Asia-400x284.png2025-05-06 14:19 44K 
[IMG]Asia-400x439.png2025-05-06 14:19 36K 
[IMG]Asia-481x382.png2025-05-06 14:20 38K 
[IMG]Asia.png2025-05-06 14:19 37K 
[IMG]Australia-150x150.png2025-05-06 14:19 6.7K 
[IMG]Australia.png2025-05-06 14:19 5.2K 
[ ]BIFR-Okays-GLOL-merger-April-08-1999.pdf2025-05-06 14:19 9.7K 
[ ]BMINTIMATION30.05.2016.pdf2025-05-06 14:19 40K 
[ ]BSE-Observation-letter.pdf2025-05-06 14:19 87K 
[IMG]BUSINESS-DEVELOPMENT-1-150x150.jpg2025-05-06 14:19 15K 
[IMG]BUSINESS-DEVELOPMENT-1-300x200.jpg2025-05-06 14:19 21K 
[IMG]BUSINESS-DEVELOPMENT-1-400x250.jpg2025-05-06 14:19 25K 
[IMG]BUSINESS-DEVELOPMENT-1-400x284.jpg2025-05-06 14:19 26K 
[IMG]BUSINESS-DEVELOPMENT-1-400x516.jpg2025-05-06 14:19 33K 
[IMG]BUSINESS-DEVELOPMENT-1-480x320.jpg2025-05-06 14:19 31K 
[IMG]BUSINESS-DEVELOPMENT-1-510x382.jpg2025-05-06 14:19 33K 
[IMG]BUSINESS-DEVELOPMENT-1-768x512.jpg2025-05-06 14:19 50K 
[IMG]BUSINESS-DEVELOPMENT-1-980x654.jpg2025-05-06 14:19 68K 
[IMG]BUSINESS-DEVELOPMENT-1-1024x683.jpg2025-05-06 14:19 72K 
[IMG]BUSINESS-DEVELOPMENT-1-1080x675.jpg2025-05-06 14:19 73K 
[IMG]BUSINESS-DEVELOPMENT-1-1080x721.jpg2025-05-06 14:19 77K 
[IMG]BUSINESS-DEVELOPMENT-1-1280x854.jpg2025-05-06 14:19 96K 
[IMG]BUSINESS-DEVELOPMENT-1-1536x1025.jpg2025-05-06 14:19 123K 
[IMG]BUSINESS-DEVELOPMENT-1.jpg2025-05-06 14:19 432K 
[IMG]BUSINESS-DEVELOPMENT-150x150.jpg2025-05-06 14:19 15K 
[IMG]BUSINESS-DEVELOPMENT-300x200.jpg2025-05-06 14:19 21K 
[IMG]BUSINESS-DEVELOPMENT-400x250.jpg2025-05-06 14:19 25K 
[IMG]BUSINESS-DEVELOPMENT-400x284.jpg2025-05-06 14:19 26K 
[IMG]BUSINESS-DEVELOPMENT-400x516.jpg2025-05-06 14:19 33K 
[IMG]BUSINESS-DEVELOPMENT-480x320.jpg2025-05-06 14:19 31K 
[IMG]BUSINESS-DEVELOPMENT-510x382.jpg2025-05-06 14:19 33K 
[IMG]BUSINESS-DEVELOPMENT-768x512.jpg2025-05-06 14:19 50K 
[IMG]BUSINESS-DEVELOPMENT-980x654.jpg2025-05-06 14:19 68K 
[IMG]BUSINESS-DEVELOPMENT-1024x683.jpg2025-05-06 14:19 72K 
[IMG]BUSINESS-DEVELOPMENT-1080x675.jpg2025-05-06 14:19 73K 
[IMG]BUSINESS-DEVELOPMENT-1080x721.jpg2025-05-06 14:19 77K 
[IMG]BUSINESS-DEVELOPMENT-1280x854.jpg2025-05-06 14:19 96K 
[IMG]BUSINESS-DEVELOPMENT-1536x1025.jpg2025-05-06 14:19 123K 
[IMG]BUSINESS-DEVELOPMENT.jpg2025-05-06 14:19 432K 
[IMG]Banner-150x150.jpg2025-05-06 14:19 4.3K 
[IMG]Banner-300x169.jpg2025-05-06 14:19 7.9K 
[IMG]Banner-400x250.jpg2025-05-06 14:19 15K 
[IMG]Banner-400x284.jpg2025-05-06 14:19 17K 
[IMG]Banner-400x516.jpg2025-05-06 14:19 18K 
[IMG]Banner-480x270.jpg2025-05-06 14:19 17K 
[IMG]Banner-510x382.jpg2025-05-06 14:19 26K 
[IMG]Banner-768x432.jpg2025-05-06 14:19 34K 
[IMG]Banner-980x551.jpg2025-05-06 14:19 49K 
[IMG]Banner-1024x576.jpg2025-05-06 14:19 52K 
[IMG]Banner-1080x608.jpg2025-05-06 14:19 56K 
[IMG]Banner-1080x675.jpg2025-05-06 14:19 64K 
[IMG]Banner-1280x720.jpg2025-05-06 14:19 71K 
[IMG]Banner-1536x864.jpg2025-05-06 14:19 92K 
[IMG]Banner.jpg2025-05-06 14:19 170K 
[ ]Basics-GmbH-1.pdf2025-05-06 14:19 689K 
[ ]Basics-GmbH-2.pdf2025-05-06 14:19 7.4M 
[ ]Basics-GmbH-3.pdf2025-05-06 14:19 20M 
[ ]Basics-GmbH-4.pdf2025-05-06 14:19 1.0M 
[ ]Basics-GmbH-5.pdf2025-05-06 14:19 553K 
[ ]Basics-GmbH.pdf2025-05-06 14:19 553K 
[ ]Be-Tabs-Investments-Proprietary-Limited.pdf2025-05-06 14:19 746K 
[ ]Be-Tabs-Investments-Proprietary-Ltd..pdf2025-05-06 14:19 309K 
[ ]Be-Tabs-Investments-proprietary-Ltd.pdf2025-05-06 14:19 378K 
[ ]Be-tabs-investment-proprietary-limited.pdf2025-05-06 14:19 374K 
[ ]Beratungsnachweisformular.pdf2025-05-06 14:19 340K 
[ ]Bestellformular_Odomzo.pdf2025-05-06 14:19 98K 
[ ]Biosintez-Public-Joint-Stock-Company.pdf2025-05-06 14:19 3.1M 
[ ]Biostudy-volunteer-in-hospital-with-pneumonia-September-10-2002.pdf2025-05-06 14:19 16K 
[ ]Board-Report-and-Management-Discussion-Analysis-1.pdf2025-05-06 14:19 1.8M 
[ ]Board-Report-and-Management-Discussion-Analysis.pdf2025-05-06 14:19 1.9M 
[ ]Board-Report-and-Management-Discussion-_-Analysis.pdf2025-05-06 14:19 1.0M 
[ ]Board-clears-demerger-proposal-February-09-2006.pdf2025-05-06 14:19 193K 
[ ]Board-to-meet-to-consider-merger-of-Pradeep-Drugs.-February-10-2001.pdf2025-05-06 14:19 15K 
[ ]Business-Responsibility-Report-1.pdf2025-05-06 14:19 224K 
[ ]Business-Responsibility-Report-2012-13.pdf2025-05-06 14:19 140K 
[ ]Business-Responsibility-Report-2013-14-1.pdf2025-05-06 14:19 145K 
[ ]Business-Responsibility-Report-2013-14.pdf2025-05-06 14:19 145K 
[ ]Business-Responsibility-Report-2016-17.pdf2025-05-06 14:19 645K 
[ ]Business-Responsibility-Report-FY14-15_0.pdf2025-05-06 14:19 462K 
[ ]Business-Responsibility-Report-FY2017-18.pdf2025-05-06 14:19 146K 
[ ]Business-Responsibility-Report-FY2019-20-1.pdf2025-05-06 14:19 528K 
[ ]Business-Responsibility-Report-FY2019-20.pdf2025-05-06 14:19 528K 
[ ]Business-Responsibility-Report.pdf2025-05-06 14:19 528K 
[ ]Business-Update-Call-Transcript.pdf2025-05-06 14:19 199K 
[ ]Buyback-of-6_-cumulative-redeemable-preference-shares-May-27-2004.pdf2025-05-06 14:19 322K 
[ ]CCM-Voting-Results-1.pdf2025-05-06 14:19 61K 
[ ]CCM-Voting-Results.pdf2025-05-06 14:19 61K 
[ ]CGR-Dec-13.pdf2025-05-06 14:19 28K 
[ ]CGR-June-13.pdf2025-05-06 14:19 29K 
[ ]CGR-June-14.pdf2025-05-06 14:19 263K 
[ ]CGR-March-13.pdf2025-05-06 14:19 177K 
[ ]CGR-March-14.pdf2025-05-06 14:19 269K 
[ ]CGR-Sept-13.pdf2025-05-06 14:19 321K 
[ ]CGR-Sept-14.pdf2025-05-06 14:19 275K 
[ ]CLARIFICATION-Chennai-Plant-August-18-1999.pdf2025-05-06 14:19 14K 
[ ]CLARIFICATION-No-intimation-from-BIFR-September-11-1999.pdf2025-05-06 14:19 6.3K 
[IMG]CRAMS-150x150.jpg2025-05-06 14:19 4.1K 
[IMG]CRAMS-300x201.jpg2025-05-06 14:19 9.0K 
[IMG]CRAMS-400x250.jpg2025-05-06 14:19 13K 
[IMG]CRAMS-400x284.jpg2025-05-06 14:19 14K 
[IMG]CRAMS-400x516.jpg2025-05-06 14:19 19K 
[IMG]CRAMS-480x322.jpg2025-05-06 14:19 18K 
[IMG]CRAMS-510x382.jpg2025-05-06 14:19 20K 
[IMG]CRAMS-768x514.jpg2025-05-06 14:19 35K 
[IMG]CRAMS-980x656.jpg2025-05-06 14:19 50K 
[IMG]CRAMS-1024x686.jpg2025-05-06 14:19 53K 
[IMG]CRAMS-1080x675.jpg2025-05-06 14:19 55K 
[IMG]CRAMS-1080x723.jpg2025-05-06 14:19 57K 
[IMG]CRAMS-1280x857.jpg2025-05-06 14:19 74K 
[IMG]CRAMS-1536x1029.jpg2025-05-06 14:19 97K 
[IMG]CRAMS.jpg2025-05-06 14:19 681K 
[ ]CSR-Policy.pdf2025-05-06 14:19 702K 
[ ]CSR-Report-2018-19.pdf2025-05-06 14:19 3.5M 
[IMG]CSR-page-Malaria-elimination-scaled-1-150x150.jpg2025-05-06 14:19 27K 
[IMG]CSR-page-Malaria-elimination-scaled-1-300x200.jpg2025-05-06 14:19 40K 
[IMG]CSR-page-Malaria-elimination-scaled-1-400x250.jpg2025-05-06 14:19 53K 
[IMG]CSR-page-Malaria-elimination-scaled-1-400x284.jpg2025-05-06 14:19 57K 
[IMG]CSR-page-Malaria-elimination-scaled-1-400x516.jpg2025-05-06 14:19 85K 
[IMG]CSR-page-Malaria-elimination-scaled-1-480x320.jpg2025-05-06 14:19 69K 
[IMG]CSR-page-Malaria-elimination-scaled-1-510x382.jpg2025-05-06 14:19 82K 
[IMG]CSR-page-Malaria-elimination-scaled-1-768x512.jpg2025-05-06 14:19 132K 
[IMG]CSR-page-Malaria-elimination-scaled-1-980x653.jpg2025-05-06 14:19 190K 
[IMG]CSR-page-Malaria-elimination-scaled-1-1024x683.jpg2025-05-06 14:19 202K 
[IMG]CSR-page-Malaria-elimination-scaled-1-1080x675.jpg2025-05-06 14:19 207K 
[IMG]CSR-page-Malaria-elimination-scaled-1-1080x720.jpg2025-05-06 14:19 219K 
[IMG]CSR-page-Malaria-elimination-scaled-1-1280x854.jpg2025-05-06 14:19 282K 
[IMG]CSR-page-Malaria-elimination-scaled-1-1536x1024.jpg2025-05-06 14:19 372K 
[IMG]CSR-page-Malaria-elimination-scaled-1-2048x1366.jpg2025-05-06 14:19 568K 
[IMG]CSR-page-Malaria-elimination-scaled-1.jpg2025-05-06 14:19 833K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-150x150.jpg2025-05-06 14:19 35K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-300x200.jpg2025-05-06 14:19 44K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-400x250.jpg2025-05-06 14:19 52K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-400x284.jpg2025-05-06 14:19 54K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-400x516.jpg2025-05-06 14:19 66K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-480x320.jpg2025-05-06 14:19 61K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-510x382.jpg2025-05-06 14:19 69K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-768x512.jpg2025-05-06 14:19 100K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-980x653.jpg2025-05-06 14:19 135K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-1024x683.jpg2025-05-06 14:19 142K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-1080x675.jpg2025-05-06 14:19 148K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-1080x720.jpg2025-05-06 14:19 152K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-1280x854.jpg2025-05-06 14:19 191K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-1536x1024.jpg2025-05-06 14:19 244K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1-2048x1366.jpg2025-05-06 14:19 363K 
[IMG]CSR-page-Sun-Pharma-Science-Foundation-scaled-1.jpg2025-05-06 14:19 515K 
[IMG]CSR_Education-150x150.jpg2025-05-06 14:19 6.4K 
[IMG]CSR_Education-300x146.jpg2025-05-06 14:19 11K 
[IMG]CSR_Education-400x250.jpg2025-05-06 14:19 22K 
[IMG]CSR_Education-400x284.jpg2025-05-06 14:19 24K 
[IMG]CSR_Education-400x516.jpg2025-05-06 14:19 38K 
[IMG]CSR_Education-480x233.jpg2025-05-06 14:19 25K 
[IMG]CSR_Education-510x382.jpg2025-05-06 14:19 38K 
[IMG]CSR_Education-768x373.jpg2025-05-06 14:19 54K 
[IMG]CSR_Education-980x476.jpg2025-05-06 14:20 82K 
[IMG]CSR_Education-1024x498.jpg2025-05-06 14:19 88K 
[IMG]CSR_Education-1080x525.jpg2025-05-06 14:19 97K 
[IMG]CSR_Education-1080x675.jpg2025-05-06 14:19 118K 
[IMG]CSR_Education-1280x622.jpg2025-05-06 14:19 128K 
[IMG]CSR_Education-1536x747.jpg2025-05-06 14:19 175K 
[IMG]CSR_Education.jpg2025-05-06 14:19 395K 
[IMG]CSR_Healthcare-150x150.jpg2025-05-06 14:19 7.4K 
[IMG]CSR_Healthcare-300x200.jpg2025-05-06 14:19 18K 
[IMG]CSR_Healthcare-400x250.jpg2025-05-06 14:19 28K 
[IMG]CSR_Healthcare-400x284.jpg2025-05-06 14:20 31K 
[IMG]CSR_Healthcare-400x516.jpg2025-05-06 14:19 45K 
[IMG]CSR_Healthcare-480x320.jpg2025-05-06 14:19 39K 
[IMG]CSR_Healthcare-510x382.jpg2025-05-06 14:19 49K 
[IMG]CSR_Healthcare-768x512.jpg2025-05-06 14:19 90K 
[IMG]CSR_Healthcare-980x653.jpg2025-05-06 14:19 140K 
[IMG]CSR_Healthcare-1024x683.jpg2025-05-06 14:19 151K 
[IMG]CSR_Healthcare-1080x675.jpg2025-05-06 14:19 160K 
[IMG]CSR_Healthcare-1080x720.jpg2025-05-06 14:19 166K 
[IMG]CSR_Healthcare-1280x853.jpg2025-05-06 14:19 224K 
[IMG]CSR_Healthcare-1536x1024.jpg2025-05-06 14:19 307K 
[IMG]CSR_Healthcare.jpg2025-05-06 14:19 660K 
[IMG]CSR_Sun-Pharma-Science-Foundation-150x150.jpg2025-05-06 14:19 6.0K 
[IMG]CSR_Sun-Pharma-Science-Foundation-300x200.jpg2025-05-06 14:19 13K 
[IMG]CSR_Sun-Pharma-Science-Foundation-400x250.jpg2025-05-06 14:19 18K 
[IMG]CSR_Sun-Pharma-Science-Foundation-400x284.jpg2025-05-06 14:19 21K 
[IMG]CSR_Sun-Pharma-Science-Foundation-400x516.jpg2025-05-06 14:19 29K 
[IMG]CSR_Sun-Pharma-Science-Foundation-480x320.jpg2025-05-06 14:19 25K 
[IMG]CSR_Sun-Pharma-Science-Foundation-510x382.jpg2025-05-06 14:19 30K 
[IMG]CSR_Sun-Pharma-Science-Foundation-768x512.jpg2025-05-06 14:19 51K 
[IMG]CSR_Sun-Pharma-Science-Foundation-980x654.jpg2025-05-06 14:19 73K 
[IMG]CSR_Sun-Pharma-Science-Foundation-1024x675.jpg2025-05-06 14:19 82K 
[IMG]CSR_Sun-Pharma-Science-Foundation.jpg2025-05-06 14:19 74K 
[ ]Call-Transcript.pdf2025-05-06 14:19 231K 
[ ]Caraco-Pharmaceuticals-Private-Limited-1.pdf2025-05-06 14:19 242K 
[ ]Caraco-Pharmaceuticals-Private-Limited-2.pdf2025-05-06 14:19 4.0M 
[ ]Caraco-Pharmaceuticals-Private-Limited.pdf2025-05-06 14:19 242K 
[IMG]Careers-1-150x150.jpg2025-05-06 14:19 7.8K 
[IMG]Careers-1-300x200.jpg2025-05-06 14:19 18K 
[IMG]Careers-1-400x250.jpg2025-05-06 14:19 27K 
[IMG]Careers-1-400x284.jpg2025-05-06 14:19 29K 
[IMG]Careers-1-400x516.jpg2025-05-06 14:19 42K 
[IMG]Careers-1-480x320.jpg2025-05-06 14:19 37K 
[IMG]Careers-1-510x382.jpg2025-05-06 14:19 43K 
[IMG]Careers-1-768x512.jpg2025-05-06 14:19 75K 
[IMG]Careers-1-980x654.jpg2025-05-06 14:19 112K 
[IMG]Careers-1-1024x683.jpg2025-05-06 14:20 120K 
[IMG]Careers-1-1080x675.jpg2025-05-06 14:19 125K 
[IMG]Careers-1-1080x721.jpg2025-05-06 14:19 130K 
[IMG]Careers-1-1280x854.jpg2025-05-06 14:19 170K 
[IMG]Careers-1-1536x1025.jpg2025-05-06 14:19 227K 
[IMG]Careers-1.jpg2025-05-06 14:19 1.3M 
[IMG]Careers-2-150x150.jpg2025-05-06 14:19 5.0K 
[IMG]Careers-2-300x200.jpg2025-05-06 14:19 9.5K 
[IMG]Careers-2-400x250.jpg2025-05-06 14:19 14K 
[IMG]Careers-2-400x284.jpg2025-05-06 14:19 16K 
[IMG]Careers-2-400x516.jpg2025-05-06 14:19 27K 
[IMG]Careers-2-480x321.jpg2025-05-06 14:19 19K 
[IMG]Careers-2-510x382.jpg2025-05-06 14:19 24K 
[IMG]Careers-2-768x513.jpg2025-05-06 14:19 39K 
[IMG]Careers-2-980x654.jpg2025-05-06 14:19 56K 
[IMG]Careers-2-1024x684.jpg2025-05-06 14:19 61K 
[IMG]Careers-2-1080x675.jpg2025-05-06 14:19 62K 
[IMG]Careers-2-1080x721.jpg2025-05-06 14:19 65K 
[IMG]Careers-2-1280x855.jpg2025-05-06 14:19 86K 
[IMG]Careers-2-1536x1026.jpg2025-05-06 14:20 114K 
[IMG]Careers-2.jpg2025-05-06 14:19 268K 
[IMG]Careers-150x150.jpg2025-05-06 14:19 7.8K 
[IMG]Careers-300x200.jpg2025-05-06 14:19 18K 
[IMG]Careers-400x250.jpg2025-05-06 14:19 27K 
[IMG]Careers-400x284.jpg2025-05-06 14:19 29K 
[IMG]Careers-400x516.jpg2025-05-06 14:19 42K 
[IMG]Careers-480x320.jpg2025-05-06 14:19 37K 
[IMG]Careers-510x382.jpg2025-05-06 14:19 43K 
[IMG]Careers-768x512.jpg2025-05-06 14:19 75K 
[IMG]Careers-980x654.jpg2025-05-06 14:19 112K 
[IMG]Careers-1024x683.jpg2025-05-06 14:19 120K 
[IMG]Careers-1080x675.jpg2025-05-06 14:19 125K 
[IMG]Careers-1080x721.jpg2025-05-06 14:19 130K 
[IMG]Careers-1280x854.jpg2025-05-06 14:19 170K 
[IMG]Careers-1536x1025.jpg2025-05-06 14:20 227K 
[IMG]Careers.jpg2025-05-06 14:19 1.3M 
[ ]Chairman-and-Managing-Director-Speech-at-25th-Annual-General-Meeting-held-on-September-26-2017.pdf2025-05-06 14:19 180K 
[ ]Chairman-speech-at-26th-Annual-General-Meeting-held-on-September-26-2018.pdf2025-05-06 14:19 111K 
[ ]Change-in-Window-Closure-Date-for-trading-by-Designated-Persons.pdf2025-05-06 14:19 32K 
[ ]Clarification-on-news-items-regarding-acquisition-of-HAL-March-09-2004.pdf2025-05-06 14:19 9.0K 
[ ]Clarification-on-recent-media-reports.pdf2025-05-06 14:19 164K 
[ ]Clarification-to-Stock-Exchanges-on-Mohali-facility.pdf2025-05-06 14:19 77K 
[ ]Clarification-to-Stock-Exchanges-on-news-regarding-Halol-facility-1.pdf2025-05-06 14:19 76K 
[ ]Clarification-to-Stock-Exchanges-on-news-regarding-Halol-facility.pdf2025-05-06 14:19 76K 
[ ]ClarificationregardingCCIapproval.pdf2025-05-06 14:19 34K 
[ ]Clause_35_Shareholding_Pattern_Dec312014.pdf2025-05-06 14:19 1.2M 
[ ]Code-of-Conduct-SPIL-as-on-31.03.2012.pdf2025-05-06 14:19 48K 
[ ]Complaint-Report-filed-by-the-Company-to-BSE-Limited-pursuant-to-filing-of-Draft-Scheme-of-Arrangement-for-Amalgamation.pdf2025-05-06 14:19 38K 
[ ]Complaint-Report-filed-by-the-Company-to-BSE-Limited-pursuant-to-filing-of-Draft-Scheme-of-Arrangement.pdf2025-05-06 14:19 232K 
[ ]Complaint-Report-filed-by-the-Company-to-National-Stock-Exchange-of-India-Limited-pursuant-to-filing-of-Draft-Scheme-of-Arrangement.pdf2025-05-06 14:19 234K 
[ ]ComplaintReportNSE.pdf2025-05-06 14:19 38K 
[IMG]Complete-Annual-Report-02-03-150x150.jpg2025-05-06 14:19 4.1K 
[IMG]Complete-Annual-Report-02-03-212x300.jpg2025-05-06 14:19 7.4K 
[IMG]Complete-Annual-Report-02-03-400x250.jpg2025-05-06 14:19 13K 
[IMG]Complete-Annual-Report-02-03-400x284.jpg2025-05-06 14:19 14K 
[IMG]Complete-Annual-Report-02-03-400x516.jpg2025-05-06 14:19 17K 
[IMG]Complete-Annual-Report-02-03-480x680.jpg2025-05-06 14:19 23K 
[IMG]Complete-Annual-Report-02-03-510x382.jpg2025-05-06 14:19 20K 
[IMG]Complete-Annual-Report-02-03-723x1024.jpg2025-05-06 14:19 42K 
[IMG]Complete-Annual-Report-02-03-768x1087.jpg2025-05-06 14:19 45K 
[IMG]Complete-Annual-Report-02-03-980x1387.jpg2025-05-06 14:19 64K 
[IMG]Complete-Annual-Report-02-03-1080x675.jpg2025-05-06 14:19 51K 
[IMG]Complete-Annual-Report-02-03-1080x1529.jpg2025-05-06 14:19 73K 
[IMG]Complete-Annual-Report-02-03-1085x1536.jpg2025-05-06 14:19 74K 
[IMG]Complete-Annual-Report-02-03.jpg2025-05-06 14:19 155K 
[IMG]Complete-Annual-Report-03-04-150x150.jpg2025-05-06 14:19 3.1K 
[IMG]Complete-Annual-Report-03-04-229x300.jpg2025-05-06 14:19 5.4K 
[IMG]Complete-Annual-Report-03-04-400x250.jpg2025-05-06 14:19 8.4K 
[IMG]Complete-Annual-Report-03-04-400x284.jpg2025-05-06 14:19 8.8K 
[IMG]Complete-Annual-Report-03-04-400x516.jpg2025-05-06 14:19 12K 
[IMG]Complete-Annual-Report-03-04-480x628.jpg2025-05-06 14:19 15K 
[IMG]Complete-Annual-Report-03-04-510x382.jpg2025-05-06 14:19 13K 
[IMG]Complete-Annual-Report-03-04-768x1005.jpg2025-05-06 14:19 33K 
[IMG]Complete-Annual-Report-03-04-782x1024.jpg2025-05-06 14:19 34K 
[IMG]Complete-Annual-Report-03-04-980x1283.jpg2025-05-06 14:19 48K 
[IMG]Complete-Annual-Report-03-04-1080x675.jpg2025-05-06 14:19 37K 
[IMG]Complete-Annual-Report-03-04-1080x1414.jpg2025-05-06 14:19 56K 
[IMG]Complete-Annual-Report-03-04-1173x1536.jpg2025-05-06 14:19 63K 
[IMG]Complete-Annual-Report-03-04.jpg2025-05-06 14:19 124K 
[IMG]Complete-Annual-Report-04-05-150x150.jpg2025-05-06 14:19 2.8K 
[IMG]Complete-Annual-Report-04-05-229x300.jpg2025-05-06 14:19 5.1K 
[IMG]Complete-Annual-Report-04-05-400x250.jpg2025-05-06 14:19 8.9K 
[IMG]Complete-Annual-Report-04-05-400x284.jpg2025-05-06 14:19 9.1K 
[IMG]Complete-Annual-Report-04-05-400x516.jpg2025-05-06 14:19 11K 
[IMG]Complete-Annual-Report-04-05-480x629.jpg2025-05-06 14:19 15K 
[IMG]Complete-Annual-Report-04-05-510x382.jpg2025-05-06 14:19 13K 
[IMG]Complete-Annual-Report-04-05-768x1006.jpg2025-05-06 14:20 29K 
[IMG]Complete-Annual-Report-04-05-782x1024.jpg2025-05-06 14:19 30K 
[IMG]Complete-Annual-Report-04-05-980x1283.jpg2025-05-06 14:19 40K 
[IMG]Complete-Annual-Report-04-05-1080x675.jpg2025-05-06 14:19 34K 
[IMG]Complete-Annual-Report-04-05-1080x1414.jpg2025-05-06 14:19 46K 
[IMG]Complete-Annual-Report-04-05-1173x1536.jpg2025-05-06 14:19 53K 
[IMG]Complete-Annual-Report-04-05.jpg2025-05-06 14:19 104K 
[IMG]Complete-Annual-Report-05-06-150x150.jpg2025-05-06 14:19 2.7K 
[IMG]Complete-Annual-Report-05-06-227x300.jpg2025-05-06 14:19 4.8K 
[IMG]Complete-Annual-Report-05-06-400x250.jpg2025-05-06 14:19 8.4K 
[IMG]Complete-Annual-Report-05-06-400x284.jpg2025-05-06 14:19 9.5K 
[IMG]Complete-Annual-Report-05-06-400x516.jpg2025-05-06 14:19 10K 
[IMG]Complete-Annual-Report-05-06-480x633.jpg2025-05-06 14:19 14K 
[IMG]Complete-Annual-Report-05-06-510x382.jpg2025-05-06 14:19 14K 
[IMG]Complete-Annual-Report-05-06-768x1013.jpg2025-05-06 14:19 33K 
[IMG]Complete-Annual-Report-05-06-776x1024.jpg2025-05-06 14:19 33K 
[IMG]Complete-Annual-Report-05-06-980x1293.jpg2025-05-06 14:19 50K 
[IMG]Complete-Annual-Report-05-06-1080x675.jpg2025-05-06 14:19 49K 
[IMG]Complete-Annual-Report-05-06-1080x1425.jpg2025-05-06 14:19 61K 
[IMG]Complete-Annual-Report-05-06-1164x1536.jpg2025-05-06 14:19 72K 
[IMG]Complete-Annual-Report-05-06.jpg2025-05-06 14:19 161K 
[IMG]Complete-Annual-Report-06-07-150x150.jpg2025-05-06 14:19 2.7K 
[IMG]Complete-Annual-Report-06-07-236x300.jpg2025-05-06 14:19 4.8K 
[IMG]Complete-Annual-Report-06-07-400x250.jpg2025-05-06 14:19 7.0K 
[IMG]Complete-Annual-Report-06-07-400x284.jpg2025-05-06 14:19 7.9K 
[IMG]Complete-Annual-Report-06-07-400x516.jpg2025-05-06 14:19 13K 
[IMG]Complete-Annual-Report-06-07-480x609.jpg2025-05-06 14:19 19K 
[IMG]Complete-Annual-Report-06-07-510x382.jpg2025-05-06 14:19 14K 
[IMG]Complete-Annual-Report-06-07-768x974.jpg2025-05-06 14:19 43K 
[IMG]Complete-Annual-Report-06-07-807x1024.jpg2025-05-06 14:19 49K 
[IMG]Complete-Annual-Report-06-07-980x1243.jpg2025-05-06 14:19 73K 
[IMG]Complete-Annual-Report-06-07-1080x675.jpg2025-05-06 14:19 52K 
[IMG]Complete-Annual-Report-06-07-1080x1370.jpg2025-05-06 14:19 90K 
[IMG]Complete-Annual-Report-06-07-1211x1536.jpg2025-05-06 14:19 111K 
[IMG]Complete-Annual-Report-06-07-1280x1624.jpg2025-05-06 14:19 121K 
[IMG]Complete-Annual-Report-06-07-1425x1800.jpg2025-05-06 14:19 161K 
[IMG]Complete-Annual-Report-06-07.jpg2025-05-06 14:19 262K 
[IMG]Complete-Annual-Report-07-08-150x150.jpg2025-05-06 14:19 6.6K 
[IMG]Complete-Annual-Report-07-08-229x300.jpg2025-05-06 14:19 14K 
[IMG]Complete-Annual-Report-07-08-400x250.jpg2025-05-06 14:19 16K 
[IMG]Complete-Annual-Report-07-08-400x284.jpg2025-05-06 14:19 19K 
[IMG]Complete-Annual-Report-07-08-400x516.jpg2025-05-06 14:19 32K 
[IMG]Complete-Annual-Report-07-08-480x629.jpg2025-05-06 14:20 43K 
[IMG]Complete-Annual-Report-07-08-510x382.jpg2025-05-06 14:19 28K 
[IMG]Complete-Annual-Report-07-08-768x1006.jpg2025-05-06 14:19 84K 
[IMG]Complete-Annual-Report-07-08-782x1024.jpg2025-05-06 14:19 87K 
[IMG]Complete-Annual-Report-07-08-980x1284.jpg2025-05-06 14:19 121K 
[IMG]Complete-Annual-Report-07-08-1080x675.jpg2025-05-06 14:19 66K 
[IMG]Complete-Annual-Report-07-08-1080x1415.jpg2025-05-06 14:19 138K 
[IMG]Complete-Annual-Report-07-08-1173x1536.jpg2025-05-06 14:19 156K 
[IMG]Complete-Annual-Report-07-08.jpg2025-05-06 14:19 279K 
[IMG]Complete-Annual-Report-08-09-150x150.jpg2025-05-06 14:19 2.6K 
[IMG]Complete-Annual-Report-08-09-236x300.jpg2025-05-06 14:19 5.1K 
[IMG]Complete-Annual-Report-08-09-400x250.jpg2025-05-06 14:19 7.1K 
[IMG]Complete-Annual-Report-08-09-400x284.jpg2025-05-06 14:19 7.3K 
[IMG]Complete-Annual-Report-08-09-400x516.jpg2025-05-06 14:19 9.8K 
[IMG]Complete-Annual-Report-08-09-480x611.jpg2025-05-06 14:19 12K 
[IMG]Complete-Annual-Report-08-09-510x382.jpg2025-05-06 14:19 9.7K 
[IMG]Complete-Annual-Report-08-09-768x978.jpg2025-05-06 14:19 24K 
[IMG]Complete-Annual-Report-08-09-804x1024.jpg2025-05-06 14:19 25K 
[IMG]Complete-Annual-Report-08-09-980x1248.jpg2025-05-06 14:19 34K 
[IMG]Complete-Annual-Report-08-09-1080x675.jpg2025-05-06 14:19 25K 
[IMG]Complete-Annual-Report-08-09-1080x1375.jpg2025-05-06 14:19 39K 
[IMG]Complete-Annual-Report-08-09-1206x1536.jpg2025-05-06 14:19 45K 
[IMG]Complete-Annual-Report-08-09.jpg2025-05-06 14:19 85K 
[IMG]Complete-Annual-Report-09-10new-150x150.jpg2025-05-06 14:19 3.5K 
[IMG]Complete-Annual-Report-09-10new-238x300.jpg2025-05-06 14:19 6.4K 
[IMG]Complete-Annual-Report-09-10new-400x250.jpg2025-05-06 14:19 9.0K 
[IMG]Complete-Annual-Report-09-10new-400x284.jpg2025-05-06 14:19 9.3K 
[IMG]Complete-Annual-Report-09-10new-400x516.jpg2025-05-06 14:19 13K 
[IMG]Complete-Annual-Report-09-10new-480x606.jpg2025-05-06 14:19 16K 
[IMG]Complete-Annual-Report-09-10new-510x382.jpg2025-05-06 14:19 13K 
[IMG]Complete-Annual-Report-09-10new-768x970.jpg2025-05-06 14:19 33K 
[IMG]Complete-Annual-Report-09-10new-811x1024.jpg2025-05-06 14:19 35K 
[IMG]Complete-Annual-Report-09-10new-980x1238.jpg2025-05-06 14:19 46K 
[IMG]Complete-Annual-Report-09-10new-1080x675.jpg2025-05-06 14:19 35K 
[IMG]Complete-Annual-Report-09-10new-1080x1364.jpg2025-05-06 14:19 53K 
[IMG]Complete-Annual-Report-09-10new-1216x1536.jpg2025-05-06 14:19 63K 
[IMG]Complete-Annual-Report-09-10new.jpg2025-05-06 14:19 106K 
[IMG]Complete-Annual-Report-10-11-1-150x150.jpg2025-05-06 14:19 3.9K 
[IMG]Complete-Annual-Report-10-11-1-231x300.jpg2025-05-06 14:19 11K 
[IMG]Complete-Annual-Report-10-11-1-400x250.jpg2025-05-06 14:19 20K 
[IMG]Complete-Annual-Report-10-11-1-400x284.jpg2025-05-06 14:19 22K 
[IMG]Complete-Annual-Report-10-11-1-400x516.jpg2025-05-06 14:19 36K 
[IMG]Complete-Annual-Report-10-11-1-480x622.jpg2025-05-06 14:19 51K 
[IMG]Complete-Annual-Report-10-11-1-510x382.jpg2025-05-06 14:19 39K 
[IMG]Complete-Annual-Report-10-11-1-768x996.jpg2025-05-06 14:19 130K 
[IMG]Complete-Annual-Report-10-11-1-790x1024.jpg2025-05-06 14:19 137K 
[IMG]Complete-Annual-Report-10-11-1-980x1271.jpg2025-05-06 14:19 198K 
[IMG]Complete-Annual-Report-10-11-1-1080x675.jpg2025-05-06 14:19 143K 
[IMG]Complete-Annual-Report-10-11-1-1080x1400.jpg2025-05-06 14:19 231K 
[IMG]Complete-Annual-Report-10-11-1-1185x1536.jpg2025-05-06 14:19 269K 
[IMG]Complete-Annual-Report-10-11-1.jpg2025-05-06 14:19 532K 
[IMG]Complete-Annual-Report-10-11-150x150.jpg2025-05-06 14:19 3.9K 
[IMG]Complete-Annual-Report-10-11-231x300.jpg2025-05-06 14:19 11K 
[IMG]Complete-Annual-Report-10-11-400x250.jpg2025-05-06 14:19 20K 
[IMG]Complete-Annual-Report-10-11-400x284.jpg2025-05-06 14:19 22K 
[IMG]Complete-Annual-Report-10-11-400x516.jpg2025-05-06 14:20 36K 
[IMG]Complete-Annual-Report-10-11-480x622.jpg2025-05-06 14:19 51K 
[IMG]Complete-Annual-Report-10-11-510x382.jpg2025-05-06 14:19 39K 
[IMG]Complete-Annual-Report-10-11-768x996.jpg2025-05-06 14:19 130K 
[IMG]Complete-Annual-Report-10-11-790x1024.jpg2025-05-06 14:19 137K 
[IMG]Complete-Annual-Report-10-11-980x1271.jpg2025-05-06 14:19 198K 
[IMG]Complete-Annual-Report-10-11-1080x675.jpg2025-05-06 14:19 143K 
[IMG]Complete-Annual-Report-10-11-1080x1400.jpg2025-05-06 14:19 231K 
[IMG]Complete-Annual-Report-10-11-1185x1536.jpg2025-05-06 14:19 269K 
[IMG]Complete-Annual-Report-10-11.jpg2025-05-06 14:19 532K 
[IMG]Complete-Annual-Report-11-132-150x150.jpg2025-05-06 14:19 4.6K 
[IMG]Complete-Annual-Report-11-132-230x300.jpg2025-05-06 14:19 10K 
[IMG]Complete-Annual-Report-11-132-400x250.jpg2025-05-06 14:19 12K 
[IMG]Complete-Annual-Report-11-132-400x284.jpg2025-05-06 14:20 13K 
[IMG]Complete-Annual-Report-11-132-400x516.jpg2025-05-06 14:19 24K 
[IMG]Complete-Annual-Report-11-132-480x625.jpg2025-05-06 14:19 33K 
[IMG]Complete-Annual-Report-11-132-510x382.jpg2025-05-06 14:19 21K 
[IMG]Complete-Annual-Report-11-132-768x1000.jpg2025-05-06 14:19 70K 
[IMG]Complete-Annual-Report-11-132-786x1024.jpg2025-05-06 14:19 73K 
[IMG]Complete-Annual-Report-11-132-980x1277.jpg2025-05-06 14:19 104K 
[IMG]Complete-Annual-Report-11-132-1080x675.jpg2025-05-06 14:19 58K 
[IMG]Complete-Annual-Report-11-132-1080x1407.jpg2025-05-06 14:19 120K 
[IMG]Complete-Annual-Report-11-132-1179x1536.jpg2025-05-06 14:19 137K 
[IMG]Complete-Annual-Report-11-132.jpg2025-05-06 14:19 258K 
[IMG]Complete-Annual-Report-12-13-150x150.jpg2025-05-06 14:19 2.1K 
[IMG]Complete-Annual-Report-12-13-230x300.jpg2025-05-06 14:19 4.2K 
[IMG]Complete-Annual-Report-12-13-400x250.jpg2025-05-06 14:19 5.1K 
[IMG]Complete-Annual-Report-12-13-400x284.jpg2025-05-06 14:19 5.2K 
[IMG]Complete-Annual-Report-12-13-400x516.jpg2025-05-06 14:19 9.9K 
[IMG]Complete-Annual-Report-12-13-480x626.jpg2025-05-06 14:20 13K 
[IMG]Complete-Annual-Report-12-13-510x382.jpg2025-05-06 14:19 7.2K 
[IMG]Complete-Annual-Report-12-13-768x1001.jpg2025-05-06 14:19 26K 
[IMG]Complete-Annual-Report-12-13-786x1024.jpg2025-05-06 14:20 27K 
[IMG]Complete-Annual-Report-12-13-980x1277.jpg2025-05-06 14:19 37K 
[IMG]Complete-Annual-Report-12-13-1080x675.jpg2025-05-06 14:19 20K 
[IMG]Complete-Annual-Report-12-13-1080x1407.jpg2025-05-06 14:19 43K 
[IMG]Complete-Annual-Report-12-13-1179x1536.jpg2025-05-06 14:19 48K 
[IMG]Complete-Annual-Report-12-13.jpg2025-05-06 14:19 98K 
[IMG]Complete-Annual-Report-13-14-150x150.jpg2025-05-06 14:19 2.3K 
[IMG]Complete-Annual-Report-13-14-230x300.jpg2025-05-06 14:19 4.5K 
[IMG]Complete-Annual-Report-13-14-400x250.jpg2025-05-06 14:19 5.3K 
[IMG]Complete-Annual-Report-13-14-400x284.jpg2025-05-06 14:19 5.6K 
[IMG]Complete-Annual-Report-13-14-400x516.jpg2025-05-06 14:19 10K 
[IMG]Complete-Annual-Report-13-14-480x626.jpg2025-05-06 14:19 14K 
[IMG]Complete-Annual-Report-13-14-510x382.jpg2025-05-06 14:19 8.4K 
[IMG]Complete-Annual-Report-13-14-768x1001.jpg2025-05-06 14:19 28K 
[IMG]Complete-Annual-Report-13-14-786x1024.jpg2025-05-06 14:19 29K 
[IMG]Complete-Annual-Report-13-14-980x1277.jpg2025-05-06 14:20 40K 
[IMG]Complete-Annual-Report-13-14-1080x675.jpg2025-05-06 14:19 24K 
[IMG]Complete-Annual-Report-13-14-1080x1407.jpg2025-05-06 14:19 47K 
[IMG]Complete-Annual-Report-13-14-1179x1536.jpg2025-05-06 14:19 53K 
[IMG]Complete-Annual-Report-13-14.jpg2025-05-06 14:19 108K 
[IMG]Complete-Annual-Report-14-15-150x150.jpg2025-05-06 14:19 4.2K 
[IMG]Complete-Annual-Report-14-15-229x300.jpg2025-05-06 14:19 9.1K 
[IMG]Complete-Annual-Report-14-15-400x250.jpg2025-05-06 14:19 12K 
[IMG]Complete-Annual-Report-14-15-400x284.jpg2025-05-06 14:19 13K 
[IMG]Complete-Annual-Report-14-15-400x516.jpg2025-05-06 14:19 21K 
[IMG]Complete-Annual-Report-14-15-480x629.jpg2025-05-06 14:19 27K 
[IMG]Complete-Annual-Report-14-15-510x382.jpg2025-05-06 14:19 20K 
[IMG]Complete-Annual-Report-14-15-768x1006.jpg2025-05-06 14:19 52K 
[IMG]Complete-Annual-Report-14-15-782x1024.jpg2025-05-06 14:19 54K 
[IMG]Complete-Annual-Report-14-15-980x1283.jpg2025-05-06 14:19 74K 
[IMG]Complete-Annual-Report-14-15-1080x675.jpg2025-05-06 14:19 48K 
[IMG]Complete-Annual-Report-14-15-1080x1414.jpg2025-05-06 14:19 84K 
[IMG]Complete-Annual-Report-14-15-1173x1536.jpg2025-05-06 14:19 95K 
[IMG]Complete-Annual-Report-14-15.jpg2025-05-06 14:19 177K 
[ ]Complete-Annual-Report-15-16-1.pdf2025-05-06 14:19 4.1M 
[ ]Complete-Annual-Report-15-16.pdf2025-05-06 14:19 4.1M 
[IMG]Complete-Annual-Report-16-17-150x150.jpg2025-05-06 14:19 5.9K 
[IMG]Complete-Annual-Report-16-17-229x300.jpg2025-05-06 14:19 14K 
[IMG]Complete-Annual-Report-16-17-400x250.jpg2025-05-06 14:19 18K 
[IMG]Complete-Annual-Report-16-17-400x284.jpg2025-05-06 14:19 21K 
[IMG]Complete-Annual-Report-16-17-400x516.jpg2025-05-06 14:19 37K 
[IMG]Complete-Annual-Report-16-17-480x629.jpg2025-05-06 14:19 51K 
[IMG]Complete-Annual-Report-16-17-510x382.jpg2025-05-06 14:19 33K 
[IMG]Complete-Annual-Report-16-17-768x1006.jpg2025-05-06 14:19 108K 
[IMG]Complete-Annual-Report-16-17-782x1024.jpg2025-05-06 14:19 112K 
[IMG]Complete-Annual-Report-16-17-980x1283.jpg2025-05-06 14:19 160K 
[IMG]Complete-Annual-Report-16-17-1080x675.jpg2025-05-06 14:19 88K 
[IMG]Complete-Annual-Report-16-17-1080x1414.jpg2025-05-06 14:19 185K 
[IMG]Complete-Annual-Report-16-17-1173x1536.jpg2025-05-06 14:19 211K 
[IMG]Complete-Annual-Report-16-17.jpg2025-05-06 14:19 401K 
[IMG]Complete-Annual-Report-17-18-150x150.jpg2025-05-06 14:19 4.9K 
[IMG]Complete-Annual-Report-17-18-212x300.jpg2025-05-06 14:19 8.7K 
[IMG]Complete-Annual-Report-17-18-400x250.jpg2025-05-06 14:19 10K 
[IMG]Complete-Annual-Report-17-18-400x284.jpg2025-05-06 14:19 12K 
[IMG]Complete-Annual-Report-17-18-400x516.jpg2025-05-06 14:19 22K 
[IMG]Complete-Annual-Report-17-18-480x679.jpg2025-05-06 14:19 30K 
[IMG]Complete-Annual-Report-17-18-510x382.jpg2025-05-06 14:19 19K 
[IMG]Complete-Annual-Report-17-18-724x1024.jpg2025-05-06 14:19 57K 
[IMG]Complete-Annual-Report-17-18-768x1086.jpg2025-05-06 14:19 62K 
[IMG]Complete-Annual-Report-17-18-980x1385.jpg2025-05-06 14:19 90K 
[IMG]Complete-Annual-Report-17-18-1080x675.jpg2025-05-06 14:19 46K 
[IMG]Complete-Annual-Report-17-18-1080x1527.jpg2025-05-06 14:19 104K 
[IMG]Complete-Annual-Report-17-18-1087x1536.jpg2025-05-06 14:19 104K 
[IMG]Complete-Annual-Report-17-18.jpg2025-05-06 14:19 219K 
[IMG]Complete-Annual-Report-18-19-150x150.jpg2025-05-06 14:19 6.9K 
[IMG]Complete-Annual-Report-18-19-212x300.jpg2025-05-06 14:19 14K 
[IMG]Complete-Annual-Report-18-19-400x250.jpg2025-05-06 14:19 18K 
[IMG]Complete-Annual-Report-18-19-400x284.jpg2025-05-06 14:19 21K 
[IMG]Complete-Annual-Report-18-19-400x516.jpg2025-05-06 14:19 35K 
[IMG]Complete-Annual-Report-18-19-480x679.jpg2025-05-06 14:19 49K 
[IMG]Complete-Annual-Report-18-19-510x382.jpg2025-05-06 14:19 31K 
[IMG]Complete-Annual-Report-18-19-724x1024.jpg2025-05-06 14:19 89K 
[IMG]Complete-Annual-Report-18-19-768x1086.jpg2025-05-06 14:19 97K 
[IMG]Complete-Annual-Report-18-19-980x1385.jpg2025-05-06 14:19 138K 
[IMG]Complete-Annual-Report-18-19-1080x675.jpg2025-05-06 14:19 74K 
[IMG]Complete-Annual-Report-18-19-1080x1527.jpg2025-05-06 14:19 160K 
[IMG]Complete-Annual-Report-18-19-1087x1536.jpg2025-05-06 14:19 161K 
[IMG]Complete-Annual-Report-18-19.jpg2025-05-06 14:19 332K 
[IMG]Complete-Annual-Report-1999-00-150x150.jpg2025-05-06 14:19 3.2K 
[IMG]Complete-Annual-Report-1999-00-234x300.jpg2025-05-06 14:19 7.2K 
[IMG]Complete-Annual-Report-1999-00-400x250.jpg2025-05-06 14:19 11K 
[IMG]Complete-Annual-Report-1999-00-400x284.jpg2025-05-06 14:19 12K 
[IMG]Complete-Annual-Report-1999-00-400x516.jpg2025-05-06 14:19 16K 
[IMG]Complete-Annual-Report-1999-00-480x615.jpg2025-05-06 14:19 21K 
[IMG]Complete-Annual-Report-1999-00-510x382.jpg2025-05-06 14:19 17K 
[IMG]Complete-Annual-Report-1999-00-768x984.jpg2025-05-06 14:19 42K 
[IMG]Complete-Annual-Report-1999-00-799x1024.jpg2025-05-06 14:19 44K 
[IMG]Complete-Annual-Report-1999-00-980x1256.jpg2025-05-06 14:19 59K 
[IMG]Complete-Annual-Report-1999-00-1080x675.jpg2025-05-06 14:19 45K 
[IMG]Complete-Annual-Report-1999-00-1080x1384.jpg2025-05-06 14:19 69K 
[IMG]Complete-Annual-Report-1999-00-1199x1536.jpg2025-05-06 14:19 80K 
[IMG]Complete-Annual-Report-1999-00.jpg2025-05-06 14:19 157K 
[IMG]Complete-Annual-Report-2000-01-150x150.jpg2025-05-06 14:19 5.3K 
[IMG]Complete-Annual-Report-2000-01-230x300.jpg2025-05-06 14:19 11K 
[IMG]Complete-Annual-Report-2000-01-400x250.jpg2025-05-06 14:19 18K 
[IMG]Complete-Annual-Report-2000-01-400x284.jpg2025-05-06 14:19 18K 
[IMG]Complete-Annual-Report-2000-01-400x516.jpg2025-05-06 14:19 24K 
[IMG]Complete-Annual-Report-2000-01-480x626.jpg2025-05-06 14:19 32K 
[IMG]Complete-Annual-Report-2000-01-510x382.jpg2025-05-06 14:19 27K 
[IMG]Complete-Annual-Report-2000-01-768x1002.jpg2025-05-06 14:19 68K 
[IMG]Complete-Annual-Report-2000-01-785x1024.jpg2025-05-06 14:19 70K 
[IMG]Complete-Annual-Report-2000-01-980x1279.jpg2025-05-06 14:19 101K 
[IMG]Complete-Annual-Report-2000-01-1080x675.jpg2025-05-06 14:20 85K 
[IMG]Complete-Annual-Report-2000-01-1080x1409.jpg2025-05-06 14:19 118K 
[IMG]Complete-Annual-Report-2000-01-1177x1536.jpg2025-05-06 14:19 138K 
[IMG]Complete-Annual-Report-2000-01.jpg2025-05-06 14:19 290K 
[ ]Complete-Annual-Report.pdf2025-05-06 14:19 4.7M 
[ ]Completion-of-Buyback-and-Submission-of-Post-Buyback-Public-Announcement.pdf2025-05-06 14:19 3.0M 
[ ]Composite-Scheme-of-Arrangement-1.pdf2025-05-06 14:19 12M 
[ ]ComtanStalevo22610.pdf2025-05-06 14:19 23K 
[ ]Conference-call-Demerger-February-07-2006.pdf2025-05-06 14:19 199K 
[ ]Conference-call-after-the-Q1-results-on-Monday-July-28-July-17-2003-1.pdf2025-05-06 14:19 9.8K 
[ ]Conference-call-after-the-Q1-results-on-Monday-July-28-July-17-2003.pdf2025-05-06 14:19 9.8K 
[ ]Conference-call-after-the-Q1-unaudited-numbers-on-Monday-July-22-July-22-2002.pdf2025-05-06 14:19 12K 
[ ]Conference-call-transcript-innovative-R_D-demerger-February-10-2006.pdf2025-05-06 14:19 334K 
[ ]Consolidated-Financial-Results-1.pdf2025-05-06 14:19 578K 
[ ]Consolidated-Financial-Results-2.pdf2025-05-06 14:19 723K 
[ ]Consolidated-Financial-Results.pdf2025-05-06 14:19 5.2M 
[ ]Consolidated-Scrutinizers-Report-for-the-NCLT-Convened-Meeting-of-Equity-Shareholders.pdf2025-05-06 14:19 259K 
[ ]Corporate-Governance-1.pdf2025-05-06 14:19 275K 
[ ]Corporate-Governance-2.pdf2025-05-06 14:20 312K 
[ ]Corporate-Governance.pdf2025-05-06 14:19 1.2M 
[ ]Correction-Letter-to-the-Letter-to-Stock-Exchange-for-outcome-of-Board-Meeting-May-26-2017.pdf2025-05-06 14:19 46K 
[ ]Corrigendum-to-Public-Announcement-for-Buy-Back-of-Equity-Shares-March-24-2020.pdf2025-05-06 14:19 4.2M 
[ ]Court-convened-meeting…...pdf2025-05-06 14:19 3.1M 
[ ]CoveringletterforNewspaperSubmissionFinal.pdf2025-05-06 14:19 3.5M 
[ ]DISCLOSURE-572.pdf2025-05-06 14:19 34K 
[ ]DMF-approval-for-Metaprolol-tartrate-received-February-14-2003-1.pdf2025-05-06 14:19 11K 
[ ]DMF-approval-for-Metaprolol-tartrate-received-February-14-2003.pdf2025-05-06 14:19 11K 
[ ]Dengue-Factsheet.pdf2025-05-06 14:19 217K 
[ ]Details-of-Independent-Directors-Familiarisation-Programme-1.pdf2025-05-06 14:19 420K 
[ ]Details-of-Independent-Directors-Familiarisation-Programme.pdf2025-05-06 14:19 420K 
[ ]Details-of-Independent-Directors-Familiarization-Program-for-FY-2015-2016.pdf2025-05-06 14:19 231K 
[ ]Details-of-Independent-Directors-Familiarization-Programme-2016-2017.pdf2025-05-06 14:19 37K 
[ ]Details-of-Independent-Directors-Familiarization-Programme-2017-2018.pdf2025-05-06 14:19 34K 
[ ]Disclosure-to-Stock-Exchanges-under-Regulation-30-–-Updates-1.pdf2025-05-06 14:19 811K 
[ ]Disclosure-to-Stock-Exchanges-under-Regulation-30-–-Updates.pdf2025-05-06 14:19 811K 
[ ]Disclosure-under-Regulation-30-of-the-SEBI-Listing-Obligations-and-Disclosure-Requirements-Regulations-2015-1.pdf2025-05-06 14:19 514K 
[ ]Disclosure-under-Regulation-30-of-the-SEBI-Listing-Obligations-and-Disclosure-Requirements-Regulations-2015.pdf2025-05-06 14:19 99K 
[ ]Dividend-Distribution-Policy.pdf2025-05-06 14:19 63K 
[ ]Dividend-Waiver-Form_2018-19.pdf2025-05-06 14:19 193K 
[ ]Documents-filed-under-clause-24......pdf2025-05-06 14:19 6.6M 
[ ]Download-complete-annual-report2.94MB.pdf2025-05-06 14:19 2.9M 
[ ]Draft-Scheme-of-Amalgamation-_-other-documents.pdf2025-05-06 14:19 1.2M 
[ ]EGM-clears-resolutions-for-split-buyback-December-20-2002.pdf2025-05-06 14:19 18K 
[ ]EMPLOYEES-STOCK-OPTION-SCHEME-Disclosure-under-SEBI-Share-Based-Employee-BenefitsRegulations2014-as-on-Mar-312020.pdf2025-05-06 14:19 539K 
[ ]EMPLOYEES-STOCK-OPTION-SCHEMES-–-Disclosure-under-SEBI-Share-Based-Employee-Benefits-Regulations-2014-as-on-March-31-2018.pdf2025-05-06 14:19 554K 
[ ]EMPLOYEES-STOCK-OPTION-SCHEMES-Disclosure-under-SEBI-Share-Based-Employee-Benefits-Regulations-2014-as-on-March-31-2019.pdf2025-05-06 14:19 541K 
[IMG]EPS-150x150.png2025-05-06 14:19 3.4K 
[IMG]EPS-300x218.png2025-05-06 14:19 6.5K 
[IMG]EPS-400x250.png2025-05-06 14:19 2.4K 
[IMG]EPS-400x284.png2025-05-06 14:19 4.0K 
[IMG]EPS-400x516.png2025-05-06 14:19 13K 
[IMG]EPS-480x349.png2025-05-06 14:19 11K 
[IMG]EPS-510x382.png2025-05-06 14:19 13K 
[IMG]EPS-768x558.png2025-05-06 14:19 21K 
[IMG]EPS-980x712.png2025-05-06 14:19 27K 
[IMG]EPS-1024x744.png2025-05-06 14:19 29K 
[IMG]EPS-1080x675.png2025-05-06 14:19 7.6K 
[IMG]EPS-1080x785.png2025-05-06 14:20 32K 
[IMG]EPS-1280x930.png2025-05-06 14:19 39K 
[IMG]EPS.png2025-05-06 14:19 14K 
[ ]ESOS-Disclosure-under-SEBI-SBEB-Regulations-2014-as-on-March-31-2017.pdf2025-05-06 14:19 349K 
[ ]Earnings-Call-Transcript-1.pdf2025-05-06 14:19 199K 
[ ]Earnings-Call-Transcript-2.pdf2025-05-06 14:19 203K 
[ ]Earnings-Call-Transcript-3.pdf2025-05-06 14:19 215K 
[ ]Earnings-Call-Transcript-4.pdf2025-05-06 14:19 181K 
[ ]Earnings-Call-Transcript-5.pdf2025-05-06 14:19 171K 
[ ]Earnings-Call-Transcript-6.pdf2025-05-06 14:19 186K 
[ ]Earnings-Call-Transcript-7.pdf2025-05-06 14:19 184K 
[ ]Earnings-Call-Transcript-8.pdf2025-05-06 14:19 197K 
[ ]Earnings-Call-Transcript-9.pdf2025-05-06 14:19 175K 
[ ]Earnings-Call-Transcript-10.pdf2025-05-06 14:19 187K 
[ ]Earnings-Call-Transcript-11.pdf2025-05-06 14:19 205K 
[ ]Earnings-Call-Transcript-12.pdf2025-05-06 14:19 197K 
[ ]Earnings-Call-Transcript-13.pdf2025-05-06 14:19 190K 
[ ]Earnings-Call-Transcript-14.pdf2025-05-06 14:19 182K 
[ ]Earnings-Call-Transcript-15.pdf2025-05-06 14:19 189K 
[ ]Earnings-Call-Transcript-16.pdf2025-05-06 14:19 189K 
[ ]Earnings-Call-Transcript-17.pdf2025-05-06 14:19 201K 
[ ]Earnings-Call-Transcript-18.pdf2025-05-06 14:19 189K 
[ ]Earnings-Call-Transcript-19.pdf2025-05-06 14:19 201K 
[ ]Earnings-Call-Transcript-20.pdf2025-05-06 14:19 176K 
[ ]Earnings-Call-Transcript-21.pdf2025-05-06 14:19 168K 
[ ]Earnings-Call-Transcript-22.pdf2025-05-06 14:19 95K 
[ ]Earnings-Call-Transcript-23.pdf2025-05-06 14:19 209K 
[ ]Earnings-Call-Transcript-24.pdf2025-05-06 14:19 190K 
[ ]Earnings-Call-Transcript-25.pdf2025-05-06 14:19 94K 
[ ]Earnings-Call-Transcript-26.pdf2025-05-06 14:19 85K 
[ ]Earnings-Call-Transcript-27.pdf2025-05-06 14:19 71K 
[ ]Earnings-Call-Transcript-28.pdf2025-05-06 14:19 84K 
[ ]Earnings-Call-Transcript-29.pdf2025-05-06 14:20 76K 
[ ]Earnings-Call-Transcript-30.pdf2025-05-06 14:19 137K 
[ ]Earnings-Call-Transcript-31.pdf2025-05-06 14:19 109K 
[ ]Earnings-Call-Transcript-32.pdf2025-05-06 14:19 109K 
[ ]Earnings-Call-Transcript-33.pdf2025-05-06 14:19 108K 
[ ]Earnings-Call-Transcript-34.pdf2025-05-06 14:19 118K 
[ ]Earnings-Call-Transcript-35.pdf2025-05-06 14:19 128K 
[ ]Earnings-Call-Transcript-36.pdf2025-05-06 14:19 104K 
[ ]Earnings-Call-Transcript-37.pdf2025-05-06 14:19 102K 
[ ]Earnings-Call-Transcript-38.pdf2025-05-06 14:19 82K 
[ ]Earnings-Call-Transcript-39.pdf2025-05-06 14:19 100K 
[ ]Earnings-Call-Transcript-40.pdf2025-05-06 14:19 94K 
[ ]Earnings-Call-Transcript-41.pdf2025-05-06 14:19 96K 
[ ]Earnings-Call-Transcript-42.pdf2025-05-06 14:19 39K 
[ ]Earnings-Call-Transcript-43.pdf2025-05-06 14:19 127K 
[ ]Earnings-Call-Transcript-44.pdf2025-05-06 14:19 103K 
[ ]Earnings-Call-Transcript-45.pdf2025-05-06 14:19 123K 
[ ]Earnings-Call-Transcript-46.pdf2025-05-06 14:19 127K 
[ ]Earnings-Call-Transcript-47.pdf2025-05-06 14:19 112K 
[ ]Earnings-Call-Transcript-48.pdf2025-05-06 14:19 132K 
[ ]Earnings-Call-Transcript-49.pdf2025-05-06 14:19 95K 
[ ]Earnings-Call-Transcript-50.pdf2025-05-06 14:19 144K 
[ ]Earnings-Call-Transcript-51.pdf2025-05-06 14:19 124K 
[ ]Earnings-Call-Transcript-52.pdf2025-05-06 14:19 107K 
[ ]Earnings-Call-Transcript-53.pdf2025-05-06 14:19 77K 
[ ]Earnings-Call-Transcript-54.pdf2025-05-06 14:19 168K 
[ ]Earnings-Call-Transcript-55.pdf2025-05-06 14:19 168K 
[ ]Earnings-Call-Transcript-56.pdf2025-05-06 14:19 234K 
[ ]Earnings-Call-Transcript-57.pdf2025-05-06 14:19 272K 
[ ]Earnings-Call-Transcript-58.pdf2025-05-06 14:19 276K 
[ ]Earnings-Call-Transcript-59.pdf2025-05-06 14:19 76K 
[ ]Earnings-Call-Transcript-60.pdf2025-05-06 14:19 69K 
[ ]Earnings-Call-Transcript-61.pdf2025-05-06 14:19 71K 
[ ]Earnings-Call-Transcript-62.pdf2025-05-06 14:19 90K 
[ ]Earnings-Call-Transcript-63.pdf2025-05-06 14:19 50K 
[ ]Earnings-Call-Transcript-64.pdf2025-05-06 14:19 73K 
[ ]Earnings-Call-Transcript-65.pdf2025-05-06 14:19 59K 
[ ]Earnings-Call-Transcript-66.pdf2025-05-06 14:19 76K 
[ ]Earnings-Call-Transcript-67.pdf2025-05-06 14:19 71K 
[ ]Earnings-Call-Transcript-68.pdf2025-05-06 14:19 65K 
[ ]Earnings-Call-Transcript.pdf2025-05-06 14:19 172K 
[ ]Earnings-conference-call-April-23-2002.pdf2025-05-06 14:19 9.2K 
[ ]EloxatinJune10.pdf2025-05-06 14:19 22K 
[ ]Endorsements.pdf2025-05-06 14:19 303K 
[ ]Enhancing-Presence-in-Digestive-Care-PDF.pdf2025-05-06 14:19 442K 
[IMG]Environment-150x150.jpg2025-05-06 14:19 8.0K 
[IMG]Environment-300x225.jpg2025-05-06 14:19 20K 
[IMG]Environment-400x250.jpg2025-05-06 14:19 27K 
[IMG]Environment-400x284.jpg2025-05-06 14:19 31K 
[IMG]Environment-400x516.jpg2025-05-06 14:19 51K 
[IMG]Environment-480x360.jpg2025-05-06 14:19 45K 
[IMG]Environment-510x382.jpg2025-05-06 14:19 50K 
[IMG]Environment-768x576.jpg2025-05-06 14:19 100K 
[IMG]Environment-980x735.jpg2025-05-06 14:19 155K 
[IMG]Environment-1024x768.jpg2025-05-06 14:19 167K 
[IMG]Environment-1080x675.jpg2025-05-06 14:19 153K 
[IMG]Environment-1080x810.jpg2025-05-06 14:19 186K 
[IMG]Environment-1280x960.jpg2025-05-06 14:19 245K 
[IMG]Environment-1536x1152.jpg2025-05-06 14:19 333K 
[IMG]Environment.jpg2025-05-06 14:19 315K 
[ ]Erinnerungskarte_Fachkreise_Odomzo.pdf2025-05-06 14:19 308K 
[ ]Erinnerungskarte_Patient_Odomzo-1.pdf2025-05-06 14:19 121K 
[ ]Erinnerungskarte_Patient_Odomzo.pdf2025-05-06 14:19 121K 
[IMG]Europe-150x150.png2025-05-06 14:19 14K 
[IMG]Europe.png2025-05-06 14:20 12K 
[ ]Extract_state_register-LLC-Ranbaxy_Pharmaceuticals-Ukraine.pdf2025-05-06 14:19 503K 
[ ]FACTSHEET.pdf2025-05-06 14:19 358K 
[ ]FDEC-Press-Release.pdf2025-05-06 14:19 481K 
[ ]FY13-Q4-Earnings-Call-Transcript.pdf2025-05-06 14:19 75K 
[ ]FY14-Q1-Press-Release-Financial.pdf2025-05-06 14:19 43K 
[ ]FY14-Q2-Earnings-Call-Transcript1.pdf2025-05-06 14:19 194K 
[ ]FY14-Q3-Earnings-Call-Transcript.pdf2025-05-06 14:19 96K 
[ ]FY15-Q1-Earnings-Call-Transcript1-1.pdf2025-05-06 14:19 193K 
[ ]FY15-Q3-Earnings-Call-Transcript.pdf2025-05-06 14:19 170K 
[ ]FY16-Q1-Earnings-Call-Transcript.pdf2025-05-06 14:19 208K 
[ ]FY16-Q2-Earnings-Call-Transcript.pdf2025-05-06 14:19 192K 
[ ]FY16-Q3-Earnings-Call-Transcript.pdf2025-05-06 14:19 185K 
[ ]FY16-Q4-Earnings-Call-Transcript.pdf2025-05-06 14:19 200K 
[ ]FY17-Q1-Earnings-Call-Transcript.pdf2025-05-06 14:19 187K 
[ ]FY17-Q2-Earnings-Call-Transcript.pdf2025-05-06 14:20 178K 
[ ]FY17-Q3-Earnings-Call-Transcript.pdf2025-05-06 14:19 190K 
[ ]FY17-Q4-Earnings-Call-Transcript.pdf2025-05-06 14:19 209K 
[ ]FY18-Q1-Earnings-Call-Transcript.pdf2025-05-06 14:19 218K 
[ ]FY18-Q2-Earnings-Call-Transcript.pdf2025-05-06 14:19 174K 
[ ]FY18-Q4-Earnings-Call-Transcript.pdf2025-05-06 14:19 184K 
[ ]FY19-Investor-update-Call-Transcript-03-Dec-18.pdf2025-05-06 14:19 170K 
[ ]FY19-Q1-Earnings-Call-Transcript.pdf2025-05-06 14:19 174K 
[ ]FY19-Q2-Earnings-Call-Transcript.pdf2025-05-06 14:19 202K 
[ ]FY19-Q3-Earnings-Call-Transcript.pdf2025-05-06 14:19 203K 
[ ]FY20-Q1-Earnings-Call-Transcript-1.pdf2025-05-06 14:19 195K 
[ ]FY20-Q1-Earnings-Call-Transcript.pdf2025-05-06 14:20 195K 
[ ]FY20-Q2-Earnings-Call-Transcript-1.pdf2025-05-06 14:20 224K 
[ ]FY20-Q2-Earnings-Call-Transcript.pdf2025-05-06 14:19 224K 
[ ]FY20-Q3-Earnings-Call-Transcript-1.pdf2025-05-06 14:19 257K 
[ ]FY20-Q3-Earnings-Call-Transcript-2.pdf2025-05-06 14:19 257K 
[ ]FY20-Q3-Earnings-Call-Transcript.pdf2025-05-06 14:19 257K 
[ ]FY20-Q4-Earnings-Call-Transcript-1.pdf2025-05-06 14:19 208K 
[ ]FY20-Q4-Earnings-Call-Transcript.pdf2025-05-06 14:19 208K 
[ ]FY21-Q1-Earnings-Call-Transcript-1.pdf2025-05-06 14:19 207K 
[ ]FY21-Q1-Earnings-Call-Transcript-2.pdf2025-05-06 14:19 207K 
[ ]FY21-Q1-Earnings-Call-Transcript.pdf2025-05-06 14:19 207K 
[ ]Fact-Sheet.pdf2025-05-06 14:19 38K 
[ ]Fair-Code-of-Disclosure.pdf2025-05-06 14:19 13K 
[ ]Fair_Code_of_Disclosures_SPIL.pdf2025-05-06 14:19 237K 
[ ]Faststone-Mercantile-Company-Private-Limited-1.pdf2025-05-06 14:19 280K 
[ ]Faststone-Mercantile-Company-Private-Limited-2.pdf2025-05-06 14:19 1.1M 
[ ]Faststone-Mercantile-Company-Private-Limited-3.pdf2025-05-06 14:19 456K 
[ ]Faststone-Mercantile-Company-Private-Limited-4.pdf2025-05-06 14:19 115K 
[ ]Faststone-Mercantile-Company-Private-Limited-5.pdf2025-05-06 14:19 1.0M 
[ ]Faststone-Mercantile-Company-Private-Limited.pdf2025-05-06 14:19 1.0M 
[ ]Faststone-Mercentile-Company-Private-Limited.pdf2025-05-06 14:19 4.9M 
[ ]Finance-Report-2019.pdf2025-05-06 14:19 4.7M 
[ ]Financial-Results-for-the-Half-Year-ended-30.09.2018.pdf2025-05-06 14:19 1.3M 
[ ]Financial-Results-for-the-half-year-and-year-ended-31.03.2016.pdf2025-05-06 14:19 200K 
[ ]Financial-Results-for-the-half-year-and-year-ended-on-31.03.2018.pdf2025-05-06 14:19 1.5M 
[ ]Financial-Results-for-the-half-year-ended-30.09.2016.pdf2025-05-06 14:19 97K 
[ ]Financial-Results-for-the-half-year-ended-on-30.09.2017.pdf2025-05-06 14:19 1.0M 
[ ]Financial-results-for-the-half-year-and-year-ended-31.03.2017.pdf2025-05-06 14:19 368K 
[ ]Financial-statements-31.03.2020-ENG-semnate.pdf2025-05-06 14:19 2.3M 
[ ]Financials-1.pdf2025-05-06 14:19 41K 
[ ]Financials-1.xls2025-05-06 14:19 465K 
[ ]Financials-1.xlsx2025-05-06 14:19 1.6M 
[ ]Financials-2.pdf2025-05-06 14:19 42K 
[ ]Financials-2.xls2025-05-06 14:19 460K 
[ ]Financials-2.xlsx2025-05-06 14:19 1.6M 
[ ]Financials-3.pdf2025-05-06 14:19 22K 
[ ]Financials-3.xls2025-05-06 14:19 488K 
[ ]Financials-3.xlsx2025-05-06 14:19 1.7M 
[ ]Financials-4.pdf2025-05-06 14:19 24K 
[ ]Financials-4.xls2025-05-06 14:19 468K 
[ ]Financials-4.xlsx2025-05-06 14:19 1.6M 
[ ]Financials-5.pdf2025-05-06 14:19 19K 
[ ]Financials-5.xls2025-05-06 14:19 188K 
[ ]Financials-5.xlsx2025-05-06 14:19 407K 
[ ]Financials-6.pdf2025-05-06 14:19 16K 
[ ]Financials-6.xls2025-05-06 14:19 166K 
[ ]Financials-6.xlsx2025-05-06 14:19 1.7M 
[ ]Financials-7.pdf2025-05-06 14:19 13K 
[ ]Financials-7.xls2025-05-06 14:19 183K 
[ ]Financials-7.xlsx2025-05-06 14:19 414K 
[ ]Financials-8.pdf2025-05-06 14:19 17K 
[ ]Financials-8.xls2025-05-06 14:19 182K 
[ ]Financials-8.xlsx2025-05-06 14:19 410K 
[ ]Financials-9.pdf2025-05-06 14:19 16K 
[ ]Financials-9.xls2025-05-06 14:19 74K 
[ ]Financials-9.xlsx2025-05-06 14:19 1.5M 
[ ]Financials-10.pdf2025-05-06 14:19 16K 
[ ]Financials-10.xls2025-05-06 14:19 52K 
[ ]Financials-10.xlsx2025-05-06 14:19 1.6M 
[ ]Financials-11.pdf2025-05-06 14:19 14K 
[ ]Financials-11.xls2025-05-06 14:19 110K 
[ ]Financials-11.xlsx2025-05-06 14:19 45K 
[ ]Financials-12.pdf2025-05-06 14:19 15K 
[ ]Financials-12.xls2025-05-06 14:19 81K 
[ ]Financials-12.xlsx2025-05-06 14:19 1.5M 
[ ]Financials-13.pdf2025-05-06 14:19 16K 
[ ]Financials-13.xls2025-05-06 14:19 115K 
[ ]Financials-13.xlsx2025-05-06 14:19 40K 
[ ]Financials-14.pdf2025-05-06 14:19 12K 
[ ]Financials-14.xls2025-05-06 14:19 121K 
[ ]Financials-14.xlsx2025-05-06 14:19 40K 
[ ]Financials-15.pdf2025-05-06 14:19 12K 
[ ]Financials-15.xls2025-05-06 14:19 103K 
[ ]Financials-15.xlsx2025-05-06 14:20 1.3M 
[ ]Financials-16.xls2025-05-06 14:19 99K 
[ ]Financials-16.xlsx2025-05-06 14:19 174K 
[ ]Financials-17.xls2025-05-06 14:19 56K 
[ ]Financials-17.xlsx2025-05-06 14:19 171K 
[ ]Financials-18.xls2025-05-06 14:19 42K 
[ ]Financials-18.xlsx2025-05-06 14:19 50K 
[ ]Financials-19.xls2025-05-06 14:19 97K 
[ ]Financials-19.xlsx2025-05-06 14:19 289K 
[ ]Financials-20.xls2025-05-06 14:19 101K 
[ ]Financials-20.xlsx2025-05-06 14:19 177K 
[ ]Financials-21.xls2025-05-06 14:19 78K 
[ ]Financials-22.xls2025-05-06 14:19 40K 
[ ]Financials-23.xls2025-05-06 14:19 54K 
[ ]Financials-24.xls2025-05-06 14:19 59K 
[ ]Financials-25.xls2025-05-06 14:19 53K 
[ ]Financials-26.xls2025-05-06 14:19 48K 
[ ]Financials-27.xls2025-05-06 14:19 48K 
[ ]Financials-28.xls2025-05-06 14:19 48K 
[ ]Financials-29.xls2025-05-06 14:19 47K 
[ ]Financials-30.xls2025-05-06 14:19 45K 
[ ]Financials-31.xls2025-05-06 14:19 53K 
[ ]Financials-32.xls2025-05-06 14:19 65K 
[ ]Financials-33.xls2025-05-06 14:19 72K 
[ ]Financials.pdf2025-05-06 14:19 68K 
[ ]Financials.xls2025-05-06 14:19 420K 
[ ]Financials.xlsx2025-05-06 14:19 1.6M 
[ ]Financials27052020FINAL.pdf2025-05-06 14:19 3.7M 
[ ]Fire-in-Unit-1-at-Panoli-August-06-2004.pdf2025-05-06 14:19 11K 
[ ]Fire-put-out-at-Sun-PharmaA¢a‚¬a„¢s-corporate-offices-June-21-2004.pdf2025-05-06 14:19 9.3K 
[ ]Form-IV-1.pdf2025-05-06 14:19 62K 
[ ]Form-IV-2.pdf2025-05-06 14:19 62K 
[ ]Form-IV.pdf2025-05-06 14:19 62K 
[ ]Form-IV1.pdf2025-05-06 14:19 62K 
[ ]Form-for-waiver-forgoing-of-right-to-receive-Dividend-for-the-financial-year-ended-March-31-2017.pdf2025-05-06 14:19 33K 
[ ]Form-for-waiver-forgoing-right-to-receice-Dividend-for-financial-year-ended-31032016-final.pdf2025-05-06 14:19 197K 
[ ]Form-for-waiver-forgoing-right-to-receice-Dividend-for-financial-year-ended-31032018.pdf2025-05-06 14:20 25K 
[ ]Form-for-waiver-forgoing-right-to-receive-Dividend-for-Y.E.31-03-14-1.pdf2025-05-06 14:19 60K 
[ ]Form-for-waiver-forgoing-right-to-receive-Dividend-for-Y.E.31-03-14.pdf2025-05-06 14:19 60K 
[ ]Form-for-waiver-forgoing-right-to-receive-Dividend-for-year-end-31-03-15.pdf2025-05-06 14:19 225K 
[ ]Form-for-waiver-forgoing-right-to-receive-Final-Dividend-for-financial-year-2019-2020_Final.pdf2025-05-06 14:19 194K 
[ ]Generic-Eloxatin®-and-Imitrex®-approval-shares-180-day-marketing-drug-exclusivity-for-generic-Eloxatin®.pdf2025-05-06 14:19 23K 
[ ]Global-Code-of-Conduct.pdf2025-05-06 14:19 1.0M 
[ ]Global-Whistle-Blower-Policy-27092018.pdf2025-05-06 14:19 103K 
[ ]Green-Eco-Development-Centre-Limited-1.pdf2025-05-06 14:19 4.0M 
[ ]Green-Eco-Development-Centre-Limited-2.pdf2025-05-06 14:19 2.7M 
[ ]Green-Eco-Development-Centre-Limited-3.pdf2025-05-06 14:19 404K 
[ ]Green-Eco-Development-Centre-Limited-4.pdf2025-05-06 14:19 341K 
[ ]Green-Eco-Development-Centre-Limited.pdf2025-05-06 14:19 3.0M 
[ ]Green-Eco-Development-Centre-Ltd.-1.pdf2025-05-06 14:20 246K 
[ ]Green-Eco-Development-Centre-Ltd..pdf2025-05-06 14:19 246K 
[ ]Gufic-Pharma-Limited-1.pdf2025-05-06 14:19 494K 
[ ]Gufic-Pharma-Limited-2.pdf2025-05-06 14:19 442K 
[ ]Gufic-Pharma-Limited.pdf2025-05-06 14:19 3.7M 
[ ]Hasmukh-Shah-joins-Sun-Pharma-board-March-23-2001.pdf2025-05-06 14:19 9.8K 
[ ]High-Court-of-Punjab-_-Haryana-Approval.pdf2025-05-06 14:19 232K 
[IMG]Homepage_Banner-image-e1566999673967-150x150.jpg2025-05-06 14:19 5.3K 
[IMG]Homepage_Banner-image-e1566999673967-300x158.jpg2025-05-06 14:19 8.1K 
[IMG]Homepage_Banner-image-e1566999673967-400x250.jpg2025-05-06 14:19 15K 
[IMG]Homepage_Banner-image-e1566999673967-400x284.jpg2025-05-06 14:19 17K 
[IMG]Homepage_Banner-image-e1566999673967-400x516.jpg2025-05-06 14:19 33K 
[IMG]Homepage_Banner-image-e1566999673967-480x253.jpg2025-05-06 14:19 17K 
[IMG]Homepage_Banner-image-e1566999673967-510x382.jpg2025-05-06 14:19 26K 
[IMG]Homepage_Banner-image-e1566999673967-768x405.jpg2025-05-06 14:19 35K 
[IMG]Homepage_Banner-image-e1566999673967-980x517.jpg2025-05-06 14:19 53K 
[IMG]Homepage_Banner-image-e1566999673967-1024x540.jpg2025-05-06 14:19 57K 
[IMG]Homepage_Banner-image-e1566999673967-1080x569.jpg2025-05-06 14:19 62K 
[IMG]Homepage_Banner-image-e1566999673967-1080x675.jpg2025-05-06 14:19 74K 
[IMG]Homepage_Banner-image-e1566999673967-1280x675.jpg2025-05-06 14:19 82K 
[IMG]Homepage_Banner-image-e1566999673967-1536x810.jpg2025-05-06 14:19 110K 
[IMG]Homepage_Banner-image-e1566999673967.jpg2025-05-06 14:19 194K 
[IMG]Homepage_Innovation-768x514-1-150x150.jpg2025-05-06 14:19 4.9K 
[IMG]Homepage_Innovation-768x514-1-300x201.jpg2025-05-06 14:19 10K 
[IMG]Homepage_Innovation-768x514-1-400x250.jpg2025-05-06 14:19 14K 
[IMG]Homepage_Innovation-768x514-1-400x284.jpg2025-05-06 14:19 16K 
[IMG]Homepage_Innovation-768x514-1-400x514.jpg2025-05-06 14:19 22K 
[IMG]Homepage_Innovation-768x514-1-480x321.jpg2025-05-06 14:19 20K 
[IMG]Homepage_Innovation-768x514-1-510x382.jpg2025-05-06 14:19 23K 
[IMG]Homepage_Innovation-768x514-1.jpg2025-05-06 14:20 50K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-150x150.jpg2025-05-06 14:19 7.1K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-300x194.jpg2025-05-06 14:19 16K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-400x250.jpg2025-05-06 14:19 24K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-400x284.jpg2025-05-06 14:19 27K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-400x516.jpg2025-05-06 14:19 46K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-480x310.jpg2025-05-06 14:20 34K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-510x382.jpg2025-05-06 14:19 43K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-768x495.jpg2025-05-06 14:19 76K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-980x632.jpg2025-05-06 14:19 117K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-1024x660.jpg2025-05-06 14:19 126K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-1080x675.jpg2025-05-06 14:19 136K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-1080x697.jpg2025-05-06 14:19 139K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-1280x826.jpg2025-05-06 14:19 185K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities-1536x991.jpg2025-05-06 14:19 249K 
[IMG]Homepage_Sustainable-_-Holistic-Development-Of-Underserved-Communities.jpg2025-05-06 14:19 522K 
[ ]ICGEB-Media-Invite.pdf2025-05-06 14:19 342K 
[ ]ILUMYA-US-Medication-Guide.pdf2025-05-06 14:19 84K 
[ ]ILUMYA-US-Prescribing-Information.pdf2025-05-06 14:19 399K 
[ ]INVESTOR-GRIEVANCE-REPORT.pdf2025-05-06 14:19 20K 
[ ]IR-Presentation-2013.pdf2025-05-06 14:19 2.5M 
[ ]IR-Presentation-August-2019-USD.pdf2025-05-06 14:19 3.7M 
[ ]IR-Presentation-August-2019.pdf2025-05-06 14:19 3.7M 
[ ]IR-Presentation-August-2020-USD.pdf2025-05-06 14:19 3.4M 
[ ]IR-Presentation-August-2020.pdf2025-05-06 14:19 3.4M 
[ ]IR-Presentation-Feb-2020-USD.pdf2025-05-06 14:19 3.7M 
[ ]IR-Presentation-Feb-2020.pdf2025-05-06 14:19 3.7M 
[ ]IR-Presentation-March-2015.pdf2025-05-06 14:19 3.1M 
[ ]IR-Presentation-May-2019-USD.pdf2025-05-06 14:19 3.7M 
[ ]IR-Presentation-May-2019.pdf2025-05-06 14:19 3.7M 
[ ]IR-Presentation-May-2020-USD.pdf2025-05-06 14:19 3.4M 
[ ]IR-Presentation-May-2020.pdf2025-05-06 14:19 3.4M 
[ ]IR-Presentation-Nov-2019.pdf2025-05-06 14:19 3.7M 
[ ]Informationsbroschre_Patient_Odomzo-1.pdf2025-05-06 14:19 177K 
[ ]Informationsbroschre_Patient_Odomzo.pdf2025-05-06 14:19 177K 
[ ]Informationsbroschuere_Fachkreise_Odomzo.pdf2025-05-06 14:19 880K 
[IMG]Innovation-1-150x150.jpg2025-05-06 14:19 7.0K 
[IMG]Innovation-1-300x201.jpg2025-05-06 14:19 15K 
[IMG]Innovation-1-400x250.jpg2025-05-06 14:19 21K 
[IMG]Innovation-1-400x284.jpg2025-05-06 14:19 23K 
[IMG]Innovation-1-400x516.jpg2025-05-06 14:19 33K 
[IMG]Innovation-1-480x321.jpg2025-05-06 14:19 29K 
[IMG]Innovation-1-510x382.jpg2025-05-06 14:19 34K 
[IMG]Innovation-1-768x514.jpg2025-05-06 14:19 57K 
[IMG]Innovation-1-980x656.jpg2025-05-06 14:19 82K 
[IMG]Innovation-1-1024x685.jpg2025-05-06 14:19 87K 
[IMG]Innovation-1-1080x675.jpg2025-05-06 14:19 90K 
[IMG]Innovation-1-1080x723.jpg2025-05-06 14:19 95K 
[IMG]Innovation-1-1280x857.jpg2025-05-06 14:19 121K 
[IMG]Innovation-1-1536x1028.jpg2025-05-06 14:19 158K 
[IMG]Innovation-1.jpg2025-05-06 14:19 1.1M 
[IMG]Innovation-150x150.jpg2025-05-06 14:20 7.0K 
[IMG]Innovation-300x201.jpg2025-05-06 14:19 15K 
[IMG]Innovation-400x250.jpg2025-05-06 14:19 21K 
[IMG]Innovation-400x284.jpg2025-05-06 14:19 23K 
[IMG]Innovation-400x516.jpg2025-05-06 14:19 33K 
[IMG]Innovation-480x321.jpg2025-05-06 14:20 29K 
[IMG]Innovation-510x382.jpg2025-05-06 14:19 34K 
[IMG]Innovation-768x514.jpg2025-05-06 14:19 57K 
[IMG]Innovation-980x656.jpg2025-05-06 14:19 82K 
[IMG]Innovation-1024x685.jpg2025-05-06 14:19 87K 
[IMG]Innovation-1080x675.jpg2025-05-06 14:19 90K 
[IMG]Innovation-1080x723.jpg2025-05-06 14:19 95K 
[IMG]Innovation-1280x857.jpg2025-05-06 14:19 121K 
[IMG]Innovation-1536x1028.jpg2025-05-06 14:19 158K 
[IMG]Innovation.jpg2025-05-06 14:19 1.1M 
[ ]Interest-payment-intimation.pdf2025-05-06 14:19 67K 
[ ]Interim-Dividend-Waiver-Form_2019-20.pdf2025-05-06 14:19 277K 
[ ]Intimation-of-Appointment-of-Director.pdf2025-05-06 14:19 73K 
[ ]Intimation-of-Book-closure-and-AGM-date.pdf2025-05-06 14:19 248K 
[ ]Intimation-of-change-in-key-managerial-person-for-determining-materiality-of-an-event-or-information.pdf2025-05-06 14:19 68K 
[ ]Intimation-of-payment-of-interest.pdf2025-05-06 14:19 55K 
[ ]Intimation-regarding-inter-se-change-in-shareholding-of-promoter-group-pursuant-to-Scheme-of-Amalgamation.pdf2025-05-06 14:19 1.1M 
[ ]Intimation-under-Regulation-30-of-Listing-Regulations.pdf2025-05-06 14:19 153K 
[ ]IntimationToStockExchange.pdf2025-05-06 14:19 4.6M 
[ ]Intimationforreclassificationofpromoter23052016.pdf2025-05-06 14:19 65K 
[ ]IntimationofBoardMeeting-1.pdf2025-05-06 14:19 97K 
[ ]IntimationofBoardMeeting.pdf2025-05-06 14:19 97K 
[ ]IntimationofBoardMeetingQ22020.pdf2025-05-06 14:19 219K 
[ ]IntimationofclosureofBuyback25092020.pdf2025-05-06 14:19 381K 
[ ]IntimationofnewspaperpublicationforIEPF.pdf2025-05-06 14:19 5.4M 
[ ]IntimationtostockexchangesMar102018.pdf2025-05-06 14:19 9.5M 
[ ]Investor-–-Shareholder-Information-–-Statutory-Communications-–-2018.pdf2025-05-06 14:19 1.0M 
[ ]Investor-Grievance-report-as-per-Regulation-133-of-the-SEBI-Regulations-2015.pdf2025-05-06 14:19 29K 
[ ]Investor-Grivance-Report-Reg-133.pdf2025-05-06 14:19 137K 
[ ]Investor-Presentation-INR-April.pdf2025-05-06 14:19 3.1M 
[ ]Investor-Presentation-INR-August.pdf2025-05-06 14:19 3.7M 
[ ]Investor-Presentation-INR-Feb-1.pdf2025-05-06 14:19 48K 
[ ]Investor-Presentation-INR-Feb-2.pdf2025-05-06 14:19 3.5M 
[ ]Investor-Presentation-INR-Feb.pdf2025-05-06 14:19 48K 
[ ]Investor-Presentation-INR-February.pdf2025-05-06 14:19 3.4M 
[ ]Investor-Presentation-INR-May.pdf2025-05-06 14:19 3.5M 
[ ]Investor-Presentation-INR-November-1.pdf2025-05-06 14:19 3.5M 
[ ]Investor-Presentation-INR-November-2.pdf2025-05-06 14:19 3.0M 
[ ]Investor-Presentation-INR-November.pdf2025-05-06 14:19 3.7M 
[ ]Investor-Presentation-INR-September.pdf2025-05-06 14:19 3.5M 
[ ]Investor-Presentation-USD-April.pdf2025-05-06 14:20 3.1M 
[ ]Investor-Presentation-USD-August.pdf2025-05-06 14:19 3.7M 
[ ]Investor-Presentation-USD-Feb-1.pdf2025-05-06 14:19 3.5M 
[ ]Investor-Presentation-USD-Feb.pdf2025-05-06 14:19 3.5M 
[ ]Investor-Presentation-USD-February.pdf2025-05-06 14:19 3.4M 
[ ]Investor-Presentation-USD-May.pdf2025-05-06 14:19 3.5M 
[ ]Investor-Presentation-USD-November-1.pdf2025-05-06 14:20 3.5M 
[ ]Investor-Presentation-USD-November-2.pdf2025-05-06 14:19 3.0M 
[ ]Investor-Presentation-USD-November.pdf2025-05-06 14:19 3.7M 
[ ]Investor-Presentation-USD-September.pdf2025-05-06 14:19 3.4M 
[ ]Investor-Relations-Presentation-INR-February.pdf2025-05-06 14:19 3.1M 
[ ]Investor-Relations-Presentation-USD-February.pdf2025-05-06 14:19 3.1M 
[ ]Investor-Relations-PresentationINR-August.pdf2025-05-06 14:19 3.0M 
[ ]Investor-Relations-PresentationINR-Feb.pdf2025-05-06 14:19 3.0M 
[ ]Investor-Relations-PresentationINR-June.pdf2025-05-06 14:19 3.0M 
[ ]Investor-Relations-PresentationINR-Nov.pdf2025-05-06 14:19 3.8M 
[ ]Investor-Relations-PresentationUSD-August.pdf2025-05-06 14:19 3.0M 
[ ]Investor-Relations-PresentationUSD-Feb.pdf2025-05-06 14:19 3.1M 
[ ]Investor-Relations-PresentationUSD-June.pdf2025-05-06 14:19 3.0M 
[ ]Investor-Relations-PresentationUSD-Nov.pdf2025-05-06 14:19 3.2M 
[ ]Investor-presentation-July-26-2007.pdf2025-05-06 14:19 954K 
[IMG]Investors_Banner-image-150x150.jpg2025-05-06 14:19 6.0K 
[IMG]Investors_Banner-image-300x199.jpg2025-05-06 14:19 13K 
[IMG]Investors_Banner-image-400x250.jpg2025-05-06 14:19 18K 
[IMG]Investors_Banner-image-400x284.jpg2025-05-06 14:19 20K 
[IMG]Investors_Banner-image-400x516.jpg2025-05-06 14:19 29K 
[IMG]Investors_Banner-image-480x319.jpg2025-05-06 14:19 25K 
[IMG]Investors_Banner-image-510x382.jpg2025-05-06 14:19 30K 
[IMG]Investors_Banner-image-768x510.jpg2025-05-06 14:19 49K 
[IMG]Investors_Banner-image-980x651.jpg2025-05-06 14:19 71K 
[IMG]Investors_Banner-image-1024x680.jpg2025-05-06 14:19 75K 
[IMG]Investors_Banner-image-1080x675.jpg2025-05-06 14:19 79K 
[IMG]Investors_Banner-image-1080x717.jpg2025-05-06 14:19 83K 
[IMG]Investors_Banner-image-1280x850.jpg2025-05-06 14:19 107K 
[IMG]Investors_Banner-image-1536x1020.jpg2025-05-06 14:19 144K 
[IMG]Investors_Banner-image.jpg2025-05-06 14:19 329K 
[IMG]Isotretinoin-150x150.png2025-05-06 14:19 21K 
[IMG]Isotretinoin-231x300.png2025-05-06 14:19 31K 
[IMG]Isotretinoin-400x250.png2025-05-06 14:19 31K 
[IMG]Isotretinoin-400x284.png2025-05-06 14:19 33K 
[IMG]Isotretinoin-400x516.png2025-05-06 14:19 49K 
[IMG]Isotretinoin-480x623.png2025-05-06 14:19 55K 
[IMG]Isotretinoin-510x382.png2025-05-06 14:19 39K 
[IMG]Isotretinoin-768x997.png2025-05-06 14:19 84K 
[IMG]Isotretinoin-788x1024.png2025-05-06 14:19 87K 
[IMG]Isotretinoin-980x1273.png2025-05-06 14:19 108K 
[IMG]Isotretinoin-1080x675.png2025-05-06 14:19 78K 
[IMG]Isotretinoin-1080x1403.png2025-05-06 14:19 121K 
[IMG]Isotretinoin-1183x1536.png2025-05-06 14:19 134K 
[IMG]Isotretinoin-1280x1662.png2025-05-06 14:19 145K 
[IMG]Isotretinoin-1577x2048.png2025-05-06 14:19 183K 
[IMG]Isotretinoin-1600x1800.png2025-05-06 14:19 155K 
[IMG]Isotretinoin.png2025-05-06 14:19 159K 
[ ]Kayaku-Co.-Ltd..pdf2025-05-06 14:19 493K 
[ ]LLC-Ranbaxy-Pharmaceuticals-Ukraine-1.pdf2025-05-06 14:19 880K 
[ ]LLC-Ranbaxy-Pharmaceuticals-Ukraine-2.pdf2025-05-06 14:19 1.4M 
[ ]LLC-Ranbaxy-Pharmaceuticals-Ukraine.pdf2025-05-06 14:19 880K 
[ ]Laboratories-Ranbaxy-S.L.U..pdf2025-05-06 14:19 940K 
[ ]Laboratories-Ranbaxy-S.L.pdf2025-05-06 14:19 2.5M 
[ ]Laboratorios-Ranbaxy-S.L.-1.pdf2025-05-06 14:19 659K 
[ ]Laboratorios-Ranbaxy-S.L..pdf2025-05-06 14:19 659K 
[ ]Laboratorios-Ranbaxy-S.L.U..pdf2025-05-06 14:19 2.6M 
[ ]Legacy-Ranbaxy-DISCLOSURE-POLICY.pdf2025-05-06 14:19 340K 
[ ]Letter-to-the-stock-exchange-for-result-correction-May-17-2004.pdf2025-05-06 14:19 14K 
[ ]LettertoSESPILNewspaperadvt.pdf2025-05-06 14:19 5.0M 
[ ]Levetiracetam-Injection-approval-June-2010.pdf2025-05-06 14:20 22K 
[ ]Litigation-update-with-Taro-Sep2010-1.pdf2025-05-06 14:19 26K 
[ ]Litigation-update-with-Taro-Sep2010.pdf2025-05-06 14:19 26K 
[IMG]Logo-Primer-150x150.jpg2025-05-06 14:19 3.2K 
[IMG]Logo-Primer-300x225.jpg2025-05-06 14:19 6.0K 
[IMG]Logo-Primer-400x250.jpg2025-05-06 14:19 9.0K 
[IMG]Logo-Primer-400x284.jpg2025-05-06 14:19 8.9K 
[IMG]Logo-Primer-400x516.jpg2025-05-06 14:19 13K 
[IMG]Logo-Primer-480x360.jpg2025-05-06 14:19 12K 
[IMG]Logo-Primer-510x382.jpg2025-05-06 14:19 13K 
[IMG]Logo-Primer-768x576.jpg2025-05-06 14:19 22K 
[IMG]Logo-Primer.jpg2025-05-06 14:19 34K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-150x150.jpg2025-05-06 14:19 19K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-300x176.jpg2025-05-06 14:19 25K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-400x250.jpg2025-05-06 14:19 32K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-400x284.jpg2025-05-06 14:19 33K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-400x516.jpg2025-05-06 14:19 42K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-480x282.jpg2025-05-06 14:19 37K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-510x382.jpg2025-05-06 14:19 43K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-768x452.jpg2025-05-06 14:19 61K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-980x576.jpg2025-05-06 14:19 83K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-1024x602.jpg2025-05-06 14:19 88K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-1080x635.jpg2025-05-06 14:19 95K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-1080x675.jpg2025-05-06 14:19 98K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-1280x753.jpg2025-05-06 14:19 120K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-1536x903.jpg2025-05-06 14:19 155K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1-2048x1204.jpg2025-05-06 14:19 238K 
[IMG]MEDP-Collection-of-blood-using-a-capillary-tube-scaled-1.jpg2025-05-06 14:19 349K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-150x150.jpg2025-05-06 14:19 31K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-225x300.jpg2025-05-06 14:19 42K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-400x250.jpg2025-05-06 14:19 50K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-400x284.jpg2025-05-06 14:19 53K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-400x516.jpg2025-05-06 14:19 75K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-480x640.jpg2025-05-06 14:19 98K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-510x382.jpg2025-05-06 14:19 72K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-768x1024.jpg2025-05-06 14:19 199K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-980x1307.jpg2025-05-06 14:19 299K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-1080x675.jpg2025-05-06 14:19 175K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-1080x1440.jpg2025-05-06 14:19 349K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-1152x1536.jpg2025-05-06 14:19 390K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-1280x1707.jpg2025-05-06 14:19 462K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-1536x2048.jpg2025-05-06 14:19 622K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1-1920x1800.jpg2025-05-06 14:19 741K 
[IMG]MEDP-Hands-on-training-being-given-by-the-project-staff-in-the-tribal-areas-of-the-district-scaled-1.jpg2025-05-06 14:19 1.0M 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-150x150.jpg2025-05-06 14:19 24K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-300x176.jpg2025-05-06 14:19 34K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-400x250.jpg2025-05-06 14:19 48K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-400x284.jpg2025-05-06 14:19 51K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-400x516.jpg2025-05-06 14:19 69K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-480x282.jpg2025-05-06 14:19 57K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-510x382.jpg2025-05-06 14:19 71K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-768x452.jpg2025-05-06 14:19 107K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-980x577.jpg2025-05-06 14:19 152K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-1024x602.jpg2025-05-06 14:19 161K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-1080x635.jpg2025-05-06 14:19 175K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-1080x675.jpg2025-05-06 14:19 182K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-1280x753.jpg2025-05-06 14:19 222K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-1536x904.jpg2025-05-06 14:19 292K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1-2048x1205.jpg2025-05-06 14:19 447K 
[IMG]MEDP-Pouring-of-buffer-solution-in-the-RDT-kit-scaled-1.jpg2025-05-06 14:19 659K 
[IMG]Mahatma-Awards-150x150.png2025-05-06 14:19 8.6K 
[IMG]Mahatma-Awards-300x78.png2025-05-06 14:19 19K 
[IMG]Mahatma-Awards-400x160.png2025-05-06 14:19 27K 
[IMG]Mahatma-Awards-480x124.png2025-05-06 14:19 40K 
[IMG]Mahatma-Awards-510x160.png2025-05-06 14:19 42K 
[IMG]Mahatma-Awards.png2025-05-06 14:19 45K 
[ ]Malaria-Factsheet.pdf2025-05-06 14:19 401K 
[ ]Malaria-Free-India-Blue-Print.pdf2025-05-06 14:19 312K 
[ ]Malaria-Free-India-public-private-partnership-receives-global-recognition.pdf2025-05-06 14:19 320K 
[ ]Management-presentation-on-NCE-and-NDDS-March-16-2007.pdf2025-05-06 14:19 452K 
[ ]Media-Invitation-1.pdf2025-05-06 14:19 292K 
[ ]Media-Invitation.pdf2025-05-06 14:19 292K 
[IMG]Media_Banner-image-150x150.jpg2025-05-06 14:19 4.6K 
[IMG]Media_Banner-image-300x200.jpg2025-05-06 14:19 9.2K 
[IMG]Media_Banner-image-400x250.jpg2025-05-06 14:19 13K 
[IMG]Media_Banner-image-400x284.jpg2025-05-06 14:19 14K 
[IMG]Media_Banner-image-400x516.jpg2025-05-06 14:19 19K 
[IMG]Media_Banner-image-480x320.jpg2025-05-06 14:19 17K 
[IMG]Media_Banner-image-510x382.jpg2025-05-06 14:19 21K 
[IMG]Media_Banner-image-768x512.jpg2025-05-06 14:19 35K 
[IMG]Media_Banner-image-980x653.jpg2025-05-06 14:19 50K 
[IMG]Media_Banner-image-1024x683.jpg2025-05-06 14:19 54K 
[IMG]Media_Banner-image-1080x675.jpg2025-05-06 14:19 56K 
[IMG]Media_Banner-image-1080x720.jpg2025-05-06 14:19 58K 
[IMG]Media_Banner-image-1280x853.jpg2025-05-06 14:19 76K 
[IMG]Media_Banner-image-1536x1024.jpg2025-05-06 14:19 101K 
[IMG]Media_Banner-image.jpg2025-05-06 14:19 232K 
[IMG]Milestones-1-150x150.jpg2025-05-06 14:19 6.7K 
[IMG]Milestones-1-300x199.jpg2025-05-06 14:19 14K 
[IMG]Milestones-1-400x250.jpg2025-05-06 14:19 21K 
[IMG]Milestones-1-400x284.jpg2025-05-06 14:19 24K 
[IMG]Milestones-1-400x516.jpg2025-05-06 14:19 43K 
[IMG]Milestones-1-480x318.jpg2025-05-06 14:19 30K 
[IMG]Milestones-1-510x382.jpg2025-05-06 14:19 37K 
[IMG]Milestones-1-768x509.jpg2025-05-06 14:19 65K 
[IMG]Milestones-1-980x649.jpg2025-05-06 14:19 96K 
[IMG]Milestones-1-1024x678.jpg2025-05-06 14:20 103K 
[IMG]Milestones-1-1080x675.jpg2025-05-06 14:19 106K 
[IMG]Milestones-1-1080x716.jpg2025-05-06 14:19 112K 
[IMG]Milestones-1-1280x848.jpg2025-05-06 14:19 147K 
[IMG]Milestones-1-1536x1018.jpg2025-05-06 14:19 197K 
[IMG]Milestones-1.jpg2025-05-06 14:19 1.1M 
[IMG]Milestones-150x150.jpg2025-05-06 14:19 6.7K 
[IMG]Milestones-300x199.jpg2025-05-06 14:19 14K 
[IMG]Milestones-400x250.jpg2025-05-06 14:19 21K 
[IMG]Milestones-400x284.jpg2025-05-06 14:19 24K 
[IMG]Milestones-400x516.jpg2025-05-06 14:20 43K 
[IMG]Milestones-480x318.jpg2025-05-06 14:19 30K 
[IMG]Milestones-510x382.jpg2025-05-06 14:19 37K 
[IMG]Milestones-768x509.jpg2025-05-06 14:19 65K 
[IMG]Milestones-980x649.jpg2025-05-06 14:19 96K 
[IMG]Milestones-1024x678.jpg2025-05-06 14:19 103K 
[IMG]Milestones-1080x675.jpg2025-05-06 14:19 106K 
[IMG]Milestones-1080x716.jpg2025-05-06 14:19 112K 
[IMG]Milestones-1280x848.jpg2025-05-06 14:19 147K 
[IMG]Milestones-1536x1018.jpg2025-05-06 14:19 197K 
[IMG]Milestones.jpg2025-05-06 14:19 1.1M 
[ ]Modern-Slavery-Act-Statement-2017-18.pdf2025-05-06 14:19 236K 
[ ]Mr-Keki-Mistry-joins-Sun-Pharma_s-board-of-directors-August-29-2002.pdf2025-05-06 14:19 12K 
[ ]Mr.-Ashwin-Dani-joins-Sun-Pharma-board-February-02-2004.pdf2025-05-06 14:19 11K 
[ ]NSE-observation-letter.pdf2025-05-06 14:19 401K 
[ ]Neetnav-Real-Estate-Private-Limited-1.pdf2025-05-06 14:19 321K 
[ ]Neetnav-Real-Estate-Private-Limited-2.pdf2025-05-06 14:19 6.5M 
[ ]Neetnav-Real-Estate-Private-Limited-3.pdf2025-05-06 14:19 1.1M 
[ ]Neetnav-Real-Estate-Private-Limited-4.pdf2025-05-06 14:19 917K 
[ ]Neetnav-Real-Estate-Private-Limited-5.pdf2025-05-06 14:19 118K 
[ ]Neetnav-Real-Estate-Private-Limited-6.pdf2025-05-06 14:19 279K 
[ ]Neetnav-Real-Estate-Private-Limited.pdf2025-05-06 14:19 279K 
[ ]Newspaper-Advertisement-Notice-of-AGM-Evoting-and-Book-Closure-English-Ahmedabad-Edition.pdf2025-05-06 14:19 1.1M 
[ ]Newspaper-Advertisement-Notice-of-AGM-Evoting-and-Book-Closure-English-Mumbai-Edition.pdf2025-05-06 14:19 1.2M 
[ ]Newspaper-Advertisement-Notice-of-AGM-Evoting-and-Book-Closure-Gujarati-Ahmedabad-Edition.pdf2025-05-06 14:19 2.2M 
[ ]Newspaper-Advertisement-regarding-Notice-for-NCLT-Convened-Meeting-of-Equity-Shareholders-Unsecured-Creditors-and-Notice-for-Remote-E-Voting-for-NCLT-Convened-Meeting-of-Equity-Shareholders-1.pdf2025-05-06 14:19 4.6M 
[ ]Newspaper-Advertisement-regarding-Notice-for-NCLT-Convened-Meeting-of-Equity-Shareholders-Unsecured-Creditors-and-Notice-for-Remote-E-Voting-for-NCLT-Convened-Meeting-of-Equity-Shareholders-2.pdf2025-05-06 14:19 4.6M 
[ ]Newspaper-Advertisement-regarding-Notice-for-NCLT-Convened-Meeting-of-Equity-Shareholders-Unsecured-Creditors-and-Notice-for-Remote-E-Voting-for-NCLT-Convened-Meeting-of-Equity-Shareholders.pdf2025-05-06 14:19 4.6M 
[ ]Newspaper-Advertisement-regarding-Notice-for-Postal-Ballot-and-Remote-E-voting-for-the-National-Company-Law-Tribunal-Convened-Meeting-of-Equity-Shareholders.pdf2025-05-06 14:19 3.9M 
[ ]Newspaper-Advertisement-regarding-Notice-of-the-National-Company-Law-Tribunal-Convened-Meetings-of-Equity-Shareholders-and-Unsecured-Creditors.pdf2025-05-06 14:19 1.7M 
[ ]Newspaper-Advertisement.pdf2025-05-06 14:19 6.5M 
[ ]Newspaper-ad-Notice-for-NCLT-Convened-Meeting-of-Equity-Shareholders-Unsecured-Creditors-and-Notice-for-Remote-E-Voting-for-NCLT-Convened-Meeting-of-Equity-Shareholders.pdf2025-05-06 14:19 4.6M 
[ ]No-Objection-NSE.pdf2025-05-06 14:19 230K 
[ ]No-objection-BSE.pdf2025-05-06 14:19 185K 
[ ]No-such-proposal-says-Sun-Pharma-Bloomberg-story-titled-22-Sun-Pharma-plans-to-acquire-remaining-stake-in-Caraco.pdf2025-05-06 14:19 13K 
[IMG]North-America-150x150.png2025-05-06 14:19 15K 
[IMG]North-America-251x300.png2025-05-06 14:19 34K 
[IMG]North-America-340x250.png2025-05-06 14:19 34K 
[IMG]North-America-340x284.png2025-05-06 14:19 40K 
[IMG]North-America-340x382.png2025-05-06 14:19 50K 
[IMG]North-America.png2025-05-06 14:19 43K 
[ ]Notice-for-Court-Convened-Meeting_SPIL_SPGI.pdf2025-05-06 14:19 566K 
[ ]Notice-of-26th-Annual-General-Meeting.pdf2025-05-06 14:19 1.4M 
[ ]Notice-of-AGM.pdf2025-05-06 14:19 474K 
[ ]Notice-of-Board-Meeting-–-August-14-2018.pdf2025-05-06 14:19 188K 
[ ]Notice-of-Board-Meeting-–-February-14-2018.pdf2025-05-06 14:19 25K 
[ ]Notice-of-Board-Meeting-10th-November-2016.pdf2025-05-06 14:19 48K 
[ ]Notice-of-Board-Meeting-November-14-2017.pdf2025-05-06 14:19 183K 
[ ]Notice-of-Board-Meeting_August-11-2017.pdf2025-05-06 14:19 39K 
[ ]Notice-of-Board-Meeting_May_26_2017.pdf2025-05-06 14:19 290K 
[ ]Notice-of-Board-meeting-–-Nov-13-2018.pdf2025-05-06 14:19 376K 
[ ]Notice-of-Court-Convened-Meeting-on-22.08.2014-Scheme-ExplStmt-Attd-Slip-_-Proxy-Form-1.pdf2025-05-06 14:19 1.8M 
[ ]Notice-of-Court-Convened-Meeting-on-22.08.2014-Scheme-ExplStmt-Attd-Slip-_-Proxy-Form.pdf2025-05-06 14:19 1.8M 
[ ]Notice-of-NCLT-Convened-Meeting-of-Equity-shareholders-Proxy-Attendance-Slip.pdf2025-05-06 14:19 3.8M 
[ ]Notice-of-Tribunal-Convened-Meeting-of-Unsecured-Creditors-of-the-Company.pdf2025-05-06 14:19 5.1M 
[ ]Notice-of-extraordinary-general-meeting-on-July-28-2007-July-19-2007.pdf2025-05-06 14:19 797K 
[ ]Notice-of-the-28th-Annual-General-Meeting.pdf2025-05-06 14:19 323K 
[ ]Notice-of-the-Board-Meeting-February-12-2019.pdf2025-05-06 14:19 184K 
[ ]NoticeBoardMeetingMay_25_2018.pdf2025-05-06 14:19 230K 
[ ]NoticeofBoardMeeting14022017.pdf2025-05-06 14:19 34K 
[ ]NoticeofPostalBallotForm.pdf2025-05-06 14:19 507K 
[IMG]O9FG4R0-e1605964456166-150x150.jpg2025-05-06 14:19 4.0K 
[IMG]O9FG4R0-e1605964456166-300x179.jpg2025-05-06 14:19 7.3K 
[IMG]O9FG4R0-e1605964456166-400x250.jpg2025-05-06 14:19 12K 
[IMG]O9FG4R0-e1605964456166-400x284.jpg2025-05-06 14:19 13K 
[IMG]O9FG4R0-e1605964456166-400x516.jpg2025-05-06 14:19 17K 
[IMG]O9FG4R0-e1605964456166-480x286.jpg2025-05-06 14:19 14K 
[IMG]O9FG4R0-e1605964456166-510x382.jpg2025-05-06 14:19 19K 
[IMG]O9FG4R0-e1605964456166-768x458.jpg2025-05-06 14:19 26K 
[IMG]O9FG4R0-e1605964456166-980x585.jpg2025-05-06 14:19 36K 
[IMG]O9FG4R0-e1605964456166-1024x611.jpg2025-05-06 14:20 39K 
[IMG]O9FG4R0-e1605964456166-1080x644.jpg2025-05-06 14:19 41K 
[IMG]O9FG4R0-e1605964456166-1080x675.jpg2025-05-06 14:19 44K 
[IMG]O9FG4R0-e1605964456166.jpg2025-05-06 14:19 57K 
[ ]OOO-Sun-Pharmaceutical-Industries-Limited.pdf2025-05-06 14:19 1.6M 
[ ]OOO-Sun-Pharmaceutical-Industries-Ltd-1.pdf2025-05-06 14:19 1.4M 
[ ]OOO-Sun-Pharmaceutical-Industries-Ltd-2.pdf2025-05-06 14:19 374K 
[ ]OOO-Sun-Pharmaceutical-Industries-Ltd.pdf2025-05-06 14:19 963K 
[ ]OOO-_Sun-Pharmaceutical-Industries-Ltd..pdf2025-05-06 14:19 222K 
[ ]OPIH-France-SARL-1.pdf2025-05-06 14:19 3.0M 
[ ]OPIH-France-SARL.pdf2025-05-06 14:19 1.3M 
[ ]Observation-Letter-BSE.pdf2025-05-06 14:19 760K 
[ ]Observation-Letter-NSE.pdf2025-05-06 14:19 215K 
[ ]Ocular-Technologies-SARL.pdf2025-05-06 14:19 1.8M 
[ ]Odomzo-PM-en-clean_revised-29Sep2020.pdf2025-05-06 14:19 454K 
[ ]Odomzo-PM-fr-clean_revised-29Sep2020.pdf2025-05-06 14:19 581K 
[IMG]Odomzo_logo-150x150.jpg2025-05-06 14:19 22K 
[IMG]Odomzo_logo-300x245.jpg2025-05-06 14:20 30K 
[IMG]Odomzo_logo-400x250.jpg2025-05-06 14:19 33K 
[IMG]Odomzo_logo-400x284.jpg2025-05-06 14:19 36K 
[IMG]Odomzo_logo-400x516.jpg2025-05-06 14:19 44K 
[IMG]Odomzo_logo-480x391.jpg2025-05-06 14:19 44K 
[IMG]Odomzo_logo-510x382.jpg2025-05-06 14:19 45K 
[IMG]Odomzo_logo-768x626.jpg2025-05-06 14:19 67K 
[IMG]Odomzo_logo-980x799.jpg2025-05-06 14:19 85K 
[IMG]Odomzo_logo-1024x835.jpg2025-05-06 14:19 89K 
[IMG]Odomzo_logo-1080x675.jpg2025-05-06 14:19 75K 
[IMG]Odomzo_logo-1080x881.jpg2025-05-06 14:19 94K 
[IMG]Odomzo_logo-1280x1044.jpg2025-05-06 14:19 112K 
[IMG]Odomzo_logo-1536x1253.jpg2025-05-06 14:20 137K 
[IMG]Odomzo_logo.jpg2025-05-06 14:19 246K 
[ ]Offer-letter-to-shareholders-regional-stock-exchanges-delisting-March-30-2002.pdf2025-05-06 14:19 37K 
[ ]Office-Pharmaceutique-Industriel-et-Hospitalier-SARL.pdf2025-05-06 14:19 2.6M 
[ ]Office-Pharmaceutique-Industries-et-Hospitalier-SARL-1.pdf2025-05-06 14:19 738K 
[ ]Office-Pharmaceutique-Industries-et-Hospitalier-SARL-2.pdf2025-05-06 14:19 683K 
[ ]Office-Pharmaceutique-Industries-et-Hospitalier-SARL.pdf2025-05-06 14:19 2.5M 
[ ]Open-Joint-Stock-Company-BIOSINTEZ-1.pdf2025-05-06 14:19 1.5M 
[ ]Open-Joint-Stock-Company-BIOSINTEZ.pdf2025-05-06 14:19 8.7M 
[ ]Optivar22610.pdf2025-05-06 14:19 22K 
[ ]Outcome-of-28th-Annual-General-Meeting.pdf2025-05-06 14:19 691K 
[ ]Outcome-of-Allottment-Commitee-Meeting_May-26-2017.pdf2025-05-06 14:19 41K 
[ ]Outcome-of-BM-12.02.2016.pdf2025-05-06 14:19 405K 
[ ]Outcome-of-BM-30.05.2016.pdf2025-05-06 14:20 720K 
[ ]Outcome-of-Board-Meeting-–-February-14-2018.pdf2025-05-06 14:20 3.7M 
[ ]Outcome-of-Board-Meeting-August-2019.pdf2025-05-06 14:19 674K 
[ ]Outcome-of-Board-Meeting-February-14-2-2017.pdf2025-05-06 14:19 571K 
[ ]Outcome-of-Board-Meeting-November-2019.pdf2025-05-06 14:19 3.5M 
[ ]Outcome-of-Board-Meeting_August-11-2017-1.pdf2025-05-06 14:19 490K 
[ ]Outcome-of-Board-Meeting_August-11-2017.pdf2025-05-06 14:19 490K 
[ ]Outcome-of-Board-Meeting_May-26-2017.pdf2025-05-06 14:19 855K 
[ ]Outcome-of-Board-meeting-–-Nov-13-2018.pdf2025-05-06 14:19 2.4M 
[ ]Outcome-of-the-Board-Meeting-February-12-2019-2.pdf2025-05-06 14:19 2.1M 
[ ]Outcome-of-the-Board-Meeting-March-2020-Approval-of-Buy-Back.pdf2025-05-06 14:19 596K 
[ ]Outcome06022020.pdf2025-05-06 14:19 2.4M 
[ ]Outcome31072020.pdf2025-05-06 14:20 3.0M 
[ ]OutcomeBM14082018.pdf2025-05-06 14:19 2.4M 
[ ]OutcomeJune232016.pdf2025-05-06 14:19 134K 
[ ]Outcomeallotmentcomm24052018.pdf2025-05-06 14:19 226K 
[ ]OutcomeofBoardMeetingQ2Nov032020Final.pdf2025-05-06 14:19 2.0M 
[ ]P.1-2-Draft-Letter-of-Offer-Sun-Pharmaceutical-Industries-Ltd-Buyback.pdf2025-05-06 14:19 1.5M 
[ ]PDC-ratio-is-500-1.-February-26-2001.pdf2025-05-06 14:19 15K 
[ ]PR-Malaria-Elimination-Programme-Receives-Mahatma-Award-for-Social-Good.pdf2025-05-06 14:19 227K 
[ ]PR-Sun-Pharma-leverages-mobile-technology-to-boost-treatment-compliance-amongst-asthma-patients.pdf2025-05-06 14:19 538K 
[IMG]Panoli-Green-Belt-Project-6-150x150.jpg2025-05-06 14:19 22K 
[IMG]Panoli-Green-Belt-Project-6-300x169.jpg2025-05-06 14:19 27K 
[IMG]Panoli-Green-Belt-Project-6-400x250.jpg2025-05-06 14:19 34K 
[IMG]Panoli-Green-Belt-Project-6-400x284.jpg2025-05-06 14:19 35K 
[IMG]Panoli-Green-Belt-Project-6-400x516.jpg2025-05-06 14:19 44K 
[IMG]Panoli-Green-Belt-Project-6-480x270.jpg2025-05-06 14:19 38K 
[IMG]Panoli-Green-Belt-Project-6-510x382.jpg2025-05-06 14:19 46K 
[IMG]Panoli-Green-Belt-Project-6-768x432.jpg2025-05-06 14:19 64K 
[IMG]Panoli-Green-Belt-Project-6-980x551.jpg2025-05-06 14:19 90K 
[IMG]Panoli-Green-Belt-Project-6.jpg2025-05-06 14:19 89K 
[ ]Patientenkarte-1.pdf2025-05-06 14:19 444K 
[ ]Patientenkarte.pdf2025-05-06 14:19 444K 
[ ]Pemelt-Campaign-Launch-PDF.pdf2025-05-06 14:19 340K 
[ ]Pola-Pharma-Inc-1.pdf2025-05-06 14:19 475K 
[ ]Pola-Pharma-Inc.pdf2025-05-06 14:19 312K 
[ ]Policy-on-Material-Subsidiaries.pdf2025-05-06 14:19 422K 
[ ]Postal-Ballot-Form-30.05.2013.pdf2025-05-06 14:19 308K 
[ ]Postal-Ballot-Form-for-NCLT-Convened-Meeting-of-Equity-Shareholders.pdf2025-05-06 14:19 104K 
[ ]Postal-Ballot-Notice-30.05.2013-.pdf2025-05-06 14:19 313K 
[ ]Presentation-to-Japanese-Investors.pdf2025-05-06 14:19 1.3M 
[ ]President-to-inaugurate-Sun-Pharma_s-research-center-December-07-2004.pdf2025-05-06 14:19 13K 
[ ]Press-Release-Absorica-capsules-for-Management-of-Severe-Recalcitrant-Nodular-Acne-in-the-US.pdf2025-05-06 14:19 365K 
[ ]Press-Release-Appointment-of-Independent-Director-on-Sun-Board.pdf2025-05-06 14:19 19K 
[ ]Press-Release-Australian-TGA-approval-of-ILUMYA.pdf2025-05-06 14:19 253K 
[ ]Press-Release-CCI-Order.pdf2025-05-06 14:19 61K 
[ ]Press-Release-Clarification-on-Silverstreet-Investment-in-Ranbaxy-1.pdf2025-05-06 14:19 60K 
[ ]Press-Release-Closure-of-Sun-Pharma-Ranbaxy-merger.pdf2025-05-06 14:20 94K 
[ ]Press-Release-DUSA-Pharmaceuticals-Inc-files-lawsuit-against-Biofrontera-Inc.pdf2025-05-06 14:19 74K 
[ ]Press-Release-Dusa-Awarded-Preliminary-Injunctive-Relief-Prohibiting-Biofrontera.pdf2025-05-06 14:19 92K 
[ ]Press-Release-European-Commission-Approval-For-ILUMETRI.pdf2025-05-06 14:19 341K 
[ ]Press-Release-Final-Nov-15-Hindi.pdf2025-05-06 14:19 202K 
[ ]Press-Release-ILUMYA-Data-Shared-at-American-Academy-of-Dermatology.pdf2025-05-06 14:19 299K 
[ ]Press-Release-ILUMYA-availabilty-in-the-United-States.pdf2025-05-06 14:19 266K 
[ ]Press-Release-Import-Alert-for-Karkhadi-unit-from-US-FDA.pdf2025-05-06 14:19 58K 
[ ]Press-Release-Investor-upadate-call-on-03-December-2018.pdf2025-05-06 14:19 165K 
[ ]Press-Release-Late-Breaking-Phase-2-Data-Showing-Potential-of-ILUMYA-for-PsA.pdf2025-05-06 14:19 111K 
[ ]Press-Release-Launch-of-CEQUA-for-the-Treatment-of-Dry-Eye-Disease-in-the-US.pdf2025-05-06 14:19 99K 
[ ]Press-Release-License-Agreement-for-Cyclosporine-A-eye-drops-in-Greater-China.pdf2025-05-06 14:19 91K 
[ ]Press-Release-License-Agreement-for-Tildrakizumab-in-Greater-China.pdf2025-05-06 14:19 154K 
[ ]Press-Release-License-Agreement-with-AstraZeneca-for-Novel-Oncology-products.pdf2025-05-06 14:19 79K 
[ ]Press-Release-Licensing-Agreement-for-Tildrakizumab.pdf2025-05-06 14:19 42K 
[ ]Press-Release-Malaria-Free-India.pdf2025-05-06 14:19 424K 
[ ]Press-Release-Odomzo-label-update.pdf2025-05-06 14:19 113K 
[ ]Press-Release-Q1FY11.pdf2025-05-06 14:19 23K 
[ ]Press-Release-Regulatory-Filing-of-Tildrakizumab-in-Japan.pdf2025-05-06 14:19 122K 
[ ]Press-Release-Revital-H-Woman-launches-‘Healthy-Conversations-initiative.pdf2025-05-06 14:19 325K 
[ ]Press-Release-Roll-out-of-Malaria-Demonstration-Project-by-FDEC.pdf2025-05-06 14:19 701K 
[ ]Press-Release-SPARC-Licenses-XelprosTM-to-Sun-Pharma.pdf2025-05-06 14:19 103K 
[ ]Press-Release-SPARC-licenses-Elepsia-XR-to-Sun-Pharma.pdf2025-05-06 14:19 103K 
[ ]Press-Release-Settlement-of-litigation-for-generic-Gleevec-1.pdf2025-05-06 14:19 65K 
[ ]Press-Release-Strides-Arcolab-acquires-CNS-divisions-of-erstwhile-Ranbaxy.pdf2025-05-06 14:19 84K 
[ ]Press-Release-Sun-AstraZeneca-India-Collaboration.pdf2025-05-06 14:19 161K 
[ ]Press-Release-Sun-Pharma-Acquires-InSite-Vision.pdf2025-05-06 14:19 70K 
[ ]Press-Release-Sun-Pharma-Announces-Buyback-of-Equity-Shares.pdf2025-05-06 14:19 65K 
[ ]Press-Release-Sun-Pharma-Announces-Launch-of-Generic-Glumetza-Tablets-in-US.pdf2025-05-06 14:19 69K 
[ ]Press-Release-Sun-Pharma-Announces-Positive-Results-of-Confirmatory-Phase-3-Clinical-Trial-for-Seciera.pdf2025-05-06 14:19 356K 
[ ]Press-Release-Sun-Pharma-Announces-Positive-Results-of-Two-Pivotal-Clinical-Trials-of-Tildrakizumab.pdf2025-05-06 14:19 88K 
[ ]Press-Release-Sun-Pharma-Announces-US-FDA-Approval-of-INFUGEM-Injection.pdf2025-05-06 14:19 75K 
[ ]Press-Release-Sun-Pharma-Announces-bonus-issue-1.pdf2025-05-06 14:19 84K 
[ ]Press-Release-Sun-Pharma-Buy-GSKs-Opiates-Business.pdf2025-05-06 14:19 98K 
[ ]Press-Release-Sun-Pharma-Coreg-CR-Approval.pdf2025-05-06 14:19 67K 
[ ]Press-Release-Sun-Pharma-Financials-Q1FY15-1.pdf2025-05-06 14:20 79K 
[ ]Press-Release-Sun-Pharma-Financials-Q2FY14.pdf2025-05-06 14:19 44K 
[ ]Press-Release-Sun-Pharma-Financials-Q3FY14.pdf2025-05-06 14:19 44K 
[ ]Press-Release-Sun-Pharma-Financials-Q3FY15.pdf2025-05-06 14:19 85K 
[ ]Press-Release-Sun-Pharma-Financials-Q4-FY14-1.pdf2025-05-06 14:19 91K 
[ ]Press-Release-Sun-Pharma-Financials-Q4FY13-1.pdf2025-05-06 14:19 116K 
[ ]Press-Release-Sun-Pharma-Ganirelix-Approval.pdf2025-05-06 14:19 235K 
[ ]Press-Release-Sun-Pharma-Glumetza-Approval.pdf2025-05-06 14:19 67K 
[ ]Press-Release-Sun-Pharma-ICGEB-announce-collaboration-to-develop-novel-dengue-vaccine.pdf2025-05-06 14:19 104K 
[ ]Press-Release-Sun-Pharma-Imatinib-Approval.pdf2025-05-06 14:19 68K 
[ ]Press-Release-Sun-Pharma-Investor-Update.pdf2025-05-06 14:19 77K 
[ ]Press-Release-Sun-Pharma-Launch-of-Drizalma-Sprinkle-in-the-US.pdf2025-05-06 14:19 112K 
[ ]Press-Release-Sun-Pharma-Launches-Ready-to-Infuse-INFUGEM-in-the-US.pdf2025-05-06 14:19 337K 
[ ]Press-Release-Sun-Pharma-Licensing-Agreement-with-CSIR-IICT.pdf2025-05-06 14:19 80K 
[ ]Press-Release-Sun-Pharma-Q1-FY16-Financial-Result.pdf2025-05-06 14:19 90K 
[ ]Press-Release-Sun-Pharma-Q1-FY17-Financial-Result.pdf2025-05-06 14:19 89K 
[ ]Press-Release-Sun-Pharma-Q1-FY18-Financial-Result.pdf2025-05-06 14:19 181K 
[ ]Press-Release-Sun-Pharma-Q1-FY19-financial-result-on-14-August-2018.pdf2025-05-06 14:19 70K 
[ ]Press-Release-Sun-Pharma-Q1-FY20-Financial-Result-1.pdf2025-05-06 14:19 86K 
[ ]Press-Release-Sun-Pharma-Q1-FY20-Financial-Result.pdf2025-05-06 14:19 86K 
[ ]Press-Release-Sun-Pharma-Q1-FY20-financial-result-on-13-August-2019.pdf2025-05-06 14:19 68K 
[ ]Press-Release-Sun-Pharma-Q1-FY21-Financial-Result-1.pdf2025-05-06 14:19 323K 
[ ]Press-Release-Sun-Pharma-Q1-FY21-Financial-Result.pdf2025-05-06 14:19 323K 
[ ]Press-Release-Sun-Pharma-Q1FY19-Financial-Result.pdf2025-05-06 14:19 86K 
[ ]Press-Release-Sun-Pharma-Q2-FY16-Financial-Result.pdf2025-05-06 14:19 93K 
[ ]Press-Release-Sun-Pharma-Q2-FY17-Financial-Result.pdf2025-05-06 14:19 91K 
[ ]Press-Release-Sun-Pharma-Q2-FY18-Financial-Result.pdf2025-05-06 14:19 90K 
[ ]Press-Release-Sun-Pharma-Q2-FY19-Financial-Result.pdf2025-05-06 14:19 88K 
[ ]Press-Release-Sun-Pharma-Q2-FY19-financial-result-on-13-November-2018.pdf2025-05-06 14:19 166K 
[ ]Press-Release-Sun-Pharma-Q2-FY20-Financial-Result-1.pdf2025-05-06 14:19 87K 
[ ]Press-Release-Sun-Pharma-Q2-FY20-Financial-Result.pdf2025-05-06 14:19 87K 
[ ]Press-Release-Sun-Pharma-Q2-FY20-financial-result-on-07-November-2019.pdf2025-05-06 14:19 104K 
[ ]Press-Release-Sun-Pharma-Q2-FY21-Financial-Result-1.pdf2025-05-06 14:19 333K 
[ ]Press-Release-Sun-Pharma-Q2-FY21-Financial-Result.pdf2025-05-06 14:19 333K 
[ ]Press-Release-Sun-Pharma-Q3-FY16-Financial-Result.pdf2025-05-06 14:19 90K 
[ ]Press-Release-Sun-Pharma-Q3-FY17-Financial-Result.pdf2025-05-06 14:19 91K 
[ ]Press-Release-Sun-Pharma-Q3-FY18-Financial-Result.pdf2025-05-06 14:19 92K 
[ ]Press-Release-Sun-Pharma-Q3-FY19-Financial-Result.pdf2025-05-06 14:19 122K 
[ ]Press-Release-Sun-Pharma-Q3-FY19-financial-result-on-12-February-2019.pdf2025-05-06 14:19 69K 
[ ]Press-Release-Sun-Pharma-Q3-FY20-financial-result-on-06-February-2020.pdf2025-05-06 14:19 68K 
[ ]Press-Release-Sun-Pharma-Q4-FY16-Financial-Result.pdf2025-05-06 14:19 91K 
[ ]Press-Release-Sun-Pharma-Q4-FY17-Financial-Result.pdf2025-05-06 14:19 92K 
[ ]Press-Release-Sun-Pharma-Q4-FY19-Financial-Result.pdf2025-05-06 14:19 89K 
[ ]Press-Release-Sun-Pharma-Q4-FY19-financial-result-on-28-May-2019.pdf2025-05-06 14:19 70K 
[ ]Press-Release-Sun-Pharma-Q4-FY20-Financial-Result-1.pdf2025-05-06 14:19 103K 
[ ]Press-Release-Sun-Pharma-Q4-FY20-Financial-Result-2.pdf2025-05-06 14:19 103K 
[ ]Press-Release-Sun-Pharma-Q4-FY20-Financial-Result.pdf2025-05-06 14:19 103K 
[ ]Press-Release-Sun-Pharma-Q4-FY20-financial-result-on-27-May-2020.pdf2025-05-06 14:19 69K 
[ ]Press-Release-Sun-Pharma-Q4FY18-Financial-Result-1.pdf2025-05-06 14:19 91K 
[ ]Press-Release-Sun-Pharma-Q4FY18-Financial-Result.pdf2025-05-06 14:19 91K 
[ ]Press-Release-Sun-Pharma-Science-Foundation-Award.pdf2025-05-06 14:19 411K 
[ ]Press-Release-Sun-Pharma-Tildrakizumab-Europe-Licensing.pdf2025-05-06 14:19 104K 
[ ]Press-Release-Sun-Pharma-acquires-Pharmalucence-1.pdf2025-05-06 14:19 56K 
[ ]Press-Release-Sun-Pharma-and-Hikma-enter-into-exclusive-licensing-agreement-for-ILUMYA™.pdf2025-05-06 14:19 96K 
[ ]Press-Release-Sun-Pharma-and-Moebius-Medical-sign-deal-to-develop-novel-liposomal-non-opiod-pain-product-for-osteoarthritis.pdf2025-05-06 14:19 94K 
[ ]Press-Release-Sun-Pharma-and-NIV-sign-Agreement.pdf2025-05-06 14:19 66K 
[ ]Press-Release-Sun-Pharma-and-Rockwell-Medical-enter-into-licensing-agreement-for-Triferic-in-India.pdf2025-05-06 14:20 87K 
[ ]Press-Release-Sun-Pharma-and-SPARC-enter-into-a-worldwide-license-agreement-for-SCD-044.pdf2025-05-06 14:19 81K 
[ ]Press-Release-Sun-Pharma-and-the-Technion-Research-Collaboration.pdf2025-05-06 14:19 111K 
[ ]Press-Release-Sun-Pharma-announces-Absorica-patent-litigation-settlement.pdf2025-05-06 14:19 72K 
[ ]Press-Release-Sun-Pharma-announces-Bryan-divestment.pdf2025-05-06 14:19 65K 
[ ]Press-Release-Sun-Pharma-announces-US-FDA-approval-for-generic-Crestor.pdf2025-05-06 14:19 66K 
[ ]Press-Release-Sun-Pharma-announces-US-launch-of-Generics-for-Olmesartan.pdf2025-05-06 14:19 75K 
[ ]Press-Release-Sun-Pharma-announces-Yonsa-approval.pdf2025-05-06 14:19 79K 
[ ]Press-Release-Sun-Pharma-announces-acquisition-of-InSite-Vision.pdf2025-05-06 14:19 87K 
[ ]Press-Release-Sun-Pharma-announces-approval-for-Ximino.pdf2025-05-06 14:19 71K 
[ ]Press-Release-Sun-Pharma-announces-brand-acquisition-in-Japan-1.pdf2025-05-06 14:20 70K 
[ ]Press-Release-Sun-Pharma-announces-manufacturing-consolidation.pdf2025-05-06 14:19 61K 
[ ]Press-Release-Sun-Pharma-announces-research-collaboration.pdf2025-05-06 14:19 88K 
[ ]Press-Release-Sun-Pharma-announces-successful-completion-of-Opiates-business-acquisition-in-Australia.pdf2025-05-06 14:19 330K 
[ ]Press-Release-Sun-Pharma-announces-the-launch-of-ILUMYA-for-treatment-of-plaque-psoriasis-in-Japan.pdf2025-05-06 14:19 142K 
[ ]Press-Release-Sun-Pharma-commences-Tender-Offer-for-Insite-Vision.pdf2025-05-06 14:19 74K 
[ ]Press-Release-Sun-Pharma-commits-donation-to-support-Indias-COVID-19-response.pdf2025-05-06 14:19 258K 
[ ]Press-Release-Sun-Pharma-focuses-on-dermatology-as-additional-engine-of-growth-for-GCH-business.pdf2025-05-06 14:19 399K 
[ ]Press-Release-Sun-Pharma-gets-approval-for-ILUMYA-in-Japan.pdf2025-05-06 14:19 82K 
[ ]Press-Release-Sun-Pharma-initiates-Phase-II-clinical-trial-on-AQCH.pdf2025-05-06 14:19 75K 
[ ]Press-Release-Sun-Pharma-launches-FluGuard-Favipiravir-at-Rs.-35-per-tablet.pdf2025-05-06 14:19 159K 
[ ]Press-Release-Sun-Pharma-launches-Gemcitabine-InfuSMART.pdf2025-05-06 14:19 1.5M 
[ ]Press-Release-Sun-Pharma-launches-Imatinib-Mesylate-in-USA.pdf2025-05-06 14:19 100K 
[ ]Press-Release-Sun-Pharma-launches-Novel-Drug-Kapspargo-Sprinkle-in-USA.pdf2025-05-06 14:19 200K 
[ ]Press-Release-Sun-Pharma-launches-Volini-Maxx.pdf2025-05-06 14:19 324K 
[ ]Press-Release-Sun-Pharma-launches-first-branded-ophthalmic-product-Bromsite-in-USA.pdf2025-05-06 14:19 123K 
[ ]Press-Release-Sun-Pharma-presents-preclinical-data-for-GL0034.pdf2025-05-06 14:19 70K 
[ ]Press-Release-Sun-Pharma-provides-business-update.pdf2025-05-06 14:19 83K 
[ ]Press-Release-Sun-Pharma-receives-EIR-for-Halol-facility.pdf2025-05-06 14:19 68K 
[ ]Press-Release-Sun-Pharma-receives-USFDA-approval-for-BromSite.pdf2025-05-06 14:19 78K 
[ ]Press-Release-Sun-Pharma-receives-Warning-Letter-for-Halol-facility.pdf2025-05-06 14:19 75K 
[ ]Press-Release-Sun-Pharma-receives-approval-from-DCGI-to-initiate-clinical-trial-with-Nafamostat-in-Covid-19-patients.pdf2025-05-06 14:19 189K 
[ ]Press-Release-Sun-Pharma-signs-Akshay-Kumar-as-Revital-H-Brand-Ambassador.pdf2025-05-06 14:19 394K 
[ ]Press-Release-Sun-Pharma-to-Announce-Late-Breaking-Results-for-Tildrakizumab.pdf2025-05-06 14:19 96K 
[ ]Press-Release-Sun-Pharma-to-acquire-Biosintez-in-Russia.pdf2025-05-06 14:19 75K 
[ ]Press-Release-Sun-Pharma-to-acquire-Pola-Pharma-Inc-in-Japan.pdf2025-05-06 14:19 78K 
[ ]Press-Release-Sun-Pharma-to-acquire-Ranbaxy.pdf2025-05-06 14:19 128K 
[ ]Press-Release-SunPharma-Intrexon-JV-1.pdf2025-05-06 14:19 61K 
[ ]Press-Release-Tildrakizumab-2017-American-Academy-of-Dermatology-Meeting.pdf2025-05-06 14:19 87K 
[ ]Press-Release-Tildrakizumab-EU-EMA-Filing.pdf2025-05-06 14:19 94K 
[ ]Press-Release-Tildrakizumab-US-FDA-Filing-Acceptance.pdf2025-05-06 14:19 93K 
[ ]Press-Release-US-FDA-approval-for-generic-Zetia®-tablets.pdf2025-05-06 14:19 68K 
[ ]Press-Release-USFDA-Approval-of-CEQUA.pdf2025-05-06 14:19 465K 
[ ]Press-Release-USFDA-approval-for-generic-Cymbalta-DR-Capsule.pdf2025-05-06 14:19 19K 
[ ]Press-Release-USFDA-approval-for-generic-Depo®-Testosterone-Injection-1.pdf2025-05-06 14:19 18K 
[ ]Press-Release-USFDA-approval-for-generic-Prandin-1.pdf2025-05-06 14:19 58K 
[ ]Press-Release-USFDA-approval-for-generic-Prandin-2.pdf2025-05-06 14:19 58K 
[ ]Press-Release-USFDA-approval-for-generic-Prevacid-DR-Cap-1.pdf2025-05-06 14:19 18K 
[ ]Press-Release-USFDA-approval-for-generic-Temodar-Capsule.pdf2025-05-06 14:19 19K 
[ ]Press-Release-USFDA-approval-of-XELPROS.pdf2025-05-06 14:19 288K 
[ ]Press-Release-Update-on-Mohali-Facility.pdf2025-05-06 14:19 65K 
[ ]Press-Release-Voluntary-Recall-of-Riomet.pdf2025-05-06 14:19 115K 
[ ]Press-Release-clinical-insights-for-ODOMZO-and-LEVULAN-KERASTICK.pdf2025-05-06 14:19 474K 
[ ]Press-Release-distribution-alliance-with-Mitsubishi-Tanabe-Pharma-Corporation-in-Japan.pdf2025-05-06 14:19 316K 
[ ]Press-Release-launch-of-Ezallor-Sprinkle-Rosuvastatin-in-the-US.pdf2025-05-06 14:19 163K 
[ ]Press-Release-long-term-insights-into-the-clinical-use-of-ILUMYA.pdf2025-05-06 14:19 381K 
[ ]Press-Release-presentation-of-long-term-follow-up-data-for-ILUMYA-at-EADV.pdf2025-05-06 14:19 374K 
[ ]Press-Release-settlement-of-patent-litigation-for-generic-Linzess.pdf2025-05-06 14:19 107K 
[ ]Press-Release.pdf2025-05-06 14:19 336K 
[ ]Press-Release_dapa_versionMarch23.pdf2025-05-06 14:20 414K 
[ ]Press-Releases-1.pdf2025-05-06 14:19 85K 
[ ]Press-Releases-2.pdf2025-05-06 14:19 109K 
[ ]Press-Releases-3.pdf2025-05-06 14:19 112K 
[ ]Press-Releases-4.pdf2025-05-06 14:19 89K 
[ ]Press-Releases-5.pdf2025-05-06 14:19 88K 
[ ]Press-Releases-6.pdf2025-05-06 14:19 89K 
[ ]Press-Releases-7.pdf2025-05-06 14:19 86K 
[ ]Press-Releases-8.pdf2025-05-06 14:19 89K 
[ ]Press-Releases-9.pdf2025-05-06 14:19 89K 
[ ]Press-Releases-10.pdf2025-05-06 14:19 88K 
[ ]Press-Releases-11.pdf2025-05-06 14:19 88K 
[ ]Press-Releases-12.pdf2025-05-06 14:19 88K 
[ ]Press-Releases-13.pdf2025-05-06 14:19 91K 
[ ]Press-Releases-14.pdf2025-05-06 14:19 88K 
[ ]Press-Releases-15.pdf2025-05-06 14:19 88K 
[ ]Press-Releases-16.pdf2025-05-06 14:19 93K 
[ ]Press-Releases-17.pdf2025-05-06 14:19 83K 
[ ]Press-Releases-18.pdf2025-05-06 14:19 42K 
[ ]Press-Releases-19.pdf2025-05-06 14:19 89K 
[ ]Press-Releases-20.pdf2025-05-06 14:19 43K 
[ ]Press-Releases-21.pdf2025-05-06 14:19 43K 
[ ]Press-Releases-22.pdf2025-05-06 14:19 111K 
[ ]Press-Releases-23.pdf2025-05-06 14:19 114K 
[ ]Press-Releases-24.pdf2025-05-06 14:19 41K 
[ ]Press-Releases-25.pdf2025-05-06 14:19 72K 
[ ]Press-Releases-26.pdf2025-05-06 14:19 42K 
[ ]Press-Releases-27.pdf2025-05-06 14:19 45K 
[ ]Press-Releases-28.pdf2025-05-06 14:19 37K 
[ ]Press-Releases-29.pdf2025-05-06 14:19 42K 
[ ]Press-Releases-30.pdf2025-05-06 14:19 38K 
[ ]Press-Releases-31.pdf2025-05-06 14:19 35K 
[ ]Press-Releases-32.pdf2025-05-06 14:19 37K 
[ ]Press-Releases-33.pdf2025-05-06 14:19 38K 
[ ]Press-Releases-34.pdf2025-05-06 14:19 39K 
[ ]Press-Releases-35.pdf2025-05-06 14:19 35K 
[ ]Press-Releases-36.pdf2025-05-06 14:19 70K 
[ ]Press-Releases-37.pdf2025-05-06 14:19 39K 
[ ]Press-Releases-38.pdf2025-05-06 14:19 41K 
[ ]Press-Releases-39.pdf2025-05-06 14:19 39K 
[ ]Press-Releases-40.pdf2025-05-06 14:19 103K 
[ ]Press-Releases-41.pdf2025-05-06 14:19 39K 
[ ]Press-Releases-42.pdf2025-05-06 14:19 41K 
[ ]Press-Releases-43.pdf2025-05-06 14:19 39K 
[ ]Press-Releases-44.pdf2025-05-06 14:19 38K 
[ ]Press-Releases-45.pdf2025-05-06 14:19 191K 
[ ]Press-Releases-46.pdf2025-05-06 14:19 38K 
[ ]Press-Releases-47.pdf2025-05-06 14:19 38K 
[ ]Press-Releases-48.pdf2025-05-06 14:19 39K 
[ ]Press-Releases-49.pdf2025-05-06 14:19 26K 
[ ]Press-Releases-50.pdf2025-05-06 14:19 26K 
[ ]Press-Releases-51.pdf2025-05-06 14:19 82K 
[ ]Press-Releases-52.pdf2025-05-06 14:19 203K 
[ ]Press-Releases-53.pdf2025-05-06 14:19 31K 
[ ]Press-Releases-54.pdf2025-05-06 14:19 22K 
[ ]Press-Releases-55.pdf2025-05-06 14:19 30K 
[ ]Press-Releases-56.pdf2025-05-06 14:19 31K 
[ ]Press-Releases-57.pdf2025-05-06 14:19 23K 
[ ]Press-Releases-58.pdf2025-05-06 14:19 25K 
[ ]Press-Releases-59.pdf2025-05-06 14:19 20K 
[ ]Press-Releases-60.pdf2025-05-06 14:19 13K 
[ ]Press-Releases-61.pdf2025-05-06 14:19 16K 
[ ]Press-Releases-62.pdf2025-05-06 14:19 20K 
[ ]Press-Releases-63.pdf2025-05-06 14:19 19K 
[ ]Press-Releases-64.pdf2025-05-06 14:20 19K 
[ ]Press-Releases-65.pdf2025-05-06 14:19 14K 
[ ]Press-Releases-66.pdf2025-05-06 14:19 18K 
[ ]Press-Releases-67.pdf2025-05-06 14:19 14K 
[ ]Press-Releases-68.pdf2025-05-06 14:19 15K 
[ ]Press-Releases-69.pdf2025-05-06 14:19 12K 
[ ]Press-Releases-70.pdf2025-05-06 14:19 16K 
[ ]Press-Releases-71.pdf2025-05-06 14:19 15K 
[ ]Press-Releases-72.pdf2025-05-06 14:19 13K 
[ ]Press-Releases.pdf2025-05-06 14:19 84K 
[ ]Press-release-for-second-interim-dividend-March-18-2000.pdf2025-05-06 14:19 12K 
[ ]Press-release-for-the-bonus-share-issue-February-01-2000.pdf2025-05-06 14:19 9.7K 
[ ]Press-release-for-the-merger-of-Milmet-Laboratories-Pvt.-Ltd.-November-26-1999.pdf2025-05-06 14:19 10K 
[ ]Press-release-for-the-proposed-research-campus-at-Chennai-October-25-1999.pdf2025-05-06 14:19 13K 
[ ]PressRelease5YearSustainedEfficacyandSafetyResultsforILUMYA.pdf2025-05-06 14:19 192K 
[ ]PressReleaseSunPharmaQ2FY21financialresulton03November2020.pdf2025-05-06 14:19 132K 
[ ]PressReleaseSunPharmaQ3FY20FinancialResult-1.pdf2025-05-06 14:19 96K 
[ ]PressReleaseSunPharmaQ3FY20FinancialResult.pdf2025-05-06 14:19 96K 
[ ]Procedure_to_claim_dividend_amount_and_shares_from_IEPF_Final.pdf2025-05-06 14:19 514K 
[ ]Proceedings-of-25th-AGM.pdf2025-05-06 14:19 2.1M 
[ ]Proceedings-of-26th-Annual-General-Meeting.pdf2025-05-06 14:19 3.3M 
[ ]Proceedings-of-NCLT-Convened-Meetings-held-on-June-20-2017.pdf2025-05-06 14:19 473K 
[ ]Proceedings-of-NCLT-Meetings-1.pdf2025-05-06 14:19 808K 
[IMG]Products-1-150x150.jpg2025-05-06 14:19 3.9K 
[IMG]Products-1-300x169.jpg2025-05-06 14:20 8.1K 
[IMG]Products-1-400x250.jpg2025-05-06 14:19 14K 
[IMG]Products-1-400x284.jpg2025-05-06 14:19 15K 
[IMG]Products-1-400x516.jpg2025-05-06 14:19 21K 
[IMG]Products-1-480x270.jpg2025-05-06 14:19 17K 
[IMG]Products-1-510x382.jpg2025-05-06 14:19 23K 
[IMG]Products-1-768x432.jpg2025-05-06 14:19 37K 
[IMG]Products-1-980x551.jpg2025-05-06 14:19 56K 
[IMG]Products-1-1024x576.jpg2025-05-06 14:19 61K 
[IMG]Products-1-1080x608.jpg2025-05-06 14:19 66K 
[IMG]Products-1-1080x675.jpg2025-05-06 14:19 71K 
[IMG]Products-1-1280x720.jpg2025-05-06 14:19 86K 
[IMG]Products-1-1536x864.jpg2025-05-06 14:19 114K 
[IMG]Products-1.jpg2025-05-06 14:19 234K 
[IMG]Products-150x150.jpg2025-05-06 14:19 3.9K 
[IMG]Products-300x169.jpg2025-05-06 14:19 8.1K 
[IMG]Products-400x250.jpg2025-05-06 14:19 14K 
[IMG]Products-400x284.jpg2025-05-06 14:20 15K 
[IMG]Products-400x516.jpg2025-05-06 14:19 21K 
[IMG]Products-480x270.jpg2025-05-06 14:19 17K 
[IMG]Products-510x382.jpg2025-05-06 14:19 23K 
[IMG]Products-768x432.jpg2025-05-06 14:19 37K 
[IMG]Products-980x551.jpg2025-05-06 14:20 56K 
[IMG]Products-1024x576.jpg2025-05-06 14:19 61K 
[IMG]Products-1080x608.jpg2025-05-06 14:19 66K 
[IMG]Products-1080x675.jpg2025-05-06 14:19 71K 
[IMG]Products-1280x720.jpg2025-05-06 14:19 86K 
[IMG]Products-1536x864.jpg2025-05-06 14:19 114K 
[IMG]Products.jpg2025-05-06 14:19 234K 
[IMG]Products_API-150x150.jpg2025-05-06 14:19 4.3K 
[IMG]Products_API-300x200.jpg2025-05-06 14:19 9.8K 
[IMG]Products_API-400x250.jpg2025-05-06 14:19 14K 
[IMG]Products_API-400x284.jpg2025-05-06 14:19 15K 
[IMG]Products_API-400x516.jpg2025-05-06 14:19 16K 
[IMG]Products_API-480x320.jpg2025-05-06 14:19 19K 
[IMG]Products_API-510x382.jpg2025-05-06 14:19 22K 
[IMG]Products_API-768x512.jpg2025-05-06 14:19 37K 
[IMG]Products_API-980x653.jpg2025-05-06 14:19 52K 
[IMG]Products_API-1024x683.jpg2025-05-06 14:19 55K 
[IMG]Products_API-1080x675.jpg2025-05-06 14:19 57K 
[IMG]Products_API-1080x720.jpg2025-05-06 14:19 60K 
[IMG]Products_API-1280x853.jpg2025-05-06 14:19 76K 
[IMG]Products_API-1536x1024.jpg2025-05-06 14:19 100K 
[IMG]Products_API.jpg2025-05-06 14:19 230K 
[IMG]Products_ARV-150x150.jpg2025-05-06 14:19 5.5K 
[IMG]Products_ARV-300x147.jpg2025-05-06 14:19 11K 
[IMG]Products_ARV-400x250.jpg2025-05-06 14:19 18K 
[IMG]Products_ARV-400x284.jpg2025-05-06 14:20 19K 
[IMG]Products_ARV-400x516.jpg2025-05-06 14:19 24K 
[IMG]Products_ARV-480x236.jpg2025-05-06 14:19 20K 
[IMG]Products_ARV-510x382.jpg2025-05-06 14:19 27K 
[IMG]Products_ARV-768x377.jpg2025-05-06 14:19 39K 
[IMG]Products_ARV-980x481.jpg2025-05-06 14:19 56K 
[IMG]Products_ARV-1024x503.jpg2025-05-06 14:19 59K 
[IMG]Products_ARV-1080x530.jpg2025-05-06 14:19 64K 
[IMG]Products_ARV-1080x675.jpg2025-05-06 14:19 75K 
[IMG]Products_ARV-1280x629.jpg2025-05-06 14:19 83K 
[IMG]Products_ARV-1536x754.jpg2025-05-06 14:19 113K 
[IMG]Products_ARV.jpg2025-05-06 14:19 271K 
[IMG]Products_Front-banner-150x150.jpg2025-05-06 14:19 4.7K 
[IMG]Products_Front-banner-300x110.jpg2025-05-06 14:19 6.0K 
[IMG]Products_Front-banner-400x250.jpg2025-05-06 14:19 14K 
[IMG]Products_Front-banner-400x284.jpg2025-05-06 14:19 15K 
[IMG]Products_Front-banner-400x516.jpg2025-05-06 14:19 21K 
[IMG]Products_Front-banner-480x176.jpg2025-05-06 14:19 12K 
[IMG]Products_Front-banner-510x382.jpg2025-05-06 14:19 22K 
[IMG]Products_Front-banner-768x281.jpg2025-05-06 14:19 23K 
[IMG]Products_Front-banner-980x359.jpg2025-05-06 14:19 33K 
[IMG]Products_Front-banner-1024x375.jpg2025-05-06 14:19 35K 
[IMG]Products_Front-banner-1080x395.jpg2025-05-06 14:19 38K 
[IMG]Products_Front-banner-1080x659.jpg2025-05-06 14:19 61K 
[IMG]Products_Front-banner-1280x469.jpg2025-05-06 14:19 49K 
[IMG]Products_Front-banner-1536x562.jpg2025-05-06 14:19 64K 
[IMG]Products_Front-banner.jpg2025-05-06 14:19 133K 
[IMG]Products_Quality-150x150.jpg2025-05-06 14:19 6.1K 
[IMG]Products_Quality-300x200.jpg2025-05-06 14:19 13K 
[IMG]Products_Quality-400x250.jpg2025-05-06 14:19 20K 
[IMG]Products_Quality-400x284.jpg2025-05-06 14:19 22K 
[IMG]Products_Quality-400x516.jpg2025-05-06 14:19 33K 
[IMG]Products_Quality-480x320.jpg2025-05-06 14:19 28K 
[IMG]Products_Quality-510x382.jpg2025-05-06 14:19 33K 
[IMG]Products_Quality-768x512.jpg2025-05-06 14:19 58K 
[IMG]Products_Quality-980x653.jpg2025-05-06 14:19 85K 
[IMG]Products_Quality-1024x683.jpg2025-05-06 14:19 90K 
[IMG]Products_Quality-1080x675.jpg2025-05-06 14:19 93K 
[IMG]Products_Quality-1080x720.jpg2025-05-06 14:19 97K 
[IMG]Products_Quality-1280x853.jpg2025-05-06 14:19 126K 
[IMG]Products_Quality-1536x1024.jpg2025-05-06 14:19 166K 
[IMG]Products_Quality-2048x1365.jpg2025-05-06 14:19 263K 
[IMG]Products_Quality.jpg2025-05-06 14:19 517K 
[ ]Profile-of-Chairman-and-MD.pdf2025-05-06 14:19 91K 
[ ]Profile-of-Sun-Pharma.pdf2025-05-06 14:19 507K 
[ ]Protonix-0710.pdf2025-05-06 14:19 23K 
[ ]Public-Announcement-Sun-Pharmaceutical-Industries-Limited-Buyback-through-Tender-Offer-Route.pdf2025-05-06 14:19 12M 
[ ]Public-Announcement-for-Buy-Back-of-Equity-Shares-–-March-18-2020.pdf2025-05-06 14:19 27M 
[ ]Q-_-A-demerger-February-10-2006.pdf2025-05-06 14:19 220K 
[ ]Q1-2013-Call-Transcript.pdf2025-05-06 14:19 229K 
[ ]Q1-2013-Consolidated-Financials.pdf2025-05-06 14:19 431K 
[ ]Q1-2013-Financial-Press-Release.pdf2025-05-06 14:19 347K 
[ ]Q1-2013-Investor-Presentation.pdf2025-05-06 14:19 558K 
[ ]Q1-2013-Limited-Review-Report-Consolidated.pdf2025-05-06 14:19 70K 
[ ]Q1-2013-Limited-Review-Report-Standalone.pdf2025-05-06 14:19 35K 
[ ]Q1-2013-Results-Presentation-To-Investors.pdf2025-05-06 14:19 558K 
[ ]Q1-2013-Standalone-Financials.pdf2025-05-06 14:19 777K 
[ ]Q1-2014-15-Call-Transcript.pdf2025-05-06 14:19 227K 
[ ]Q1-2014-15-Consolidated-Financials.pdf2025-05-06 14:19 1.0M 
[ ]Q1-2014-15-Financial-Press-Release.pdf2025-05-06 14:19 248K 
[ ]Q1-2014-15-Investor-Presentation.pdf2025-05-06 14:19 554K 
[ ]Q1-2014-15-Limited-Review-Report-Consolidated.pdf2025-05-06 14:19 692K 
[ ]Q1-2014-15-Limited-Review-Report-Standalone.pdf2025-05-06 14:19 462K 
[ ]Q1-2014-15-Standalone-Financials.pdf2025-05-06 14:19 1.1M 
[ ]Q1FY21-SPIL-Financial-Results.pdf2025-05-06 14:19 32K 
[ ]Q1FY2010-11-Earnings-Call-Transcript.pdf2025-05-06 14:19 114K 
[ ]Q1FY2010-11-Financial-Results.xls2025-05-06 14:19 174K 
[ ]Q1FY2010-11-Results-Press-Release.pdf2025-05-06 14:19 42K 
[ ]Q1FY2011-12-Financial-Results.xls2025-05-06 14:19 205K 
[ ]Q1_FY2015_Investor_Presentation_Revised.pdf2025-05-06 14:19 554K 
[ ]Q2-2012-Results-Presentation-To-Investors-1.pdf2025-05-06 14:19 740K 
[ ]Q2-2012-Results-Presentation-To-Investors.pdf2025-05-06 14:19 740K 
[ ]Q2-2013-Call-Transcript.pdf2025-05-06 14:19 253K 
[ ]Q2-2013-Consolidated-Financials.pdf2025-05-06 14:19 1.1M 
[ ]Q2-2013-Financial-Press-Release.pdf2025-05-06 14:19 80K 
[ ]Q2-2013-Investor-Presentation-1.pdf2025-05-06 14:19 529K 
[ ]Q2-2013-Investor-Presentation.pdf2025-05-06 14:19 529K 
[ ]Q2-2013-Limited-Review-Report-Consolidated.pdf2025-05-06 14:19 612K 
[ ]Q2-2013-Limited-Review-Report-Standalone.pdf2025-05-06 14:19 311K 
[ ]Q2-2013-Standalone-Financials.pdf2025-05-06 14:19 1.0M 
[ ]Q2-2014-15-Consolidated-Financials.pdf2025-05-06 14:19 2.3M 
[ ]Q2-2014-15-Financial-Press-Release.pdf2025-05-06 14:19 321K 
[ ]Q2-2014-15-Investor-Presentation.pdf2025-05-06 14:19 661K 
[ ]Q2-2014-15-Limited-Review-Report-Consolidated.pdf2025-05-06 14:20 1.0M 
[ ]Q2-2014-15-Limited-Review-Report-Standalone.pdf2025-05-06 14:19 512K 
[ ]Q2-2014-15-Standalone-Financials.pdf2025-05-06 14:19 2.1M 
[ ]Q2-FY20-SPIL-Financial-Results-1.pdf2025-05-06 14:19 91K 
[ ]Q2-FY20-SPIL-Financial-Results.pdf2025-05-06 14:20 91K 
[ ]Q2-results-on-October-28-2002-October-21-2002.pdf2025-05-06 14:19 12K 
[ ]Q2FY21-Financial-Results-1.pdf2025-05-06 14:19 136K 
[ ]Q2FY21-Financial-Results.pdf2025-05-06 14:19 136K 
[ ]Q2FY2010-11-Financial-Results.xls2025-05-06 14:19 216K 
[ ]Q3-2013-Call-Transcript.pdf2025-05-06 14:19 240K 
[ ]Q3-2013-Consolidated-Financials.pdf2025-05-06 14:19 943K 
[ ]Q3-2013-Financial-Press-Release.pdf2025-05-06 14:19 66K 
[ ]Q3-2013-Investor-Presentation-1.pdf2025-05-06 14:19 739K 
[ ]Q3-2013-Investor-Presentation.pdf2025-05-06 14:19 739K 
[ ]Q3-2013-Limited-Review-Report-Consolidated.pdf2025-05-06 14:19 1.0M 
[ ]Q3-2013-Limited-Review-Report-Standalone.pdf2025-05-06 14:19 515K 
[ ]Q3-2013-Standalone-Financials.pdf2025-05-06 14:19 907K 
[ ]Q3-2014-15-Consolidated-Financials.pdf2025-05-06 14:19 550K 
[ ]Q3-2014-15-Financial-Press-Release.pdf2025-05-06 14:19 559K 
[ ]Q3-2014-15-Limited-Review-Report-Standalone-1.pdf2025-05-06 14:19 112K 
[ ]Q3-2014-15-Limited-Review-Report-Standalone.pdf2025-05-06 14:19 112K 
[ ]Q3-conf-call-announcement-for-Jan-30-January-30-2003-1.pdf2025-05-06 14:19 12K 
[ ]Q3-conf-call-announcement-for-Jan-30-January-30-2003.pdf2025-05-06 14:19 12K 
[ ]Q3-numbers-on-January-30-January-20-2003-1.pdf2025-05-06 14:19 13K 
[ ]Q3-numbers-on-January-30-January-20-2003.pdf2025-05-06 14:19 13K 
[ ]Q3-result-conference-Call-January-21-2005.pdf2025-05-06 14:19 90K 
[ ]Q3-results-conf-call-Jan-285pm-IST-January-28-2004.pdf2025-05-06 14:19 9.7K 
[ ]Q3-sales-up-27_-net-profit-up-36_-January-29-2007.pdf2025-05-06 14:19 39K 
[ ]Q3FY20FinancialResult-1.pdf2025-05-06 14:19 39K 
[ ]Q3FY20FinancialResult.pdf2025-05-06 14:19 39K 
[ ]Q3FY2005-06-Financial-Results.xls2025-05-06 14:19 47K 
[ ]Q3_2012_results-presentation_to_investors.pdf2025-05-06 14:19 661K 
[ ]Q4-2007-08-results-on-30-May-2008-earnings-call-on-30-May-2008-at-6-30-PM-IST.pdf2025-05-06 14:19 23K 
[ ]Q4-2011-full-year-results-presentation.pdf2025-05-06 14:19 708K 
[ ]Q4-2013-Call-Transcript.pdf2025-05-06 14:19 244K 
[ ]Q4-2013-Consolidated-Financials.pdf2025-05-06 14:19 198K 
[ ]Q4-2013-Financial-Press-Release.pdf2025-05-06 14:19 18K 
[ ]Q4-2013-Investor-Presentation-1.pdf2025-05-06 14:19 673K 
[ ]Q4-2013-Investor-Presentation.pdf2025-05-06 14:19 695K 
[ ]Q4-2013-Limited-Review-Report-Consolidated.pdf2025-05-06 14:19 97K 
[ ]Q4-2013-Limited-Review-Report-Standalone.pdf2025-05-06 14:19 180K 
[ ]Q4-2013-Standalone-Financials.pdf2025-05-06 14:19 188K 
[ ]Q4-and-Full-Year-2012-Results-Presentation-to-Investors.pdf2025-05-06 14:19 680K 
[ ]Q4-conf-call-on-May5-May-05-2003-1.pdf2025-05-06 14:19 13K 
[ ]Q4-conf-call-on-May5-May-05-2003.pdf2025-05-06 14:19 13K 
[ ]Q4-results-on-June-6-conf-call-June-7-June-06-2005.pdf2025-05-06 14:19 191K 
[ ]Q4FY20SPIL-Financial-Results-1.pdf2025-05-06 14:19 107K 
[ ]Q4FY20SPIL-Financial-Results.pdf2025-05-06 14:19 107K 
[ ]Q5-2013-14-Call-Transcript.pdf2025-05-06 14:19 232K 
[ ]Q5-2013-14-Consolidated-Financials.pdf2025-05-06 14:19 1.5M 
[ ]Q5-2013-14-Financial-Press-Release.pdf2025-05-06 14:19 45K 
[ ]Q5-2013-14-Investor-Presentation-1.pdf2025-05-06 14:19 666K 
[ ]Q5-2013-14-Investor-Presentation.pdf2025-05-06 14:19 666K 
[ ]Q5-2013-14-Limited-Review-Report-Consolidated.pdf2025-05-06 14:19 901K 
[ ]Q5-2013-14-Limited-Review-Report-Standalone.pdf2025-05-06 14:19 650K 
[ ]Q5-2013-14-Standalone-Financials.pdf2025-05-06 14:19 1.5M 
[ ]Quarter-4-conference-call-on-April-28-at-10am-April-28-2005.pdf2025-05-06 14:19 11K 
[ ]RPTDisclosure30092020.pdf2025-05-06 14:19 331K 
[ ]RPTDisclosureIntimationtoSE.pdf2025-05-06 14:19 478K 
[ ]Ranbaxy-Australia-Proprietary-Ltd..pdf2025-05-06 14:19 460K 
[ ]Ranbaxy-Australia-Pty-Ltd.pdf2025-05-06 14:19 2.5M 
[ ]Ranbaxy-Belgium-N.V.-1.pdf2025-05-06 14:19 955K 
[ ]Ranbaxy-Belgium-N.V..pdf2025-05-06 14:19 263K 
[ ]Ranbaxy-Drugs-Limited-1.pdf2025-05-06 14:19 454K 
[ ]Ranbaxy-Drugs-Limited.pdf2025-05-06 14:19 591K 
[ ]Ranbaxy-Egypt-L.L.C.-1.pdf2025-05-06 14:19 559K 
[ ]Ranbaxy-Egypt-L.L.C..pdf2025-05-06 14:19 598K 
[ ]Ranbaxy-Europe-Limited-1.pdf2025-05-06 14:19 8.8M 
[ ]Ranbaxy-Europe-Limited-2.pdf2025-05-06 14:20 148K 
[ ]Ranbaxy-Europe-Limited-3.pdf2025-05-06 14:19 234K 
[ ]Ranbaxy-Europe-Limited.pdf2025-05-06 14:19 3.5M 
[ ]Ranbaxy-Farmaceutica-Ltda.-1.pdf2025-05-06 14:19 434K 
[ ]Ranbaxy-Farmaceutica-Ltda.-2.pdf2025-05-06 14:19 311K 
[ ]Ranbaxy-Farmaceutica-Ltda.-3.pdf2025-05-06 14:19 6.3M 
[ ]Ranbaxy-Farmaceutica-Ltda.-4.pdf2025-05-06 14:19 715K 
[ ]Ranbaxy-Farmaceutica-Ltda..pdf2025-05-06 14:20 511K 
[ ]Ranbaxy-GmbH-1.pdf2025-05-06 14:19 628K 
[ ]Ranbaxy-GmbH-2.pdf2025-05-06 14:19 377K 
[ ]Ranbaxy-Gmbh.pdf2025-05-06 14:19 7.4M 
[ ]Ranbaxy-Holdings-U.K-Limited.pdf2025-05-06 14:19 1.1M 
[ ]Ranbaxy-Holdings-U.K.-Limited-1.pdf2025-05-06 14:19 722K 
[ ]Ranbaxy-Holdings-U.K.-Limited-2.pdf2025-05-06 14:19 143K 
[ ]Ranbaxy-Holdings-U.K.-Limited.pdf2025-05-06 14:19 588K 
[ ]Ranbaxy-Holdings-UK-Ltd..pdf2025-05-06 14:19 144K 
[ ]Ranbaxy-Inc.-1.pdf2025-05-06 14:19 572K 
[ ]Ranbaxy-Inc.-and-Subsidiaries.pdf2025-05-06 14:19 535K 
[ ]Ranbaxy-Inc..pdf2025-05-06 14:19 1.0M 
[ ]Ranbaxy-Ireland-Limited-1.pdf2025-05-06 14:19 214K 
[ ]Ranbaxy-Ireland-Limited-2.pdf2025-05-06 14:19 230K 
[ ]Ranbaxy-Ireland-Limited-3.pdf2025-05-06 14:19 1.1M 
[ ]Ranbaxy-Ireland-Limited-4.pdf2025-05-06 14:19 263K 
[ ]Ranbaxy-Ireland-Limited-5.pdf2025-05-06 14:19 568K 
[ ]Ranbaxy-Ireland-Limited.pdf2025-05-06 14:19 20K 
[ ]Ranbaxy-Italia-S.P.A-1.pdf2025-05-06 14:19 8.2M 
[ ]Ranbaxy-Italia-S.P.A.-1.pdf2025-05-06 14:19 2.3M 
[ ]Ranbaxy-Italia-S.P.A..pdf2025-05-06 14:19 887K 
[ ]Ranbaxy-Italia-S.p.A.pdf2025-05-06 14:19 1.5M 
[ ]Ranbaxy-Malaysia-SDN-BHD.pdf2025-05-06 14:19 263K 
[ ]Ranbaxy-Malaysia-Sdn.-Bhd.-1.pdf2025-05-06 14:19 1.7M 
[ ]Ranbaxy-Malaysia-Sdn.-Bhd.-2.pdf2025-05-06 14:19 1.2M 
[ ]Ranbaxy-Malaysia-Sdn.-Bhd..pdf2025-05-06 14:19 1.3M 
[ ]Ranbaxy-Morocco-LLC.pdf2025-05-06 14:19 267K 
[ ]Ranbaxy-Netherlands-B.V.-1.pdf2025-05-06 14:19 443K 
[ ]Ranbaxy-Netherlands-B.V..pdf2025-05-06 14:19 431K 
[ ]Ranbaxy-Nigeria-Limited-1.pdf2025-05-06 14:19 869K 
[ ]Ranbaxy-Nigeria-Limited-2.pdf2025-05-06 14:19 756K 
[ ]Ranbaxy-Nigeria-Limited-3.pdf2025-05-06 14:19 604K 
[ ]Ranbaxy-Nigeria-Limited-4.pdf2025-05-06 14:19 583K 
[ ]Ranbaxy-Nigeria-Limited-5.pdf2025-05-06 14:19 1.3M 
[ ]Ranbaxy-Nigeria-Limited.pdf2025-05-06 14:19 662K 
[ ]Ranbaxy-PRP-Peru-SAC..pdf2025-05-06 14:20 555K 
[ ]Ranbaxy-PRP-Peru-SAC.pdf2025-05-06 14:19 272K 
[ ]Ranbaxy-Pharma-Proprietary-Ltd.pdf2025-05-06 14:19 3.6M 
[ ]Ranbaxy-Pharmaceutical-Proprietary-Limited.pdf2025-05-06 14:19 1.8M 
[ ]Ranbaxy-Pharmaceuticals-Canada-Inc.-1.pdf2025-05-06 14:19 721K 
[ ]Ranbaxy-Pharmaceuticals-Canada-Inc.-2.pdf2025-05-06 14:19 284K 
[ ]Ranbaxy-Pharmaceuticals-Canada-Inc.-3.pdf2025-05-06 14:19 349K 
[ ]Ranbaxy-Pharmaceuticals-Canada-Inc..pdf2025-05-06 14:19 2.1M 
[ ]Ranbaxy-Pharmaceuticals-Pty-Limited.pdf2025-05-06 14:19 3.1M 
[ ]Ranbaxy-Pharmaceuticals-Pty-Ltd.-Previously-known-as-Be-Tabs-Pharmaceuticals-Proprietary-Ltd..pdf2025-05-06 14:19 480K 
[ ]Ranbaxy-Pharmaceuticals-Pty-Ltd..pdf2025-05-06 14:19 418K 
[ ]Ranbaxy-Pharmaceuticals-Pty-Ltd.pdf2025-05-06 14:19 843K 
[ ]Ranbaxy-Pharmaceuticals-Ukraine-LLC-1.pdf2025-05-06 14:19 417K 
[ ]Ranbaxy-Pharmaceuticals-Ukraine-LLC-2.pdf2025-05-06 14:19 2.0M 
[ ]Ranbaxy-Pharmaceuticals-Ukraine-LLC-3.pdf2025-05-06 14:19 969K 
[ ]Ranbaxy-Pharmaceuticals-Ukraine-LLC.pdf2025-05-06 14:19 12M 
[ ]Ranbaxy-Pharmacie-Generiques-1.pdf2025-05-06 14:19 789K 
[ ]Ranbaxy-Pharmacie-Generiques-2.pdf2025-05-06 14:19 7.2M 
[ ]Ranbaxy-Pharmacie-Generiques-SAS-1.pdf2025-05-06 14:19 2.2M 
[ ]Ranbaxy-Pharmacie-Generiques-SAS.pdf2025-05-06 14:19 3.3M 
[ ]Ranbaxy-Pharmacie-Generiques.pdf2025-05-06 14:19 3.0M 
[ ]Ranbaxy-Poland-S.P.-Zoo.pdf2025-05-06 14:19 1.0M 
[ ]Ranbaxy-Poland-SP.-Z.O.O.pdf2025-05-06 14:19 2.8M 
[ ]Ranbaxy-Poland-Sp.-Z-o.O.-1.pdf2025-05-06 14:19 3.4M 
[ ]Ranbaxy-Poland-Sp.-Z-o.O..pdf2025-05-06 14:19 1.7M 
[ ]Ranbaxy-Portugal-Com-E-Desenvolv-DeProd-Farmaceuticos-Unipessoal-Lda.pdf2025-05-06 14:19 1.0M 
[ ]Ranbaxy-S.A.-Proprietary-Ltd..pdf2025-05-06 14:19 754K 
[ ]Ranbaxy-South-Africa-Proprietary-Limited-1.pdf2025-05-06 14:19 711K 
[ ]Ranbaxy-South-Africa-Proprietary-Limited.pdf2025-05-06 14:19 1.6M 
[ ]Ranbaxy-South-Africa-Pty-Limited.pdf2025-05-06 14:19 4.9M 
[ ]Ranbaxy-South-Africa-Pty-Ltd-and-its-subsidiary.pdf2025-05-06 14:19 1.5M 
[ ]Ranbaxy-Thailand-Co.-Limited.pdf2025-05-06 14:19 132K 
[ ]Ranbaxy-Thailand-Co.-Ltd.pdf2025-05-06 14:19 3.6M 
[ ]Ranbaxy-Thailand-Company-Limited-1.pdf2025-05-06 14:19 1.0M 
[ ]Ranbaxy-Thailand-Company-Limited-2.pdf2025-05-06 14:19 3.0M 
[ ]Ranbaxy-Thailand-Company-Limited.pdf2025-05-06 14:20 958K 
[ ]Ranbaxy-U.K-Limited.pdf2025-05-06 14:19 680K 
[ ]Ranbaxy-U.K.-Limited-1.pdf2025-05-06 14:19 330K 
[ ]Ranbaxy-U.K.-Limited-2.pdf2025-05-06 14:19 266K 
[ ]Ranbaxy-U.K.-Limited.pdf2025-05-06 14:19 170K 
[ ]Ranbaxy-UK-Limited..pdf2025-05-06 14:19 343K 
[ ]Ranbaxy-UK-Limited.pdf2025-05-06 14:19 130K 
[ ]RanbaxyMalaysia-Sdn-Bhd.pdf2025-05-06 14:19 1.5M 
[ ]Ranbaxy_Notice-20111.pdf2025-05-06 14:19 131K 
[ ]Realstone-Infra-Limited.pdf2025-05-06 14:19 133K 
[ ]Realstone-Multitrade-Private-Limited-1.pdf2025-05-06 14:19 4.6M 
[ ]Realstone-Multitrade-Private-Limited-2.pdf2025-05-06 14:19 963K 
[ ]Realstone-Multitrade-Private-Limited-3.pdf2025-05-06 14:19 422K 
[ ]Realstone-Multitrade-Private-Limited-4.pdf2025-05-06 14:19 748K 
[ ]Realstone-Multitrade-Private-Limited.pdf2025-05-06 14:19 238K 
[ ]Receipt-of-approval-for-reclassification-of-shares-under-Regulation-31A7-of-the-SEBI-Listing-Obligation-Disclosure-Requirements-Regulations-2015.pdf2025-05-06 14:19 41K 
[IMG]Recognition-1-150x150.jpg2025-05-06 14:19 4.6K 
[IMG]Recognition-1-300x200.jpg2025-05-06 14:19 11K 
[IMG]Recognition-1-400x250.jpg2025-05-06 14:19 15K 
[IMG]Recognition-1-400x284.jpg2025-05-06 14:19 16K 
[IMG]Recognition-1-400x516.jpg2025-05-06 14:20 20K 
[IMG]Recognition-1-480x321.jpg2025-05-06 14:19 21K 
[IMG]Recognition-1-510x382.jpg2025-05-06 14:19 22K 
[IMG]Recognition-1-768x513.jpg2025-05-06 14:19 40K 
[IMG]Recognition-1-980x654.jpg2025-05-06 14:19 57K 
[IMG]Recognition-1-1024x684.jpg2025-05-06 14:19 61K 
[IMG]Recognition-1-1080x675.jpg2025-05-06 14:19 63K 
[IMG]Recognition-1-1080x721.jpg2025-05-06 14:19 66K 
[IMG]Recognition-1-1280x855.jpg2025-05-06 14:19 85K 
[IMG]Recognition-1-1536x1026.jpg2025-05-06 14:19 113K 
[IMG]Recognition-1.jpg2025-05-06 14:19 820K 
[IMG]Recognition-150x150.jpg2025-05-06 14:19 4.6K 
[IMG]Recognition-300x200.jpg2025-05-06 14:19 11K 
[IMG]Recognition-400x250.jpg2025-05-06 14:19 15K 
[IMG]Recognition-400x284.jpg2025-05-06 14:19 16K 
[IMG]Recognition-400x516.jpg2025-05-06 14:19 20K 
[IMG]Recognition-480x321.jpg2025-05-06 14:19 21K 
[IMG]Recognition-510x382.jpg2025-05-06 14:19 22K 
[IMG]Recognition-768x513.jpg2025-05-06 14:19 40K 
[IMG]Recognition-980x654.jpg2025-05-06 14:19 57K 
[IMG]Recognition-1024x684.jpg2025-05-06 14:19 61K 
[IMG]Recognition-1080x675.jpg2025-05-06 14:19 63K 
[IMG]Recognition-1080x721.jpg2025-05-06 14:19 66K 
[IMG]Recognition-1280x855.jpg2025-05-06 14:19 85K 
[IMG]Recognition-1536x1026.jpg2025-05-06 14:19 113K 
[IMG]Recognition.jpg2025-05-06 14:19 820K 
[ ]Record-Date-intimation-for-interest-payment.pdf2025-05-06 14:19 68K 
[ ]Record-date-for-bonus-is-May-29-May-29-2004.pdf2025-05-06 14:19 13K 
[ ]Regln-7-3-SPLL-30-09-2016.pdf2025-05-06 14:19 39K 
[ ]Regulation-73-certificate.pdf2025-05-06 14:19 161K 
[ ]Regulation-133-SPLL.pdf2025-05-06 14:19 28K 
[ ]Relastone-Multitrade-Private-Limited.pdf2025-05-06 14:19 116K 
[ ]Related-Party-Disclosure-on-consodilated-basis-for-half-year-ended-September-30-2019-1.pdf2025-05-06 14:19 392K 
[ ]Related-Party-Disclosure-on-consodilated-basis-for-half-year-ended-September-30-2019.pdf2025-05-06 14:19 392K 
[ ]Related-Party-Transaction-Policy.pdf2025-05-06 14:19 560K 
[ ]Reminder-card-Osteonecrosis-of-the-jaw_-Zoledronic-acid-SUN_5mg-1.pdf2025-05-06 14:19 14K 
[ ]Reminder-card-Osteonecrosis-of-the-jaw_-Zoledronic-acid-SUN_5mg.pdf2025-05-06 14:19 14K 
[ ]Remuneration-Policy.pdf2025-05-06 14:19 41K 
[IMG]Responsibility-1-150x150.jpg2025-05-06 14:19 8.2K 
[IMG]Responsibility-1-300x169.jpg2025-05-06 14:19 17K 
[IMG]Responsibility-1-400x250.jpg2025-05-06 14:19 29K 
[IMG]Responsibility-1-400x284.jpg2025-05-06 14:19 31K 
[IMG]Responsibility-1-400x516.jpg2025-05-06 14:19 47K 
[IMG]Responsibility-1-480x270.jpg2025-05-06 14:19 36K 
[IMG]Responsibility-1-510x382.jpg2025-05-06 14:19 48K 
[IMG]Responsibility-1-768x432.jpg2025-05-06 14:19 75K 
[IMG]Responsibility-1-980x551.jpg2025-05-06 14:19 109K 
[IMG]Responsibility-1-1024x576.jpg2025-05-06 14:19 115K 
[IMG]Responsibility-1-1080x607.jpg2025-05-06 14:19 124K 
[IMG]Responsibility-1-1080x675.jpg2025-05-06 14:19 132K 
[IMG]Responsibility-1-1280x720.jpg2025-05-06 14:19 158K 
[IMG]Responsibility-1.jpg2025-05-06 14:19 248K 
[IMG]Responsibility-150x150.jpg2025-05-06 14:19 8.2K 
[IMG]Responsibility-300x169.jpg2025-05-06 14:19 17K 
[IMG]Responsibility-400x250.jpg2025-05-06 14:19 29K 
[IMG]Responsibility-400x284.jpg2025-05-06 14:19 31K 
[IMG]Responsibility-400x516.jpg2025-05-06 14:19 47K 
[IMG]Responsibility-480x270.jpg2025-05-06 14:19 36K 
[IMG]Responsibility-510x382.jpg2025-05-06 14:19 48K 
[IMG]Responsibility-768x432.jpg2025-05-06 14:19 75K 
[IMG]Responsibility-980x551.jpg2025-05-06 14:19 109K 
[IMG]Responsibility-1024x576.jpg2025-05-06 14:19 115K 
[IMG]Responsibility-1080x607.jpg2025-05-06 14:19 124K 
[IMG]Responsibility-1080x675.jpg2025-05-06 14:19 132K 
[IMG]Responsibility-1280x720.jpg2025-05-06 14:19 158K 
[IMG]Responsibility.jpg2025-05-06 14:19 248K 
[ ]Results-Press-Release-1.pdf2025-05-06 14:19 79K 
[ ]Results-Press-Release.pdf2025-05-06 14:19 79K 
[ ]Revital-H-MSD-Release_Final.pdf2025-05-06 14:19 415K 
[ ]Revital-H-Press-Release.pdf2025-05-06 14:19 129K 
[ ]Rexcel-Egypt-Company-LLC-1.pdf2025-05-06 14:19 2.2M 
[ ]Rexcel-Egypt-Company-LLC.pdf2025-05-06 14:19 1.9M 
[ ]Rexcel-Egypt-CompanyLLC-1.pdf2025-05-06 14:19 4.4M 
[ ]Rexcel-Egypt-CompanyLLC.pdf2025-05-06 14:19 541K 
[ ]Rexcel-Egypt-L.L.C.-1.pdf2025-05-06 14:19 733K 
[ ]Rexcel-Egypt-L.L.C..pdf2025-05-06 14:19 539K 
[ ]Rilutor-tentative-approval-28-09-10.pdf2025-05-06 14:19 22K 
[ ]S.C-Terapia-S.A..pdf2025-05-06 14:20 1.7M 
[ ]S.C-Terapia-S.A.pdf2025-05-06 14:19 5.6M 
[ ]SC-Terapia-SA.pdf2025-05-06 14:19 1.0M 
[ ]SCRUTINIZERS-REPORT.pdf2025-05-06 14:19 423K 
[ ]SEINTIMATIONBM31122015SPIL.pdf2025-05-06 14:19 32K 
[ ]SEIntimationofBM.pdf2025-05-06 14:19 98K 
[ ]SHP_30.06.2019.pdf2025-05-06 14:19 51K 
[ ]SHP_30.06.2020_FINAL.pdf2025-05-06 14:19 55K 
[ ]SHP_30.09.2019.pdf2025-05-06 14:19 55K 
[ ]SHP_30.09.2020_Final.pdf2025-05-06 14:19 55K 
[ ]SHP_31.12.2019.pdf2025-05-06 14:19 46K 
[ ]SKISEN_-LABS-PVT-LTD.pdf2025-05-06 14:19 546K 
[ ]SPII-Donates-2.5-Million-Hydroxychloroquine-Sulfate-Tablets-in-the-U.S.-For-Potential-COVID-19-Treatment.pdf2025-05-06 14:19 151K 
[ ]SPIL-Attendance-Slip-for-NCLT-Convened-Meeting-of-Equity-Shareholders-1.pdf2025-05-06 14:19 75K 
[ ]SPIL-Attendance-Slip-for-NCLT-Convened-Meeting-of-Equity-Shareholders.pdf2025-05-06 14:19 75K 
[ ]SPIL-Attendance-Slip-for-NCLT-Convened-Meeting-of-Unsecured-Creditors.pdf2025-05-06 14:19 40K 
[ ]SPIL-Authorized-KMP-to-determine-materiality-of-event-or-information.pdf2025-05-06 14:19 23K 
[ ]SPIL-Buyback-LOF.pdf2025-05-06 14:19 5.0M 
[ ]SPIL-CTC-BM-July-2020-for-SPGFZE-Merger-signed.pdf2025-05-06 14:19 117K 
[ ]SPIL-Compliance-Policy-Effective-11-08-2017.pdf2025-05-06 14:19 136K 
[ ]SPIL-DE-Mexico-S.A.de_.pdf2025-05-06 14:20 2.1M 
[ ]SPIL-De-Mexico-S.A.-DE-C.V..pdf2025-05-06 14:19 1.3M 
[ ]SPIL-De-Mexico-S.A.-De-C.V.-1.pdf2025-05-06 14:19 67K 
[ ]SPIL-De-Mexico-S.A.-De-C.V.pdf2025-05-06 14:19 730K 
[ ]SPIL-Intimation-of-Board-Meeting-February-2020.pdf2025-05-06 14:19 155K 
[ ]SPIL-Intimation-to-Stock-Exchanges_Jan-22-2016-regarding-CCI-approval-for-sale-of-CNS-division.pdf2025-05-06 14:19 34K 
[ ]SPIL-NCLT-Convened-Meeting-Notices-of-Equity-shareholders-along-with-Proxy-Form.pdf2025-05-06 14:19 2.2M 
[ ]SPIL-Notice-of-23rd-AGM-2015.pdf2025-05-06 14:19 537K 
[ ]SPIL-Notice-of-24th-AGM-2016.pdf2025-05-06 14:19 175K 
[ ]SPIL-Notice-of-25th-AGM-2016-17.pdf2025-05-06 14:19 429K 
[ ]SPIL-Outcome-of-22nd-AGM-2014-Voting-Results-as-per-35AScrutinizer-Reports-1.pdf2025-05-06 14:19 1.7M 
[ ]SPIL-Outcome-of-22nd-AGM-2014-Voting-Results-as-per-35AScrutinizer-Reports.pdf2025-05-06 14:19 1.7M 
[ ]SPIL-Q1-FY20-Financial-Results.pdf2025-05-06 14:19 48K 
[ ]SPIL-Q4FY19-Financial-Results.pdf2025-05-06 14:19 81K 
[ ]SPIL-Reg-30_Disclosure-Ranbaxy-Malaysia-Sdn-Bhd_19-Feb-2018.pdf2025-05-06 14:19 70K 
[ ]SPIL-Reply-to-BSE-on-News-Clarification-Ankleshwar-unit-Feb-5-2018.pdf2025-05-06 14:19 46K 
[ ]SPIL-Reply-to-BSE-on-news-clarification-Ahmednagar-unit-Dec-29-2016-rev.pdf2025-05-06 14:19 19K 
[ ]SPIL-Reply-to-NSE-on-News-Clarification-Ankleshwar-unit-Feb-5-2018.pdf2025-05-06 14:19 59K 
[ ]SPIL-Result-of-Postal-Ballot-as-per-Clause-35A_06.11.2015.pdf2025-05-06 14:19 154K 
[ ]SPIL-Stock-Exchange-reply-letter-Mohali-FDA-Inspection-Sep-11-2018.pdf2025-05-06 14:19 77K 
[ ]SPIL-Stock-exchange-reply-letter-Sep-7-2018.pdf2025-05-06 14:19 76K 
[ ]SPIL-Stock-exchange-reply-letter-for-Clarification-on-news-item-8-June-2018.pdf2025-05-06 14:19 60K 
[ ]SPIL-intimation-of-withdrawal-of-credit-rating.pdf2025-05-06 14:19 431K 
[ ]SPIL24thAGMVOTINGRESULTS.pdf2025-05-06 14:19 422K 
[ ]SPILIntimationBookClosureAGM.pdf2025-05-06 14:19 243K 
[ ]SPILIntimationofBoardMeeting-1.pdf2025-05-06 14:19 157K 
[ ]SPILIntimationofBoardMeeting.pdf2025-05-06 14:19 157K 
[ ]SPILProceedingsAGM17092016.pdf2025-05-06 14:19 682K 
[ ]SPILReplytoNSEonnewsclarificationAhmednagarunitDec292016.pdf2025-05-06 14:19 16K 
[ ]SPILSEIntimationofBMAugust2019.pdf2025-05-06 14:19 181K 
[ ]SPILSubmissionofAOA.pdf2025-05-06 14:19 788K 
[ ]SPIL_Attendance_Slip_ProxyForm-_2016-17.pdf2025-05-06 14:19 379K 
[ ]SPIL_Draft-AOA-with-proposed-amendments.pdf2025-05-06 14:19 498K 
[ ]SPIL_MOA_full_set_2019.pdf2025-05-06 14:19 44M 
[ ]SPIL_Policy-on-Determining-Materiality-of-Events-and-Information.pdf2025-05-06 14:19 26K 
[ ]SPILpriorIntimationtoStkExchangesforInterimDividend03022020.pdf2025-05-06 14:19 43K 
[ ]SPLL-2011-12.pdf2025-05-06 14:19 1.5M 
[ ]SPLL-2012-13.pdf2025-05-06 14:19 232K 
[ ]SPLL-2013-14.pdf2025-05-06 14:19 1.8M 
[ ]SPLL-2014-15.pdf2025-05-06 14:19 1.2M 
[ ]SPLL-2015-16.pdf2025-05-06 14:19 2.3M 
[ ]SPLL-2016-17.pdf2025-05-06 14:19 9.5M 
[ ]SPLL-2017-18.pdf2025-05-06 14:19 16M 
[ ]SPLL_Investor-Complaints_Reg-133-30.09.2016.pdf2025-05-06 14:19 29K 
[ ]STOCKEXCHANGEINTIMATION.pdf2025-05-06 14:19 226K 
[ ]Sales-growth-30_-profit-increased-35_-R_D-spend-Rs.-2924-million-May-18-2007.pdf2025-05-06 14:19 38K 
[ ]Scheme-of-Arrangement-Compliance-of-Regulation-37of-SEBI-Listing.pdf2025-05-06 14:19 28M 
[ ]Scheme-of-Arrangement-Regulations-2015.pdf2025-05-06 14:19 17M 
[ ]Scheme-of-Arrangement-between-Ranbaxy-_-Sun-Pharma-1.pdf2025-05-06 14:19 4.1M 
[ ]Scheme-of-Arrangement-between-Ranbaxy-_-Sun-Pharma.pdf2025-05-06 14:19 4.1M 
[ ]Scheme-of-arrangement-reconstruction-between-SunPharma-GlobalFZE-SunPharmaceuticalIndustriesLtd-1.pdf2025-05-06 14:19 4.6M 
[ ]Scheme-of-arrangement-reconstruction-between-SunPharma-GlobalFZE-SunPharmaceuticalIndustriesLtd.pdf2025-05-06 14:19 4.6M 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-150x150.png2025-05-06 14:19 26K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-212x300.png2025-05-06 14:19 56K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-400x250.png2025-05-06 14:19 78K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-400x284.png2025-05-06 14:19 88K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-400x516.png2025-05-06 14:19 135K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-480x680.png2025-05-06 14:19 190K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-510x382.png2025-05-06 14:19 135K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-723x1024.png2025-05-06 14:19 339K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-768x1088.png2025-05-06 14:19 370K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-980x1389.png2025-05-06 14:19 521K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-1080x675.png2025-05-06 14:19 343K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-1080x1531.png2025-05-06 14:19 594K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM-1084x1536.png2025-05-06 14:19 598K 
[IMG]Screenshot-2020-12-11-at-4.38.53-PM.png2025-05-06 14:19 1.4M 
[ ]ScrutinizerReportVotingResults.pdf2025-05-06 14:19 1.5M 
[ ]Scrutinizers-Report-for-the-NCLT-Convened-Meeting-of-Unsecured-Creditors.pdf2025-05-06 14:19 244K 
[ ]Second-quarter-results-on-Oct.-19-October-09-2006.pdf2025-05-06 14:19 24K 
[ ]Secretarial-Audit-Report-of-Material-Subsidiaries_2019-20.pdf2025-05-06 14:19 311K 
[ ]Self-Declaration-Format-for-Non-Resident-Shareholders-1.pdf2025-05-06 14:19 35K 
[ ]Self-Declaration-Format-for-Non-Resident-Shareholders.pdf2025-05-06 14:19 35K 
[ ]Shareholding-Patter-–-September-30-2018.pdf2025-05-06 14:19 49K 
[ ]Shareholding-Pattern-1.pdf2025-05-06 14:20 46K 
[ ]Shareholding-Pattern-2.pdf2025-05-06 14:19 46K 
[ ]Shareholding-Pattern-3.pdf2025-05-06 14:19 61K 
[ ]Shareholding-Pattern-4.pdf2025-05-06 14:19 38K 
[ ]Shareholding-Pattern-5.pdf2025-05-06 14:19 80K 
[ ]Shareholding-Pattern-6.pdf2025-05-06 14:19 39K 
[ ]Shareholding-Pattern-7.pdf2025-05-06 14:19 77K 
[ ]Shareholding-Pattern-8.pdf2025-05-06 14:19 68K 
[ ]Shareholding-Pattern-9.pdf2025-05-06 14:19 68K 
[ ]Shareholding-Pattern-10.pdf2025-05-06 14:19 70K 
[ ]Shareholding-Pattern-11.pdf2025-05-06 14:19 191K 
[ ]Shareholding-Pattern-12.pdf2025-05-06 14:19 60K 
[ ]Shareholding-Pattern-13.pdf2025-05-06 14:19 61K 
[ ]Shareholding-Pattern-14.pdf2025-05-06 14:19 80K 
[ ]Shareholding-Pattern-15.pdf2025-05-06 14:19 81K 
[ ]Shareholding-Pattern-16.pdf2025-05-06 14:19 81K 
[ ]Shareholding-Pattern-17.pdf2025-05-06 14:19 98K 
[ ]Shareholding-Pattern-18.pdf2025-05-06 14:19 156K 
[ ]Shareholding-Pattern-19.pdf2025-05-06 14:19 73K 
[ ]Shareholding-Pattern-20.pdf2025-05-06 14:19 84K 
[ ]Shareholding-Pattern-21.pdf2025-05-06 14:19 69K 
[ ]Shareholding-Pattern-22.pdf2025-05-06 14:19 78K 
[ ]Shareholding-Pattern-23.pdf2025-05-06 14:19 691K 
[ ]Shareholding-Pattern-24.pdf2025-05-06 14:19 79K 
[ ]Shareholding-Pattern-25.pdf2025-05-06 14:19 79K 
[ ]Shareholding-Pattern-26.pdf2025-05-06 14:19 77K 
[ ]Shareholding-Pattern-27.pdf2025-05-06 14:19 76K 
[ ]Shareholding-Pattern-28.pdf2025-05-06 14:19 79K 
[ ]Shareholding-Pattern-29.pdf2025-05-06 14:19 29K 
[ ]Shareholding-Pattern-30.pdf2025-05-06 14:19 77K 
[ ]Shareholding-Pattern-31.pdf2025-05-06 14:19 27K 
[ ]Shareholding-Pattern-32.pdf2025-05-06 14:19 18K 
[ ]Shareholding-Pattern-33.pdf2025-05-06 14:19 23K 
[ ]Shareholding-Pattern-34.pdf2025-05-06 14:19 27K 
[ ]Shareholding-Pattern-35.pdf2025-05-06 14:19 22K 
[ ]Shareholding-Pattern-36.pdf2025-05-06 14:19 21K 
[ ]Shareholding-Pattern-37.pdf2025-05-06 14:19 27K 
[ ]Shareholding-Pattern-38.pdf2025-05-06 14:19 23K 
[ ]Shareholding-Pattern-39.pdf2025-05-06 14:19 21K 
[ ]Shareholding-Pattern-40.pdf2025-05-06 14:19 19K 
[ ]Shareholding-Pattern-41.pdf2025-05-06 14:19 16K 
[ ]Shareholding-Pattern-42.pdf2025-05-06 14:19 25K 
[ ]Shareholding-Pattern-43.pdf2025-05-06 14:19 24K 
[ ]Shareholding-Pattern-44.pdf2025-05-06 14:19 16K 
[ ]Shareholding-Pattern-45.pdf2025-05-06 14:19 18K 
[ ]Shareholding-Pattern-46.pdf2025-05-06 14:19 22K 
[ ]Shareholding-Pattern-47.pdf2025-05-06 14:20 26K 
[ ]Shareholding-Pattern-48.pdf2025-05-06 14:19 24K 
[ ]Shareholding-Pattern-49.pdf2025-05-06 14:19 24K 
[ ]Shareholding-Pattern-50.pdf2025-05-06 14:19 21K 
[ ]Shareholding-Pattern-51.pdf2025-05-06 14:19 29K 
[ ]Shareholding-Pattern-52.pdf2025-05-06 14:19 29K 
[ ]Shareholding-Pattern-53.pdf2025-05-06 14:19 13K 
[ ]Shareholding-Pattern-54.pdf2025-05-06 14:19 82K 
[ ]Shareholding-Pattern-55.pdf2025-05-06 14:19 21K 
[ ]Shareholding-Pattern-56.pdf2025-05-06 14:20 17K 
[ ]Shareholding-Pattern-57.pdf2025-05-06 14:19 17K 
[ ]Shareholding-Pattern-58.pdf2025-05-06 14:19 34K 
[ ]Shareholding-Pattern-59.pdf2025-05-06 14:19 27K 
[ ]Shareholding-Pattern-60.pdf2025-05-06 14:19 14K 
[ ]Shareholding-Pattern-61.pdf2025-05-06 14:19 19K 
[ ]Shareholding-Pattern-62.pdf2025-05-06 14:19 19K 
[ ]Shareholding-Pattern-63.pdf2025-05-06 14:19 19K 
[ ]Shareholding-Pattern-64.pdf2025-05-06 14:19 16K 
[ ]Shareholding-Pattern-65.pdf2025-05-06 14:19 19K 
[ ]Shareholding-Pattern-66.pdf2025-05-06 14:19 21K 
[ ]Shareholding-Pattern-67.pdf2025-05-06 14:19 15K 
[ ]Shareholding-Pattern-68.pdf2025-05-06 14:19 16K 
[ ]Shareholding-Pattern-69.pdf2025-05-06 14:19 12K 
[ ]Shareholding-Pattern-70.pdf2025-05-06 14:19 19K 
[ ]Shareholding-Pattern-71.pdf2025-05-06 14:19 18K 
[ ]Shareholding-Pattern-72.pdf2025-05-06 14:19 11K 
[ ]Shareholding-Pattern-73.pdf2025-05-06 14:19 14K 
[ ]Shareholding-Pattern-74.pdf2025-05-06 14:19 13K 
[ ]Shareholding-Pattern-2018.pdf2025-05-06 14:19 49K 
[ ]Shareholding-Pattern.pdf2025-05-06 14:19 38K 
[ ]Shareholding__Pattern.pdf2025-05-06 14:19 56K 
[ ]Silverstreet-Developers-LLP.pdf2025-05-06 14:19 97K 
[ ]Situatii-financiare-31.03.2020-ROM-semnate.pdf2025-05-06 14:19 2.4M 
[ ]Skisen-Labs-Private-Limited-1.pdf2025-05-06 14:19 5.0M 
[ ]Skisen-Labs-Private-Limited-2.pdf2025-05-06 14:19 1.0M 
[ ]Skisen-Labs-Private-Limited-3.pdf2025-05-06 14:19 429K 
[ ]Skisen-Labs-Private-Limited-4.pdf2025-05-06 14:19 112K 
[ ]Skisen-Labs-Private-Limited.pdf2025-05-06 14:19 254K 
[ ]Softdeal-Trading-Company-Private-Limited-1.pdf2025-05-06 14:19 3.7M 
[ ]Softdeal-Trading-Company-Private-Limited-2.pdf2025-05-06 14:19 1.0M 
[ ]Softdeal-Trading-Company-Private-Limited-3.pdf2025-05-06 14:19 414K 
[ ]Softdeal-Trading-Company-Private-Limited-4.pdf2025-05-06 14:19 116K 
[ ]Softdeal-Trading-Company-Private-Limited-5.pdf2025-05-06 14:19 750K 
[ ]Softdeal-Trading-Company-Private-Limited.pdf2025-05-06 14:19 250K 
[ ]Sonke-Pharmaceuticals-Proprietary-Ltd..pdf2025-05-06 14:20 448K 
[ ]Sonke-Pharmaceuticals-Proprietory-Limited.pdf2025-05-06 14:19 3.4M 
[IMG]South-America-150x150.png2025-05-06 14:19 7.6K 
[IMG]South-America-200x300.png2025-05-06 14:19 17K 
[IMG]South-America-207x250.png2025-05-06 14:20 8.9K 
[IMG]South-America-207x284.png2025-05-06 14:19 11K 
[IMG]South-America.png2025-05-06 14:19 11K 
[ ]Spokesperson-Bios.pdf2025-05-06 14:19 316K 
[ ]Standalone-Financial-Results-1.pdf2025-05-06 14:19 481K 
[ ]Standalone-Financial-Results-2.pdf2025-05-06 14:19 553K 
[ ]Standalone-Financial-Results.pdf2025-05-06 14:19 3.3M 
[ ]Stock-Exchange-Intimation-10-06-13-Postal-Ballot.pdf2025-05-06 14:19 58K 
[ ]Stock-Exchange-Letter-–-Reply.pdf2025-05-06 14:19 50K 
[ ]Stock-Exchange-Letter-–-Update-on-USFDA-Inspection-for-Halol-facility.pdf2025-05-06 14:19 45K 
[ ]Stock-Exchange-Letter-Antitrust-Litigation-in-US.pdf2025-05-06 14:19 96K 
[ ]Stock-Exchange-Letter-CCI-Communication-1.pdf2025-05-06 14:19 59K 
[ ]Stock-Exchange-Letter-CCI-Communication.pdf2025-05-06 14:19 59K 
[ ]Stock-Exchange-Letter-Clarification-on-Recent-Media-Reports.pdf2025-05-06 14:19 180K 
[ ]Stock-Exchange-Letter-Completion-of-transaction-Pola-Pharma-Japan.pdf2025-05-06 14:19 65K 
[ ]Stock-Exchange-Letter-Intimation-of-settlement-in-re-Modafinil-Antitrust-Litigation-in-US-with-certain-plaintiffs.pdf2025-05-06 14:19 163K 
[ ]Stock-Exchange-Letter-Sun-Pharma-Investor-Update.pdf2025-05-06 14:19 77K 
[ ]Stock-Exchange-Letter-Update-on-Halol-facility.pdf2025-05-06 14:19 154K 
[ ]Stock-Exchange-Letter-Update-on-USFDA-Halol-Inspection.pdf2025-05-06 14:19 59K 
[ ]Stock-Exchange-Letter-update-on-commercialsed-XELPROS-in-US.pdf2025-05-06 14:19 1.1M 
[ ]StockExchangeIntimation06022020ID-1.pdf2025-05-06 14:19 6.4M 
[ ]StockExchangeIntimation06022020ID.pdf2025-05-06 14:19 6.4M 
[ ]Submission-of-Corrigendum-to-the-Post-Buyback-Public-Announcement.pdf2025-05-06 14:19 2.0M 
[ ]Subsidiary-Accounts-1.pdf2025-05-06 14:19 181K 
[ ]Subsidiary-Accounts-2.pdf2025-05-06 14:20 217K 
[ ]Subsidiary-Accounts.pdf2025-05-06 14:19 891K 
[ ]Summary-of-CSR-Policy.pdf2025-05-06 14:19 702K 
[ ]Summary-of-CSR-Policy_SPIL.pdf2025-05-06 14:19 702K 
[ ]Sun-CSR-Report-19-20.DP_-1.pdf-1.pdf2025-05-06 14:19 3.9M 
[ ]Sun-CSR-Report-19-20.DP_.pdf.pdf2025-05-06 14:19 3.9M 
[ ]Sun-Farmaceutica-Do-Brasil-Ltda-1.pdf2025-05-06 14:19 175K 
[ ]Sun-Farmaceutica-Do-Brasil-Ltda-Previously-Known-as-TKS-Farmaceutica-Ltda.pdf2025-05-06 14:19 247K 
[ ]Sun-Farmaceutica-Do-Brasil-Ltda.pdf2025-05-06 14:19 527K 
[ ]Sun-Farmaceutica-Do-Brazil-Ltda.pdf2025-05-06 14:19 853K 
[ ]Sun-Farmaceutica-do-Brasil-Ltda..pdf2025-05-06 14:19 914K 
[ ]Sun-Global-Canada-Pty-Ltd-1.pdf2025-05-06 14:19 407K 
[ ]Sun-Global-Canada-Pty-Ltd-2.pdf2025-05-06 14:19 126K 
[ ]Sun-Global-Canada-Pty-Ltd.pdf2025-05-06 14:19 588K 
[ ]Sun-Global-Canada-Pty.-Ltd.-1.pdf2025-05-06 14:19 70K 
[ ]Sun-Global-Canada-Pty.-Ltd..pdf2025-05-06 14:19 2.1M 
[ ]Sun-Global-Development-FZE-1.pdf2025-05-06 14:19 1.3M 
[ ]Sun-Global-Development-FZE-2.pdf2025-05-06 14:19 1.1M 
[ ]Sun-Global-Development-FZE-3.pdf2025-05-06 14:19 3.6M 
[ ]Sun-Global-Development-FZE-4.pdf2025-05-06 14:19 1.4M 
[ ]Sun-Global-Development-FZE.pdf2025-05-06 14:19 911K 
[ ]Sun-Laboratories-FZE-1.pdf2025-05-06 14:19 1.3M 
[ ]Sun-Laboratories-FZE-2.pdf2025-05-06 14:19 1.2M 
[ ]Sun-Laboratories-FZE-3.pdf2025-05-06 14:19 4.1M 
[ ]Sun-Laboratories-FZE-4.pdf2025-05-06 14:19 1.7M 
[ ]Sun-Laboratories-FZE.pdf2025-05-06 14:19 928K 
[ ]Sun-Pharma-–-Proxy-Form-for-NCLT-Convened-Meeting-for-Equity-Shareholders.pdf2025-05-06 14:19 63K 
[ ]Sun-Pharma-2Q-2007-08-results-on-Oct-25-2007_-earnings-call-on-Oct-26-at-10-am-IST-October-10-2007.pdf2025-05-06 14:19 24K 
[ ]Sun-Pharma-AGM-Notice-2013-14-1.pdf2025-05-06 14:19 227K 
[ ]Sun-Pharma-AGM-Notice-2013-14.pdf2025-05-06 14:19 227K 
[ ]Sun-Pharma-ANZ-Pty-Ltd-1.pdf2025-05-06 14:19 1.2M 
[ ]Sun-Pharma-ANZ-Pty-Ltd-2.pdf2025-05-06 14:19 1.7M 
[ ]Sun-Pharma-ANZ-Pty-Ltd-3.pdf2025-05-06 14:19 871K 
[ ]Sun-Pharma-ANZ-Pty-Ltd.pdf2025-05-06 14:19 1.2M 
[ ]Sun-Pharma-AR-2019-20.pdf2025-05-06 14:19 4.7M 
[ ]Sun-Pharma-Announces-U.S.-FDA-Approval-of-ILUMYA.pdf2025-05-06 14:19 283K 
[ ]Sun-Pharma-Announces-US-FDA-Acceptance-of-NDA-for-OTX-101.pdf2025-05-06 14:19 386K 
[ ]Sun-Pharma-Announces-US-Launch-of-Authorized-Generic-for-Welchol-Tablets.pdf2025-05-06 14:19 70K 
[ ]Sun-Pharma-BRR.pdf2025-05-06 14:19 123K 
[ ]Sun-Pharma-CHC-enters-anti-fungal-powder-OTC-category-with-ABZORB.pdf2025-05-06 14:19 412K 
[ ]Sun-Pharma-Canada-Inc..pdf2025-05-06 14:19 732K 
[ ]Sun-Pharma-Commences-All-Cash-Tender-Offer-to-Purchase-Taro-Ordinary-Shares-for-USD-7.75-Per-Share-June-30-2008.pdf2025-05-06 14:19 26K 
[ ]Sun-Pharma-Comments-on-Taros-Potential-Sale-of-its-Irish-Operations-June-5-2008.pdf2025-05-06 14:19 43K 
[ ]Sun-Pharma-De-Mexico-S.A.-DE-C.V.-1.pdf2025-05-06 14:19 245K 
[ ]Sun-Pharma-De-Mexico-S.A.-DE-C.V.-2.pdf2025-05-06 14:19 2.0M 
[ ]Sun-Pharma-De-Mexico-S.A.-DE-C.V..pdf2025-05-06 14:19 5.0M 
[ ]Sun-Pharma-De-Mexico-S.A.-De-C.V.pdf2025-05-06 14:19 3.4M 
[ ]Sun-Pharma-De-Mexico-S.A.de_.pdf2025-05-06 14:19 8.1M 
[ ]Sun-Pharma-De-Venezuela-C.A-1.pdf2025-05-06 14:19 5.5M 
[ ]Sun-Pharma-De-Venezuela-C.A-2.pdf2025-05-06 14:19 11M 
[ ]Sun-Pharma-De-Venezuela-C.A-3.pdf2025-05-06 14:19 6.3M 
[ ]Sun-Pharma-De-Venezuela-C.A.pdf2025-05-06 14:19 5.4M 
[ ]Sun-Pharma-De-VenezuelaC.A..pdf2025-05-06 14:19 6.2M 
[ ]Sun-Pharma-Distributors-Limited-1.pdf2025-05-06 14:19 2.7M 
[ ]Sun-Pharma-Distributors-Limited.pdf2025-05-06 14:19 296K 
[ ]Sun-Pharma-East-Africa-Limited-1.pdf2025-05-06 14:19 81K 
[ ]Sun-Pharma-East-Africa-Limited-2.pdf2025-05-06 14:19 43K 
[ ]Sun-Pharma-East-Africa-Limited-3.pdf2025-05-06 14:19 153K 
[ ]Sun-Pharma-East-Africa-Limited.pdf2025-05-06 14:19 305K 
[ ]Sun-Pharma-East-Africa-Ltd.pdf2025-05-06 14:19 191K 
[ ]Sun-Pharma-Egypt-Limited-LLC-1.pdf2025-05-06 14:19 6.3M 
[ ]Sun-Pharma-Egypt-Limited-LLC.pdf2025-05-06 14:19 576K 
[ ]Sun-Pharma-Extends-Tender-Offer-for-Taro-July-14-2008.pdf2025-05-06 14:19 25K 
[ ]Sun-Pharma-Global-FZE-1.pdf2025-05-06 14:19 1.5M 
[ ]Sun-Pharma-Global-FZE-2.pdf2025-05-06 14:19 1.2M 
[ ]Sun-Pharma-Global-FZE-3.pdf2025-05-06 14:19 8.2M 
[ ]Sun-Pharma-Global-FZE-4.pdf2025-05-06 14:19 3.5M 
[ ]Sun-Pharma-Global-FZE.pdf2025-05-06 14:19 1.1M 
[ ]Sun-Pharma-Global-Inc-BVI.pdf2025-05-06 14:19 703K 
[ ]Sun-Pharma-H1-post-results-conference-call-on-Wednesday-October-22-11am-October-22-2003-1.pdf2025-05-06 14:19 12K 
[ ]Sun-Pharma-H1-post-results-conference-call-on-Wednesday-October-22-11am-October-22-2003.pdf2025-05-06 14:19 12K 
[ ]Sun-Pharma-H1-results-on-Oct-28-October-18-2005.pdf2025-05-06 14:19 62K 
[ ]Sun-Pharma-HealthCare-FZE.pdf2025-05-06 14:19 884K 
[ ]Sun-Pharma-Healthcare-FZE-1.pdf2025-05-06 14:19 1.3M 
[ ]Sun-Pharma-Healthcare-FZE-2.pdf2025-05-06 14:19 1.1M 
[ ]Sun-Pharma-Healthcare-FZE-3.pdf2025-05-06 14:19 3.5M 
[ ]Sun-Pharma-Holding-USA-Inc.-_-Subs.pdf2025-05-06 14:19 222K 
[ ]Sun-Pharma-Holdings-1.pdf2025-05-06 14:19 4.1M 
[ ]Sun-Pharma-Holdings-2.pdf2025-05-06 14:19 6.2M 
[ ]Sun-Pharma-Holdings-3.pdf2025-05-06 14:19 1.0M 
[ ]Sun-Pharma-Holdings-Previously-Known-as-Nogad-Holdings.pdf2025-05-06 14:19 501K 
[ ]Sun-Pharma-Holdings-USA-Inc-and-entities.pdf2025-05-06 14:19 2.1M 
[ ]Sun-Pharma-Holdings.pdf2025-05-06 14:19 883K 
[ ]Sun-Pharma-Industries-SAC.pdf2025-05-06 14:19 1.0M 
[ ]Sun-Pharma-Japan-Ltd-1.pdf2025-05-06 14:20 94K 
[ ]Sun-Pharma-Japan-Ltd.-1.pdf2025-05-06 14:19 376K 
[ ]Sun-Pharma-Japan-Ltd.-2.pdf2025-05-06 14:19 117K 
[ ]Sun-Pharma-Japan-Ltd.-3.pdf2025-05-06 14:19 120K 
[ ]Sun-Pharma-Japan-Ltd..pdf2025-05-06 14:19 1.0M 
[ ]Sun-Pharma-Japan-Ltd.pdf2025-05-06 14:19 761K 
[ ]Sun-Pharma-Laboratories-Limited-1.pdf2025-05-06 14:19 14M 
[ ]Sun-Pharma-Laboratories-Limited-2.pdf2025-05-06 14:19 12M 
[ ]Sun-Pharma-Laboratories-Limited-3.pdf2025-05-06 14:19 1.1M 
[ ]Sun-Pharma-Laboratories-Limited-4.pdf2025-05-06 14:19 971K 
[ ]Sun-Pharma-Laboratories-Limited.pdf2025-05-06 14:19 10M 
[ ]Sun-Pharma-Mea-Jlt.pdf2025-05-06 14:19 1.9M 
[ ]Sun-Pharma-Medicare-Limited.pdf2025-05-06 14:19 18M 
[ ]Sun-Pharma-Netherlands-B.V.-1.pdf2025-05-06 14:19 718K 
[ ]Sun-Pharma-Netherlands-B.V.-Formerly-known-as-Ranbaxy-Netherlands-B.V..pdf2025-05-06 14:19 5.5M 
[ ]Sun-Pharma-Netherlands-B.V..pdf2025-05-06 14:19 5.6M 
[ ]Sun-Pharma-Philippines-Inc..pdf2025-05-06 14:19 18M 
[ ]Sun-Pharma-Philippines-Inc.pdf2025-05-06 14:19 672K 
[ ]Sun-Pharma-Phillipines-Inc.-1.pdf2025-05-06 14:19 4.2M 
[ ]Sun-Pharma-Phillipines-Inc.-2.pdf2025-05-06 14:19 16M 
[ ]Sun-Pharma-Phillipines-Inc..pdf2025-05-06 14:19 559K 
[ ]Sun-Pharma-Prandin-Supreme-Court-Judgment.pdf2025-05-06 14:19 82K 
[ ]Sun-Pharma-Press-Conference-Invitation.pdf2025-05-06 14:19 401K 
[ ]Sun-Pharma-Press-Release-Extension-of-Imatinib-Savings-Card-program.pdf2025-05-06 14:19 137K 
[ ]Sun-Pharma-Q1-FY-2014-15-financial-result-on-August-12-2014-1.pdf2025-05-06 14:19 67K 
[ ]Sun-Pharma-Q1-FY14-financial-result-August09-2013-1.pdf2025-05-06 14:19 19K 
[ ]Sun-Pharma-Q1-FY16-financial-result-on-August-11-2015.pdf2025-05-06 14:19 71K 
[ ]Sun-Pharma-Q1-FY17-financial-result-on-August-12-2016.pdf2025-05-06 14:19 69K 
[ ]Sun-Pharma-Q1-FY18-financial-result-on-August-11-2017.pdf2025-05-06 14:19 69K 
[ ]Sun-Pharma-Q1-post-results-conference-call-on-Monday-August-2-at-11.00-am-August-02-2004.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-Q1-post-results-conference-call-on-Thursday-July-28-at-11am-IST-July-28-2005.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-Q2-FY14-financial-result-on-13-Nov-2013-1-1.pdf2025-05-06 14:19 21K 
[ ]Sun-Pharma-Q2-FY14-financial-result-on-13-Nov-2013-1.pdf2025-05-06 14:19 21K 
[ ]Sun-Pharma-Q2-FY17-financial-result-on-November-10-2016.pdf2025-05-06 14:19 40K 
[ ]Sun-Pharma-Q2-H1-FY16-financial-result-Nov-07-2015.pdf2025-05-06 14:19 71K 
[ ]Sun-Pharma-Q2-and-H1-FY-2014-15-financial-result-on-November-13-2014.pdf2025-05-06 14:19 68K 
[ ]Sun-Pharma-Q3-FY14-financial-result-on-February14.pdf2025-05-06 14:19 21K 
[ ]Sun-Pharma-Q3-FY16-financial-result-on-February12-2c-2016.pdf2025-05-06 14:19 69K 
[ ]Sun-Pharma-Q3-FY17-financial-result-on-February-14-2017.pdf2025-05-06 14:19 70K 
[ ]Sun-Pharma-Q3-and-9m-FY-2014-15-financial-result-on-February-14-2015.pdf2025-05-06 14:19 67K 
[ ]Sun-Pharma-Q4-FY14-financial-result-on-May-29-2014-1.pdf2025-05-06 14:19 67K 
[ ]Sun-Pharma-Q4-FY16-financial-result-on-May-30-2016.pdf2025-05-06 14:19 69K 
[ ]Sun-Pharma-Q4-FY17-financial-result-on-May-26-2017.pdf2025-05-06 14:19 70K 
[ ]Sun-Pharma-Q4-FY18-financial-result-on-25-May-2017.pdf2025-05-06 14:19 70K 
[ ]Sun-Pharma-Q4-and-FY-2014-15-financial-result-on-May-29-2015.pdf2025-05-06 14:19 70K 
[ ]Sun-Pharma-Q4-post-results-conference-call-on-Thursday-April-22-12-noon-April-22-2004.pdf2025-05-06 14:19 9.9K 
[ ]Sun-Pharma-Responds-to-Taros-purported-Termination-of-Merger-Agreement-May-29-2008.pdf2025-05-06 14:19 85K 
[ ]Sun-Pharma-SA-Pty-Ltd-1.pdf2025-05-06 14:19 55K 
[ ]Sun-Pharma-SA-Pty-Ltd.pdf2025-05-06 14:19 1.8M 
[ ]Sun-Pharma-Science-Awards-Media-Invitation.pdf2025-05-06 14:19 395K 
[ ]Sun-Pharma-Science-Foundation.pdf2025-05-06 14:19 306K 
[ ]Sun-Pharma-Switzerland-Limited-1.pdf2025-05-06 14:19 4.4M 
[ ]Sun-Pharma-Switzerland-Limited.pdf2025-05-06 14:19 7.9M 
[ ]Sun-Pharma-Switzerland-Ltd.-1.pdf2025-05-06 14:19 1.9M 
[ ]Sun-Pharma-Switzerland-Ltd..pdf2025-05-06 14:19 7.2M 
[ ]Sun-Pharma-Switzerland-Ltd.pdf2025-05-06 14:19 277K 
[ ]Sun-Pharma-Update-on-Protonix-litigation-Apr-2010.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharma-and-China-Medical-System-Holdings-Enter-into-Licensing-Agreement-for-Generic-Products-in-Mainland-C.pdf2025-05-06 14:19 79K 
[ ]Sun-Pharma-and-Samsung-BioLogics-announce-strategic-manufacturing-tie-up-for-Tildrakizumab.pdf2025-05-06 14:19 77K 
[ ]Sun-Pharma-announces-Bonus-Preference-Shares-carrying-coupon-of-6-in-ratio-of-4-shares-of-Rs-1-each-per-1-equity-share-held-July-28-2002.pdf2025-05-06 14:19 12K 
[ ]Sun-Pharma-announces-USFDA-approval-for-Sinemet-CR-an-extended-release-version-of-Carbidopa-with-Levodopa-August-25-2007-1.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-announces-USFDA-approval-for-Sinemet-CR-an-extended-release-version-of-Carbidopa-with-Levodopa-August-25-2007-2.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-announces-USFDA-approval-for-Sinemet-CR-an-extended-release-version-of-Carbidopa-with-Levodopa-August-25-2007.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-announces-USFDA-approval-for-generic-Casodex®-tablets.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharma-announces-USFDA-approval-to-market-generic-ExelonA®-Capsules-October-24-2007.pdf2025-05-06 14:19 25K 
[ ]Sun-Pharma-announces-USFDA-approval-to-market-generic-Octreotide-injection-August-19-2007.pdf2025-05-06 14:19 24K 
[ ]Sun-Pharma-announces-USFDA-approval-to-market-generic-Paraplatin-injection-September-23-2008.pdf2025-05-06 14:19 29K 
[ ]Sun-Pharma-announces-USFDA-approval-to-market-generic-Protonix-Tablets-Company-gets-its-first-180-day-marketing-exclusivity-on-a-first-to-file-ANDA-with-para-IV-certification.pdf2025-05-06 14:20 25K 
[ ]Sun-Pharma-announces-USFDA-approval-to-market-generic-Trileptal®-Tablets-180-day-marketing-exclusivity.pdf2025-05-06 14:19 25K 
[ ]Sun-Pharma-announces-audited-numbers-dividend-bonus-preference-M-J-Pharma-swap-record-date-May-31-2002.pdf2025-05-06 14:19 18K 
[ ]Sun-Pharma-announces-bonus-February-01-2000.pdf2025-05-06 14:19 7.7K 
[ ]Sun-Pharma-announces-divestment-of-US-manufacturing-units.pdf2025-05-06 14:19 65K 
[ ]Sun-Pharma-announces-settlement-of-litigation-over-generic-ExelonA®-December-06-2007.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharma-announces-swap-ratio-for-Phlox-Pharma-merger-July-31-2004.pdf2025-05-06 14:19 13K 
[ ]Sun-Pharma-board-proposes-buyback-plan-October-28-2002.pdf2025-05-06 14:19 8.0K 
[ ]Sun-Pharma-board-to-consider-bonus-on-Feb-1-January-21-2000.pdf2025-05-06 14:19 7.6K 
[ ]Sun-Pharma-board-to-consider-merger-of-export-subsidiary-March-31-2000.pdf2025-05-06 14:19 9.9K 
[ ]Sun-Pharma-board-to-meet-July-27-July-18-2005.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-board-to-meet-July-31-Q1-results-July-19-2004.pdf2025-05-06 14:19 7.8K 
[ ]Sun-Pharma-board-to-meet-on-Oct-21-first-half-results-October-18-2004.pdf2025-05-06 14:19 20K 
[ ]Sun-Pharma-board-to-meet_-to-consider-issue-of-convertible-debentures-April-02-2004.pdf2025-05-06 14:19 12K 
[ ]Sun-Pharma-buys-Taro-Pharma-shares-from-Brandes-February-19-2008.pdf2025-05-06 14:19 19K 
[ ]Sun-Pharma-buys-manufacturing-facility-in-Bryan-Ohio-September-14-2005.pdf2025-05-06 14:19 67K 
[ ]Sun-Pharma-clarifies-on-news-stories.-January-20-2001.pdf2025-05-06 14:19 17K 
[ ]Sun-Pharma-closes-Able-Labs-acquisition-in-the-US-December-23-2005.pdf2025-05-06 14:19 178K 
[ ]Sun-Pharma-completes-275-mill-FCCB-November-27-2004.pdf2025-05-06 14:19 9.8K 
[ ]Sun-Pharma-conference-call-after-the-Q1-results-on-Monday-July-28-July-28-2003-1.pdf2025-05-06 14:19 9.8K 
[ ]Sun-Pharma-conference-call-after-the-Q1-results-on-Monday-July-28-July-28-2003.pdf2025-05-06 14:19 9.8K 
[ ]Sun-Pharma-de-Venezuela-CA..pdf2025-05-06 14:19 3.3M 
[ ]Sun-Pharma-declares-40_-second-interim-dividend-March-18-2000.pdf2025-05-06 14:19 42K 
[ ]Sun-Pharma-declares-60_-interim-dividend-November-06-1999.pdf2025-05-06 14:19 9.0K 
[ ]Sun-Pharma-declares-interim-dividend-November-29-2004.pdf2025-05-06 14:19 9.6K 
[ ]Sun-Pharma-exercises-its-options-to-acquire-the-shares-of-the-controlling-shareholders-of-Taro-Pharma.pdf2025-05-06 14:19 29K 
[ ]Sun-Pharma-extends-tender-offer-for-Taro-October-03-2008.pdf2025-05-06 14:19 38K 
[ ]Sun-Pharma-flood-at-plant-sites-August-04-2004.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-gets-USFDA-approval-for-generic-Depakote-®-delayed-release-tablets-July-30-2008-1.pdf2025-05-06 14:19 30K 
[ ]Sun-Pharma-gets-USFDA-approval-for-generic-Depakote-®-delayed-release-tablets-July-30-2008.pdf2025-05-06 14:19 30K 
[ ]Sun-Pharma-gets-USFDA-approval-for-generic-Fosamax®-tablets-September-12-2008.pdf2025-05-06 14:19 30K 
[ ]Sun-Pharma-gets-USFDA-approval-to-market-generic-Demadex®-Tablets-February-27-2008.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-gets-USFDA-tentative-approval-for-generic-Gemzar®-injection-March-5-2008.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharma-hikes-stake-in-Caraco-to-63.14_-March-13-2004.pdf2025-05-06 14:19 13K 
[ ]Sun-Pharma-launches-‘Thank-you-Doctor-campaign.pdf2025-05-06 14:19 198K 
[ ]Sun-Pharma-launches-225-mill-FCCB-Issue-November-18-2004-1.pdf2025-05-06 14:19 10K 
[ ]Sun-Pharma-launches-225-mill-FCCB-Issue-November-18-2004.pdf2025-05-06 14:19 10K 
[ ]Sun-Pharma-launches-Smoquit-August-10-2001.pdf2025-05-06 14:19 10K 
[ ]Sun-Pharma-launches-anticancer-with-novel-biodegradable-microsphere-technology-product-readily-available-at-distribution-centers-first-time-in-India-July-16-2002.pdf2025-05-06 14:19 15K 
[ ]Sun-Pharma-launches-generic-Protonix-®-January-30-2008.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-purchases-additional-stake-in-Caraco-to-hold-over-60-_-equity-February-03-2004.pdf2025-05-06 14:19 13K 
[ ]Sun-Pharma-reaffirms-commitment-to-Taro-facilities-and-employees-July-28-2008.pdf2025-05-06 14:19 27K 
[ ]Sun-Pharma-receives-notice-for-termination-of-merger-from-Taro-May-28-2008.pdf2025-05-06 14:19 28K 
[ ]Sun-Pharma-receives-will-not-sue-covenant-on-generic-Effexor-XR-®-ANDA.pdf2025-05-06 14:19 24K 
[ ]Sun-Pharma-shares-guidance-for-2005-2006-May-06-2005.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-shares-plans-recent-Hungarian-and-US-acquisitions-October-04-2005.pdf2025-05-06 14:19 62K 
[ ]Sun-Pharma-signs-agreement-with-MedImmune-for-generic-Ethyol®.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharma-subsidiary-acquires-100_-of-Chattem-Chemicals-Inc.-a-US-based-DEA-registered-narcotic-API-importer-_-producer-November-5-2008.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-to-acquire-Biosintez-in-Russia.pdf2025-05-06 14:19 105K 
[ ]Sun-Pharma-to-acquire-Ocular-Technologies-1.pdf2025-05-06 14:19 52K 
[ ]Sun-Pharma-to-acquire-Ocular-Technologies.pdf2025-05-06 14:20 52K 
[ ]Sun-Pharma-to-acquire-Taro-Pharma-in-a-USD-454-million-deal.pdf2025-05-06 14:19 30K 
[ ]Sun-Pharma-to-acquire-a-bulk-active-company-Phlox-Pharma-has-EDMF-approval-UKMCA-USFDA-compliant-plant-July-06-2004.pdf2025-05-06 14:19 10K 
[ ]Sun-Pharma-to-announce-Q2-and-H1-2008-09-results-on-Oct-25-2008-October-15-2008.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-to-announce-Q3-2007-08-results-on-January-30-2008-January-16-2008.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-to-announce-audited-q4-numbers-on-May-3-April-25-2003-1.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-to-announce-audited-q4-numbers-on-May-3-April-25-2003.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-to-announce-unaudited-H1-numbers-on-October-21-October-21-2003-1.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-to-announce-unaudited-H1-numbers-on-October-21-October-21-2003.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-to-announce-unaudited-q1-numbers-on-July-28-July-28-2003-1.pdf2025-05-06 14:20 8.8K 
[ ]Sun-Pharma-to-announce-unaudited-q1-numbers-on-July-28-July-28-2003.pdf2025-05-06 14:19 8.8K 
[ ]Sun-Pharma-to-buy-3-US-brands-for-5.4-mill-Entry-in-brand-market-in-North-America-September-23-2004.pdf2025-05-06 14:19 15K 
[ ]Sun-Pharma-to-buy-manufacturing-site-in-Hungary-August-10-2005.pdf2025-05-06 14:19 59K 
[ ]Sun-Pharma-to-donate-hostel-for-medical-college-May-12-2005.pdf2025-05-06 14:19 14K 
[ ]Sun-Pharma-to-license-key-Escitalopram®-patent-applications-to-Lundbeck.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharma-to-raise-350mill-EGM-announced-April-08-2004.pdf2025-05-06 14:19 9.6K 
[ ]Sun-Pharma-to-set-up-new-research-campus-in-Chennai-October-25-1999.pdf2025-05-06 14:19 11K 
[ ]Sun-Pharma-update-on-ANDA-for-generic-Effexor-XR-USFDA-grants-Osmotica_s-citizen-petition-November-27-2008.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharma_s-board-to-meet-Jan-30-Q3-results-January-30-2006.pdf2025-05-06 14:19 181K 
[ ]Sun-Pharma_s-bulk-active-and-tablet-manufacturing-factories-are-cleared-by-USFDA-May-26-2004.pdf2025-05-06 14:19 16K 
[ ]Sun-Pharma_s-lead-molecule-enters-Phase-II-in-the-US-October-20-2006.pdf2025-05-06 14:19 24K 
[ ]Sun-Pharma_s-new-plant-at-Dadra-commences-operations-March-28-2002.pdf2025-05-06 14:19 9.0K 
[ ]Sun-Pharmaceutical-Bangaldesh-Ltd-1.pdf2025-05-06 14:19 88K 
[ ]Sun-Pharmaceutical-Bangaldesh-Ltd-2.pdf2025-05-06 14:19 83K 
[ ]Sun-Pharmaceutical-Bangaldesh-Ltd.pdf2025-05-06 14:19 872K 
[ ]Sun-Pharmaceutical-Bangladesh-Limited.pdf2025-05-06 14:19 942K 
[ ]Sun-Pharmaceutical-Bangladesh-Ltd..pdf2025-05-06 14:20 1.6M 
[ ]Sun-Pharmaceutical-Extends-Tender-Offer-for-Taro-September-3-2008.pdf2025-05-06 14:19 27K 
[ ]Sun-Pharmaceutical-Holdings-USA-Inc-and-Subsidiaries.pdf2025-05-06 14:19 1.9M 
[ ]Sun-Pharmaceutical-Industries-Australia-Pty-Ltd-1.pdf2025-05-06 14:19 4.2M 
[ ]Sun-Pharmaceutical-Industries-Australia-Pty-Ltd-2.pdf2025-05-06 14:19 7.3M 
[ ]Sun-Pharmaceutical-Industries-Australia-Pty-Ltd.pdf2025-05-06 14:19 3.5M 
[ ]Sun-Pharmaceutical-Industries-Australia-Pty.-Ltd..pdf2025-05-06 14:19 3.8M 
[ ]Sun-Pharmaceutical-Industries-Europe-B.V.-1.pdf2025-05-06 14:19 9.7M 
[ ]Sun-Pharmaceutical-Industries-Europe-B.V.-2.pdf2025-05-06 14:19 5.0M 
[ ]Sun-Pharmaceutical-Industries-Europe-B.V.-3.pdf2025-05-06 14:19 4.0M 
[ ]Sun-Pharmaceutical-Industries-Europe-B.V..pdf2025-05-06 14:19 9.8M 
[ ]Sun-Pharmaceutical-Industries-Inc-and-its-subsidiaries.pdf2025-05-06 14:19 532K 
[ ]Sun-Pharmaceutical-Industries-Inc.-and-Subsidiaries.pdf2025-05-06 14:19 1.7M 
[ ]Sun-Pharmaceutical-Industries-Inc.-and-its-subsidiaries-1.pdf2025-05-06 14:19 357K 
[ ]Sun-Pharmaceutical-Industries-Inc.-and-its-subsidiaries.pdf2025-05-06 14:19 536K 
[ ]Sun-Pharmaceutical-Medicare-Limited.pdf2025-05-06 14:19 255K 
[ ]Sun-Pharmaceutical-Peru-S.A.C-1.pdf2025-05-06 14:19 364K 
[ ]Sun-Pharmaceutical-Peru-S.A.C-2.pdf2025-05-06 14:19 364K 
[ ]Sun-Pharmaceutical-Peru-S.A.C-3.pdf2025-05-06 14:19 388K 
[ ]Sun-Pharmaceutical-Peru-S.A.C..pdf2025-05-06 14:19 81K 
[ ]Sun-Pharmaceutical-Peru-S.A.C.pdf2025-05-06 14:19 2.5M 
[ ]Sun-Pharmaceutical-Peru-SAC.pdf2025-05-06 14:19 1.0M 
[ ]Sun-Pharmaceutical-Spain-S.L.U-1.pdf2025-05-06 14:19 2.9M 
[ ]Sun-Pharmaceutical-Spain-S.L.U.pdf2025-05-06 14:19 1.6M 
[ ]Sun-Pharmaceutical-UK-Ltd..pdf2025-05-06 14:19 1.5M 
[ ]Sun-Pharmaceutical-announces-USFDA-approval-to-market-generic-Cerebyx®-March-19-2008.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharmaceutical-announces-USFDA-approval-to-market-generic-Ethyol-®-With-180-day-marketing-exclusivity-March-15-2008.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharmaceutical-announces-USFDA-approval-to-market-generic-Sinemet®-tablets-November-5-2008.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharmaceutical-announces-USFDA-approval-to-market-generic-Tessalon®-March-21-2008.pdf2025-05-06 14:19 22K 
[ ]Sun-Pharmaceutical-announces-launch-of-generic-Ethyo-May-31-2008.pdf2025-05-06 14:19 23K 
[ ]Sun-Pharmaceutical-extends-tender-offer-for-Taro-to-Dec-19-2008-November-7-2008.pdf2025-05-06 14:19 26K 
[ ]Sun-Pharmaceutical-extends-tender-offer-for-Taro-to-January-9-2009.pdf2025-05-06 14:19 38K 
[ ]Sun-Pharmaceuticals-France-1.pdf2025-05-06 14:19 5.6M 
[ ]Sun-Pharmaceuticals-France-2.pdf2025-05-06 14:19 661K 
[ ]Sun-Pharmaceuticals-France-3.pdf2025-05-06 14:19 1.3M 
[ ]Sun-Pharmaceuticals-France-4.pdf2025-05-06 14:19 2.3M 
[ ]Sun-Pharmaceuticals-France-5.pdf2025-05-06 14:19 569K 
[ ]Sun-Pharmaceuticals-France-6.pdf2025-05-06 14:19 569K 
[ ]Sun-Pharmaceuticals-France-7.pdf2025-05-06 14:19 9.5M 
[ ]Sun-Pharmaceuticals-France.pdf2025-05-06 14:19 5.6M 
[ ]Sun-Pharmaceuticals-Germany-GmbH-1.pdf2025-05-06 14:19 5.3M 
[ ]Sun-Pharmaceuticals-Germany-GmbH-2.pdf2025-05-06 14:19 483K 
[ ]Sun-Pharmaceuticals-Germany-GmbH-3.pdf2025-05-06 14:19 9.1M 
[ ]Sun-Pharmaceuticals-Germany-GmbH-4.pdf2025-05-06 14:19 5.6M 
[ ]Sun-Pharmaceuticals-Germany-GmbH-5.pdf2025-05-06 14:19 3.2M 
[ ]Sun-Pharmaceuticals-Germany-GmbH.pdf2025-05-06 14:19 94K 
[ ]Sun-Pharmaceuticals-Industries-Europe-B.V..pdf2025-05-06 14:19 3.8M 
[ ]Sun-Pharmaceuticals-Industries-SAC.pdf2025-05-06 14:19 2.9M 
[ ]Sun-Pharmaceuticals-Italia-S.R.L.-1.pdf2025-05-06 14:19 3.4M 
[ ]Sun-Pharmaceuticals-Italia-S.R.L..pdf2025-05-06 14:19 2.9M 
[ ]Sun-Pharmaceuticals-Italia-SRL-1.pdf2025-05-06 14:19 6.4M 
[ ]Sun-Pharmaceuticals-Italia-SRL.pdf2025-05-06 14:19 9.6M 
[ ]Sun-Pharmaceuticals-Korea-Ltd-1.pdf2025-05-06 14:19 98K 
[ ]Sun-Pharmaceuticals-Korea-Ltd-2.pdf2025-05-06 14:19 98K 
[ ]Sun-Pharmaceuticals-Korea-Ltd-3.pdf2025-05-06 14:19 144K 
[ ]Sun-Pharmaceuticals-Korea-Ltd.-1.pdf2025-05-06 14:19 2.0M 
[ ]Sun-Pharmaceuticals-Korea-Ltd.-2.pdf2025-05-06 14:19 69K 
[ ]Sun-Pharmaceuticals-Korea-Ltd..pdf2025-05-06 14:19 30K 
[ ]Sun-Pharmaceuticals-Korea-Ltd.pdf2025-05-06 14:19 563K 
[ ]Sun-Pharmaceuticals-Morocco-LLC-Formerly-known-as-Ranbaxy-Morocco-LLC.pdf2025-05-06 14:19 425K 
[ ]Sun-Pharmaceuticals-Morocco-LLC-Sarlau.pdf2025-05-06 14:19 2.7M 
[ ]Sun-Pharmaceuticals-Morocco-Sarlau.pdf2025-05-06 14:20 1.7M 
[ ]Sun-Pharmaceuticals-SA-Pty-Limited.pdf2025-05-06 14:19 1.7M 
[ ]Sun-Pharmaceuticals-SA-Pty-Ltd..pdf2025-05-06 14:19 68K 
[ ]Sun-Pharmaceuticals-SA-Pty-Ltd.pdf2025-05-06 14:19 117K 
[ ]Sun-Pharmaceuticals-UK-Limited-1.pdf2025-05-06 14:19 8.6M 
[ ]Sun-Pharmaceuticals-UK-Limited-2.pdf2025-05-06 14:19 45K 
[ ]Sun-Pharmaceuticals-UK-Limited.pdf2025-05-06 14:19 4.1M 
[ ]Sun-Pharmas-board-to-meet-audited-accounts-MJ-Pharma-merger-May-27-2002.pdf2025-05-06 14:19 19K 
[ ]Sun-Pharmas-second-letter-to-Taro-Pharma-regarding-Taros-Irish-subsidiary-.pdf2025-05-06 14:19 45K 
[ ]Sun-Ranbaxy-Investor-Presentation-1.pdf2025-05-06 14:19 370K 
[ ]Sun-Ranbaxy-Investor-Presentation.pdf2025-05-06 14:19 393K 
[ ]Sun-To-File-Amendment-to-Tender-Offer-for-Taro-Waiving-Certain-Conditions-August-27-2008.pdf2025-05-06 14:19 34K 
[ ]Sun-pharma-to-meet.pdf2025-05-06 14:19 12K 
[ ]SunPharma-Q2-FY18-financial-result-on-November-14-2017.pdf2025-05-06 14:19 69K 
[ ]SunPharmaAR2019-20-1.pdf2025-05-06 14:19 4.7M 
[ ]SunPharmaAR2019-20.pdf2025-05-06 14:19 4.9M 
[ ]SunPharmaQ4FY13.pdf2025-05-06 14:19 70K 
[ ]SunPharma_Q3_FY18_financial_result_on_February_14_2018.pdf2025-05-06 14:19 70K 
[ ]SunPharmaceuticalIndustries-SAC.pdf2025-05-06 14:19 432K 
[ ]SunWinOverTaro.pdf2025-05-06 14:19 27K 
[IMG]Sunology-1-150x150.jpg2025-05-06 14:19 6.0K 
[IMG]Sunology-1-300x200.jpg2025-05-06 14:19 13K 
[IMG]Sunology-1-400x250.jpg2025-05-06 14:19 18K 
[IMG]Sunology-1-400x284.jpg2025-05-06 14:19 20K 
[IMG]Sunology-1-400x516.jpg2025-05-06 14:19 27K 
[IMG]Sunology-1-480x320.jpg2025-05-06 14:19 25K 
[IMG]Sunology-1-510x382.jpg2025-05-06 14:19 29K 
[IMG]Sunology-1-768x512.jpg2025-05-06 14:19 48K 
[IMG]Sunology-1-980x653.jpg2025-05-06 14:19 70K 
[IMG]Sunology-1-1024x683.jpg2025-05-06 14:19 75K 
[IMG]Sunology-1-1080x675.jpg2025-05-06 14:19 77K 
[IMG]Sunology-1-1080x720.jpg2025-05-06 14:19 82K 
[IMG]Sunology-1-1280x853.jpg2025-05-06 14:19 108K 
[IMG]Sunology-1-1536x1024.jpg2025-05-06 14:19 149K 
[IMG]Sunology-1.jpg2025-05-06 14:19 1.5M 
[IMG]Sunology-150x150.jpg2025-05-06 14:19 6.0K 
[IMG]Sunology-300x200.jpg2025-05-06 14:19 13K 
[IMG]Sunology-400x250.jpg2025-05-06 14:19 18K 
[IMG]Sunology-400x284.jpg2025-05-06 14:19 20K 
[IMG]Sunology-400x516.jpg2025-05-06 14:19 27K 
[IMG]Sunology-480x320.jpg2025-05-06 14:19 25K 
[IMG]Sunology-510x382.jpg2025-05-06 14:19 29K 
[IMG]Sunology-768x512.jpg2025-05-06 14:19 48K 
[IMG]Sunology-980x653.jpg2025-05-06 14:19 70K 
[IMG]Sunology-1024x683.jpg2025-05-06 14:20 75K 
[IMG]Sunology-1080x675.jpg2025-05-06 14:19 77K 
[IMG]Sunology-1080x720.jpg2025-05-06 14:19 82K 
[IMG]Sunology-1280x853.jpg2025-05-06 14:19 108K 
[IMG]Sunology-1536x1024.jpg2025-05-06 14:19 149K 
[IMG]Sunology.jpg2025-05-06 14:19 1.5M 
[ ]Sunpharma-Egypt-LLC.pdf2025-05-06 14:19 2.2M 
[ ]Tamsulosinapprl160710.pdf2025-05-06 14:19 22K 
[ ]Taro-International-Ltd..pdf2025-05-06 14:19 133K 
[ ]Taro-International-Ltd.pdf2025-05-06 14:19 66K 
[ ]Taro-Pharmaceticals-North-America-Inc..pdf2025-05-06 14:19 113K 
[ ]Taro-Pharmaceutical-Industries-Limited-and-its-subsidiaries.pdf2025-05-06 14:19 959K 
[ ]Taro-Pharmaceutical-Industries-Ltd.-Taro.pdf2025-05-06 14:19 70K 
[ ]Taro-Pharmaceutical-Industries-Ltd.-and-its-subsidiaries-1.pdf2025-05-06 14:19 1.2M 
[ ]Taro-Pharmaceutical-Industries-Ltd.-and-its-subsidiaries.pdf2025-05-06 14:19 1.2M 
[ ]Taro-Pharmaceutical-Industries-Ltd..pdf2025-05-06 14:19 106K 
[ ]Taro-Pharmaceutical-Industries-Ltd.pdf2025-05-06 14:19 1.3M 
[ ]Taro-Pharmaceuticals-Europe-B.V..pdf2025-05-06 14:19 38K 
[ ]Taro-Pharmaceuticals-Inc.-1.pdf2025-05-06 14:19 137K 
[ ]Taro-Pharmaceuticals-Inc..pdf2025-05-06 14:19 812K 
[ ]Taro-Pharmaceuticals-Industries-Ltd..pdf2025-05-06 14:19 1.1M 
[ ]Taro-Pharmaceuticals-North-America-Inc..pdf2025-05-06 14:19 49K 
[ ]Taro-Pharmaceuticals-USA-Inc.-1.pdf2025-05-06 14:19 82K 
[ ]Taro-Pharmaceuticals-USA-Inc..pdf2025-05-06 14:19 1.9M 
[ ]Tax_Statement.pdf2025-05-06 14:19 229K 
[ ]Tel-Aviv-Court-Rules-in-Favor-of-Sun-Pharmaceutical_-No-Special-Tender-Offer-August-27-2008.pdf2025-05-06 14:19 37K 
[ ]Terapia-SA.pdf2025-05-06 14:19 432K 
[ ]Terms-and-conditions-for-Independent-Director.pdf2025-05-06 14:19 7.8K 
[ ]TermsncondsforIndpntDirectorSPIL.pdf2025-05-06 14:19 7.8K 
[ ]Transcript-Sun-Pharma-Ranbaxy-Merger-Conference-Call.pdf2025-05-06 14:19 234K 
[ ]Transcript-of-management-presentation-on-NCE-and-NDDS.pdf2025-05-06 14:19 94K 
[ ]US-FTC-Clearance.pdf2025-05-06 14:19 23K 
[ ]USFDA-grants-tentative-approval-for-Sun-Pharmas-ANDA-for-Galantamine-tablets.pdf2025-05-06 14:19 23K 
[ ]Unaudited-Q3-numbers-on-January-28-January-28-2004.pdf2025-05-06 14:19 11K 
[ ]Universal-Enterprises-Private-Limited-1.pdf2025-05-06 14:19 4.2M 
[ ]Universal-Enterprises-Private-Limited-2.pdf2025-05-06 14:19 360K 
[ ]Universal-Enterprises-Private-Limited.pdf2025-05-06 14:19 2.3M 
[ ]Universal-Enterprises-Pvt-Ltd..pdf2025-05-06 14:19 386K 
[ ]Upadate-on-Intimation-under-Regulation-30-of-Listing-Regulations.pdf2025-05-06 14:19 98K 
[ ]Update-on-Gemzar-litigation-29-July-2010.pdf2025-05-06 14:19 23K 
[ ]Update-on-US-FDA-Dadra-Inspection.pdf2025-05-06 14:19 206K 
[ ]Update-on-Wind-Energy-Project.pdf2025-05-06 14:19 58K 
[ ]Update-on-acquisition-of-Ocular-Technologies-Sarl-–-closure-of-transaction-1.pdf2025-05-06 14:19 22K 
[ ]Update-on-acquisition-of-Ocular-Technologies-Sarl-–-closure-of-transaction.pdf2025-05-06 14:19 22K 
[IMG]VSV-150x150.png2025-05-06 14:19 8.7K 
[IMG]VSV-300x300.png2025-05-06 14:19 23K 
[IMG]VSV-400x250.png2025-05-06 14:19 30K 
[IMG]VSV-400x284.png2025-05-06 14:19 32K 
[IMG]VSV-400x516.png2025-05-06 14:19 46K 
[IMG]VSV-480x480.png2025-05-06 14:19 45K 
[IMG]VSV-510x382.png2025-05-06 14:19 46K 
[IMG]VSV-768x768.png2025-05-06 14:19 86K 
[IMG]VSV-980x980.png2025-05-06 14:19 117K 
[IMG]VSV-1024x1024.png2025-05-06 14:19 125K 
[IMG]VSV-1080x675.png2025-05-06 14:19 115K 
[IMG]VSV-1080x1080.png2025-05-06 14:19 134K 
[IMG]VSV-1280x1280.png2025-05-06 14:19 166K 
[IMG]VSV-1536x1536.png2025-05-06 14:19 209K 
[IMG]VSV-2048x2048.png2025-05-06 14:19 303K 
[IMG]VSV-2880x1800.png2025-05-06 14:20 393K 
[IMG]VSV.png2025-05-06 14:19 768K 
[IMG]Values-1-150x150.jpg2025-05-06 14:19 6.2K 
[IMG]Values-1-300x200.jpg2025-05-06 14:20 13K 
[IMG]Values-1-400x250.jpg2025-05-06 14:19 19K 
[IMG]Values-1-400x284.jpg2025-05-06 14:20 21K 
[IMG]Values-1-400x516.jpg2025-05-06 14:19 32K 
[IMG]Values-1-480x320.jpg2025-05-06 14:19 26K 
[IMG]Values-1-510x382.jpg2025-05-06 14:19 31K 
[IMG]Values-1-768x512.jpg2025-05-06 14:19 53K 
[IMG]Values-1-980x653.jpg2025-05-06 14:19 78K 
[IMG]Values-1-1024x683.jpg2025-05-06 14:19 84K 
[IMG]Values-1-1080x675.jpg2025-05-06 14:19 86K 
[IMG]Values-1-1080x720.jpg2025-05-06 14:19 90K 
[IMG]Values-1-1280x853.jpg2025-05-06 14:19 119K 
[IMG]Values-1-1536x1024.jpg2025-05-06 14:19 161K 
[IMG]Values-1.jpg2025-05-06 14:20 1.3M 
[IMG]Values-150x150.jpg2025-05-06 14:19 6.2K 
[IMG]Values-300x200.jpg2025-05-06 14:19 13K 
[IMG]Values-400x250.jpg2025-05-06 14:19 19K 
[IMG]Values-400x284.jpg2025-05-06 14:19 21K 
[IMG]Values-400x516.jpg2025-05-06 14:19 32K 
[IMG]Values-480x320.jpg2025-05-06 14:19 26K 
[IMG]Values-510x382.jpg2025-05-06 14:19 31K 
[IMG]Values-768x512.jpg2025-05-06 14:19 53K 
[IMG]Values-980x653.jpg2025-05-06 14:19 78K 
[IMG]Values-1024x683.jpg2025-05-06 14:19 84K 
[IMG]Values-1080x675.jpg2025-05-06 14:19 86K 
[IMG]Values-1080x720.jpg2025-05-06 14:19 90K 
[IMG]Values-1280x853.jpg2025-05-06 14:19 119K 
[IMG]Values-1536x1024.jpg2025-05-06 14:19 161K 
[IMG]Values.jpg2025-05-06 14:19 1.3M 
[ ]Venlafaxine-ER-190810.pdf2025-05-06 14:19 107K 
[ ]Vidyut-Investments-Limited.pdf2025-05-06 14:19 510K 
[ ]Volini-Spray-360-degree-l-Press-Release.pdf2025-05-06 14:19 446K 
[ ]Voting-Result-of-Court-Convened-Meeting-of-SPIL-to-consider-the-Scheme-of-Merger-of-SPGI-with-the-Company.pdf2025-05-06 14:19 160K 
[ ]Voting-Results-at-AGM-held-on-July-28-1.pdf2025-05-06 14:19 881K 
[ ]Voting-Results-at-AGM-held-on-July-28.pdf2025-05-06 14:19 881K 
[ ]Voting-Results-of-26th-Annual-General-Meeting-to-Stock-Exchanges-along-with-Scrutinizers-Report.pdf2025-05-06 14:19 3.3M 
[ ]Voting-Results-of-NCLT-Convened-Meeting-of-Equity-Shareholders.pdf2025-05-06 14:19 361K 
[ ]VotingResultNCLTmeeting01062018-1.pdf2025-05-06 14:19 1.1M 
[ ]VotingResults28thAGM.pdf2025-05-06 14:19 2.1M 
[ ]Warning-Letter-31-8-2010.pdf2025-05-06 14:19 22K 
[ ]Warning-Letter-for-Halol-facility-Call-Transcript.pdf2025-05-06 14:19 172K 
[IMG]Water-Sanitation-150x150.jpeg2025-05-06 14:19 7.0K 
[IMG]Water-Sanitation-300x200.jpeg2025-05-06 14:19 15K 
[IMG]Water-Sanitation-400x250.jpeg2025-05-06 14:19 23K 
[IMG]Water-Sanitation-400x284.jpeg2025-05-06 14:19 26K 
[IMG]Water-Sanitation-400x516.jpeg2025-05-06 14:19 43K 
[IMG]Water-Sanitation-480x320.jpeg2025-05-06 14:19 33K 
[IMG]Water-Sanitation-510x382.jpeg2025-05-06 14:19 42K 
[IMG]Water-Sanitation-768x512.jpeg2025-05-06 14:19 74K 
[IMG]Water-Sanitation-980x653.jpeg2025-05-06 14:19 112K 
[IMG]Water-Sanitation-1024x683.jpeg2025-05-06 14:19 120K 
[IMG]Water-Sanitation-1080x675.jpeg2025-05-06 14:19 123K 
[IMG]Water-Sanitation-1080x720.jpeg2025-05-06 14:19 131K 
[IMG]Water-Sanitation-1280x853.jpeg2025-05-06 14:19 172K 
[IMG]Water-Sanitation-1536x1024.jpeg2025-05-06 14:19 228K 
[IMG]Water-Sanitation.jpeg2025-05-06 14:19 206K 
[ ]Way-forward-on-demerger.pdf2025-05-06 14:19 42K 
[ ]Webcast-Recording-of-28th-Annual-General-Meeting-of-the-Company-for-the-year-2019-20.docx2025-05-06 14:19 13K 
[ ]Whistle-Blower-Policy-for-Sun-Pharmaceutical-Industries-Limited-_-its-Subsidiaries.pdf2025-05-06 14:19 309K 
[ ]ZAO-Ranbaxy.pdf2025-05-06 14:19 1.9M 
[ ]Zenotech-Laboratories-Limited.pdf2025-05-06 14:19 1.9M 
[ ]Zenotech-Laboratories-Ltd..pdf2025-05-06 14:19 1.1M 
[ ]Zoledronic-acid-SUN-DK-Patient-Reminder-Card.pdf2025-05-06 14:19 1.4M 
[ ]Zoledronic-acid-SUN-FI-MEDIC.pdf2025-05-06 14:19 38K 
[ ]Zoledronic-acid-SUN-FI-Patient-Reminder-Card.pdf2025-05-06 14:19 1.4M 
[ ]Zoledronic-acid-SUN-FI-patient-guide.pdf2025-05-06 14:19 104K 
[ ]aRMM-orale-retinoiden-Materiaal-Apotheker-version-1.0.pdf2025-05-06 14:19 56K 
[ ]aRMM-orale-retinoiden-Materiaal-Arts-version-1.0.pdf2025-05-06 14:19 88K 
[ ]aRMM-orale-retinoiden-Materiaal-Patiënt-version-1.0.pdf2025-05-06 14:19 57K 
[IMG]aima-logo.jpg2025-05-06 14:19 4.0K 
[ ]ar2002.pdf2025-05-06 14:19 30M 
[ ]ar2003.pdf2025-05-06 14:19 3.7M 
[ ]ar2004.pdf2025-05-06 14:19 5.4M 
[ ]ar2005.pdf2025-05-06 14:19 3.1M 
[ ]ar2007.pdf2025-05-06 14:19 3.6M 
[IMG]assocham-icon.jpg2025-05-06 14:19 2.3K 
[IMG]business-india.png2025-05-06 14:19 3.3K 
[IMG]business-standard.png2025-05-06 14:19 2.8K 
[IMG]chart_ranbaxy_31-3-2014-150x150.jpg2025-05-06 14:19 5.3K 
[IMG]chart_ranbaxy_31-3-2014-300x182.jpg2025-05-06 14:19 7.6K 
[IMG]chart_ranbaxy_31-3-2014-400x250.jpg2025-05-06 14:19 11K 
[IMG]chart_ranbaxy_31-3-2014-400x284.jpg2025-05-06 14:19 13K 
[IMG]chart_ranbaxy_31-3-2014-400x333.jpg2025-05-06 14:19 17K 
[IMG]chart_ranbaxy_31-3-2014-480x292.jpg2025-05-06 14:19 14K 
[IMG]chart_ranbaxy_31-3-2014-510x333.jpg2025-05-06 14:19 18K 
[IMG]chart_ranbaxy_31-3-2014.jpg2025-05-06 14:19 18K 
[ ]clause_35_shareholding_pattern_sep_30_2014.pdf2025-05-06 14:19 1.1M 
[IMG]cnbc-18.png2025-05-06 14:19 5.8K 
[IMG]cnbc-cfo.png2025-05-06 14:19 5.9K 
[IMG]cnn-ibn.png2025-05-06 14:19 5.8K 
[ ]completeannual-report.pdf2025-05-06 14:19 2.2M 
[IMG]corporate-150x150.jpg2025-05-06 14:19 11K 
[IMG]corporate-300x188.jpg2025-05-06 14:19 20K 
[IMG]corporate-400x250.jpg2025-05-06 14:19 30K 
[IMG]corporate-400x284.jpg2025-05-06 14:19 32K 
[IMG]corporate-400x438.jpg2025-05-06 14:19 45K 
[IMG]corporate-480x300.jpg2025-05-06 14:19 39K 
[IMG]corporate-510x382.jpg2025-05-06 14:20 47K 
[IMG]corporate.jpg2025-05-06 14:19 128K 
[ ]de-spc-Temozolomide092019_public.pdf2025-05-06 14:19 384K 
[ ]de-spc-Zoledrons„ure082016_public.pdf2025-05-06 14:19 261K 
[ ]de-spc-anastrozolesun012018_public.pdf2025-05-06 14:19 297K 
[ ]de-spc-atosiban375082016clean_public.pdf2025-05-06 14:19 190K 
[ ]de-spc-atosiban675082016clean_public.pdf2025-05-06 14:19 185K 
[ ]de-spc-baclofen0point05mg1mlclean_public.pdf2025-05-06 14:19 207K 
[ ]de-spc-baclofen10mg20ml10mg5mlclean_public.pdf2025-05-06 14:19 218K 
[ ]de-spc-caspofungin022017clean_public.pdf2025-05-06 14:19 248K 
[ ]de-spc-cefuroxbasicssusp112019clean-public.pdf2025-05-06 14:19 482K 
[ ]de-spc-cefuroxfct082018clean_public.pdf2025-05-06 14:19 203K 
[ ]de-spc-esomeprazolnormonv0400clean_public.pdf2025-05-06 14:19 260K 
[ ]de-spc-esomeprazolsun032018_public.pdf2025-05-06 14:19 254K 
[ ]de-spc-fulvestrant062019clean_public.pdf2025-05-06 14:19 475K 
[ ]de-spc-gemcitabin10mgmlv0400_public.pdf2025-05-06 14:19 336K 
[ ]de-spc-gemcitabine200mg1gV026clean_public.pdf2025-05-06 14:20 334K 
[ ]de-spc-imicila032017v0400clean_public.pdf2025-05-06 14:19 189K 
[ ]de-spc-letrozolv0500V014_public.pdf2025-05-06 14:19 349K 
[ ]de-spc-levetiracetam092019clean_public.pdf2025-05-06 14:19 360K 
[ ]de-spc-melphalan022019clean_public.pdf2025-05-06 14:19 123K 
[ ]de-spc-meropenem-500mg_1g_ieh042017clean_public.pdf2025-05-06 14:19 198K 
[ ]de-spc-midazolamv0100_public.pdf2025-05-06 14:19 251K 
[ ]de-spc-octreotid062017clean_public.pdf2025-05-06 14:19 205K 
[ ]de-spc-odomzo052020_public.pdf2025-05-06 14:19 261K 
[ ]de-spc-oxaliplatin022018_public.pdf2025-05-06 14:19 215K 
[ ]de-spc-pantoprazolnormon062019clean_public.pdf2025-05-06 14:19 244K 
[ ]de-spc-pantoprazolsun072019clean_public.pdf2025-05-06 14:19 246K 
[ ]de-spc-paricalcitol022019clean_public.pdf2025-05-06 14:19 234K 
[ ]de-spc-riluzol50mg122017clean_public.pdf2025-05-06 14:19 177K 
[ ]de-spc-sildenafilsun50100mgv0400clean_public.pdf2025-05-06 14:19 214K 
[ ]de-spc-tamsulosine082019v1500_public.pdf2025-05-06 14:19 235K 
[ ]de-spc-terlipressin122017v0200clean_public.pdf2025-05-06 14:19 120K 
[ ]de-spc-tobramycin032017_public.pdf2025-05-06 14:19 187K 
[IMG]dilip-shanghvi.jpg2025-05-06 14:19 4.1K 
[ ]disclosure-to-stock-exchange-under-regulation-1.pdf2025-05-06 14:19 798K 
[ ]disclosure-to-stock-exchange-under-regulation.pdf2025-05-06 14:19 798K 
[ ]download-Annual-Report2.94MB-1.pdf2025-05-06 14:19 3.0M 
[ ]download-Annual-Report2.94MB.pdf2025-05-06 14:19 3.0M 
[ ]download-complete-Annual-Report.pdf2025-05-06 14:19 1.7M 
[IMG]download-complete-annual-report4.07MB-150x150.jpg2025-05-06 14:19 5.4K 
[IMG]download-complete-annual-report4.07MB-229x300.jpg2025-05-06 14:19 11K 
[IMG]download-complete-annual-report4.07MB-400x250.jpg2025-05-06 14:19 22K 
[IMG]download-complete-annual-report4.07MB-400x284.jpg2025-05-06 14:19 23K 
[IMG]download-complete-annual-report4.07MB-400x516.jpg2025-05-06 14:19 31K 
[IMG]download-complete-annual-report4.07MB-480x629.jpg2025-05-06 14:19 44K 
[IMG]download-complete-annual-report4.07MB-510x382.jpg2025-05-06 14:19 36K 
[IMG]download-complete-annual-report4.07MB-768x1006.jpg2025-05-06 14:19 104K 
[IMG]download-complete-annual-report4.07MB-782x1024.jpg2025-05-06 14:19 107K 
[IMG]download-complete-annual-report4.07MB-980x1283.jpg2025-05-06 14:19 163K 
[IMG]download-complete-annual-report4.07MB-1080x675.jpg2025-05-06 14:19 119K 
[IMG]download-complete-annual-report4.07MB-1080x1414.jpg2025-05-06 14:19 194K 
[IMG]download-complete-annual-report4.07MB-1173x1536.jpg2025-05-06 14:19 225K 
[IMG]download-complete-annual-report4.07MB.jpg2025-05-06 14:19 512K 
[ ]download-complete-annual-report4.07MB.pdf2025-05-06 14:19 4.1M 
[ ]download-completeAnnualReport2.3MB-1.pdf2025-05-06 14:19 2.0M 
[ ]download-completeAnnualReport2.3MB-2.pdf2025-05-06 14:19 2.2M 
[ ]download-completeAnnualReport2.3MB-3.pdf2025-05-06 14:19 7.8M 
[ ]download-completeAnnualReport2.3MB-4.pdf2025-05-06 14:19 15M 
[ ]download-completeAnnualReport2.3MB-5.pdf2025-05-06 14:19 9.7M 
[ ]download-completeAnnualReport2.3MB-6.pdf2025-05-06 14:19 19M 
[ ]download-completeAnnualReport2.3MB-7.pdf2025-05-06 14:19 25M 
[ ]download-completeAnnualReport2.3MB-8.pdf2025-05-06 14:19 19M 
[ ]download-completeAnnualReport2.3MB.pdf2025-05-06 14:19 3.4M 
[IMG]dun-bradstreet.png2025-05-06 14:19 7.1K 
[IMG]economic-times.png2025-05-06 14:19 2.9K 
[IMG]ernst-young.png2025-05-06 14:19 3.6K 
[IMG]favicon-96x96-1.png2025-05-06 14:19 9.7K 
[IMG]fgi-logo.jpg2025-05-06 14:19 7.5K 
[IMG]forbes.png2025-05-06 14:19 3.8K 
[IMG]frost-sullivan.png2025-05-06 14:19 4.1K 
[IMG]gautam-doshi.jpg2025-05-06 14:19 3.6K 
[ ]global-blower-file.pdf2025-05-06 14:19 309K 
[IMG]hda-icon.jpg2025-05-06 14:19 3.9K 
[IMG]home-banner-150x150.jpg2025-05-06 14:19 5.1K 
[IMG]home-banner-300x153.jpg2025-05-06 14:19 10K 
[IMG]home-banner-400x250.jpg2025-05-06 14:19 17K 
[IMG]home-banner-400x284.jpg2025-05-06 14:19 18K 
[IMG]home-banner-400x516.jpg2025-05-06 14:19 25K 
[IMG]home-banner-480x244.jpg2025-05-06 14:19 21K 
[IMG]home-banner-510x382.jpg2025-05-06 14:19 27K 
[IMG]home-banner-768x390.jpg2025-05-06 14:20 42K 
[IMG]home-banner-980x498.jpg2025-05-06 14:19 62K 
[IMG]home-banner-1024x521.jpg2025-05-06 14:19 66K 
[IMG]home-banner-1080x549.jpg2025-05-06 14:19 72K 
[IMG]home-banner-1080x675.jpg2025-05-06 14:19 83K 
[IMG]home-banner-1280x651.jpg2025-05-06 14:19 95K 
[IMG]home-banner.jpg2025-05-06 14:19 133K 
[IMG]ima-logo.jpg2025-05-06 14:19 8.7K 
[IMG]imc-150x150.jpg2025-05-06 14:19 7.0K 
[IMG]imc.jpg2025-05-06 14:19 11K 
[IMG]israel-makov.jpg2025-05-06 14:19 4.2K 
[ ]list_of_shareholders_unclaimed_dividend_amount_for_the_year_2010.pdf2025-05-06 14:19 13M 
[ ]list_of_shareholders_unclaimed_final_dividend_amount_for_the_year_2007-1.pdf2025-05-06 14:19 9.3M 
[ ]list_of_shareholders_unclaimed_interim_dividend_amount_for_the_year_2007.pdf2025-05-06 14:19 4.1M 
[IMG]logo.png2025-05-06 14:19 8.8K 
[IMG]manufacturing-150x150.jpg2025-05-06 14:19 12K 
[IMG]manufacturing-300x188.jpg2025-05-06 14:19 22K 
[IMG]manufacturing-400x250.jpg2025-05-06 14:19 32K 
[IMG]manufacturing-400x284.jpg2025-05-06 14:19 36K 
[IMG]manufacturing-400x438.jpg2025-05-06 14:19 52K 
[IMG]manufacturing-480x300.jpg2025-05-06 14:19 42K 
[IMG]manufacturing-510x382.jpg2025-05-06 14:19 54K 
[IMG]manufacturing.jpg2025-05-06 14:19 130K 
[IMG]mt-sample-background-1-150x150.jpg2025-05-06 14:19 2.5K 
[IMG]mt-sample-background-1-300x200.jpg2025-05-06 14:19 5.5K 
[IMG]mt-sample-background-1-400x250.jpg2025-05-06 14:19 8.7K 
[IMG]mt-sample-background-1-400x284.jpg2025-05-06 14:19 9.7K 
[IMG]mt-sample-background-1-400x516.jpg2025-05-06 14:19 17K 
[IMG]mt-sample-background-1-480x320.jpg2025-05-06 14:19 12K 
[IMG]mt-sample-background-1-510x382.jpg2025-05-06 14:19 16K 
[IMG]mt-sample-background-1-768x512.jpg2025-05-06 14:19 30K 
[IMG]mt-sample-background-1-980x653.jpg2025-05-06 14:19 49K 
[IMG]mt-sample-background-1-1024x683.jpg2025-05-06 14:19 53K 
[IMG]mt-sample-background-1-1080x675.jpg2025-05-06 14:19 56K 
[IMG]mt-sample-background-1-1080x720.jpg2025-05-06 14:19 58K 
[IMG]mt-sample-background-1-1280x853.jpg2025-05-06 14:19 82K 
[IMG]mt-sample-background-1-1536x1024.jpg2025-05-06 14:19 115K 
[IMG]mt-sample-background-1.jpg2025-05-06 14:19 212K 
[IMG]ndtv-logo.jpg2025-05-06 14:19 1.8K 
[IMG]ndtv-profilt.png2025-05-06 14:19 3.7K 
[ ]notice_of_agm_2013_14.pdf2025-05-06 14:19 425K 
[IMG]odomzo-logo-fr-150x150.jpg2025-05-06 14:19 8.0K 
[IMG]odomzo-logo-fr-300x245.jpg2025-05-06 14:19 16K 
[IMG]odomzo-logo-fr-350x250.jpg2025-05-06 14:19 21K 
[IMG]odomzo-logo-fr-350x284.jpg2025-05-06 14:19 21K 
[IMG]odomzo-logo-fr.jpg2025-05-06 14:19 52K 
[ ]outcome-of-allotment-commitee-sept26-2017.pdf2025-05-06 14:19 541K 
[ ]outcome-of-board-meeting_14-november-2017.pdf2025-05-06 14:19 675K 
[ ]outcomeof-allottment-commitee-meeting_14-november-2017.pdf2025-05-06 14:19 39K 
[IMG]padmashri.jpg2025-05-06 14:19 3.9K 
[ ]proxy_form_and_attendence_slip_2013_14.pdf2025-05-06 14:19 1.1M 
[ ]ranbaxy_agm_notice_attendance_slip_and_porxy_form.pdf2025-05-06 14:19 216K 
[ ]ranbaxy_annual_report_2012.pdf2025-05-06 14:19 4.9M 
[ ]ranbaxy_annual_report_2013_14_updated.pdf2025-05-06 14:19 4.8M 
[ ]ranbaxy_annualreport-2006.pdf2025-05-06 14:19 2.8M 
[ ]ranbaxy_ar2008_3deluxe.pdf2025-05-06 14:19 8.0M 
[ ]ranbaxy_ar2010_2published.pdf2025-05-06 14:19 7.4M 
[ ]ranbaxy_ar_2011_1.pdf2025-05-06 14:19 4.4M 
[IMG]rd-150x150.jpg2025-05-06 14:19 13K 
[IMG]rd-300x188.jpg2025-05-06 14:19 26K 
[IMG]rd-400x250.jpg2025-05-06 14:19 39K 
[IMG]rd-400x284.jpg2025-05-06 14:19 42K 
[IMG]rd-400x438.jpg2025-05-06 14:19 57K 
[IMG]rd-480x300.jpg2025-05-06 14:19 52K 
[IMG]rd-510x382.jpg2025-05-06 14:19 63K 
[IMG]rd.jpg2025-05-06 14:19 160K 
[IMG]rekha-sethi.jpg2025-05-06 14:19 5.2K 
[IMG]sailesh-desai.jpg2025-05-06 14:19 3.8K 
[ ]sam.pdf2025-05-06 14:19 132K 
[IMG]share_6_june-150x150.jpg2025-05-06 14:19 4.4K 
[IMG]share_6_june-300x184.jpg2025-05-06 14:19 6.3K 
[IMG]share_6_june-400x250.jpg2025-05-06 14:19 9.6K 
[IMG]share_6_june-400x284.jpg2025-05-06 14:19 11K 
[IMG]share_6_june-400x360.jpg2025-05-06 14:19 16K 
[IMG]share_6_june-480x294.jpg2025-05-06 14:19 12K 
[IMG]share_6_june-510x360.jpg2025-05-06 14:19 17K 
[IMG]share_6_june.jpg2025-05-06 14:19 17K 
[IMG]share_holding_chart_dec13-150x150.jpg2025-05-06 14:19 5.3K 
[IMG]share_holding_chart_dec13-300x182.jpg2025-05-06 14:19 7.6K 
[IMG]share_holding_chart_dec13-400x250.jpg2025-05-06 14:20 12K 
[IMG]share_holding_chart_dec13-400x284.jpg2025-05-06 14:19 14K 
[IMG]share_holding_chart_dec13-400x333.jpg2025-05-06 14:19 18K 
[IMG]share_holding_chart_dec13-480x292.jpg2025-05-06 14:19 14K 
[IMG]share_holding_chart_dec13-510x333.jpg2025-05-06 14:19 19K 
[IMG]share_holding_chart_dec13.jpg2025-05-06 14:19 20K 
[IMG]share_holding_dec_2014-150x150.jpg2025-05-06 14:19 5.5K 
[IMG]share_holding_dec_2014-300x182.jpg2025-05-06 14:19 8.0K 
[IMG]share_holding_dec_2014-400x250.jpg2025-05-06 14:19 12K 
[IMG]share_holding_dec_2014-400x284.jpg2025-05-06 14:19 14K 
[IMG]share_holding_dec_2014-400x333.jpg2025-05-06 14:19 17K 
[IMG]share_holding_dec_2014-480x292.jpg2025-05-06 14:19 15K 
[IMG]share_holding_dec_2014-510x333.jpg2025-05-06 14:19 18K 
[IMG]share_holding_dec_2014.jpg2025-05-06 14:19 18K 
[IMG]share_holding_pattern_13-150x150.jpg2025-05-06 14:19 5.4K 
[IMG]share_holding_pattern_13-300x190.jpg2025-05-06 14:19 8.1K 
[IMG]share_holding_pattern_13-400x250.jpg2025-05-06 14:19 12K 
[IMG]share_holding_pattern_13-400x284.jpg2025-05-06 14:19 13K 
[IMG]share_holding_pattern_13-400x366.jpg2025-05-06 14:19 18K 
[IMG]share_holding_pattern_13-480x303.jpg2025-05-06 14:19 16K 
[IMG]share_holding_pattern_13-510x366.jpg2025-05-06 14:19 20K 
[IMG]share_holding_pattern_13.jpg2025-05-06 14:19 21K 
[IMG]share_pattern_march-150x150.jpg2025-05-06 14:19 3.9K 
[IMG]share_pattern_march-300x190.jpg2025-05-06 14:19 6.0K 
[IMG]share_pattern_march-400x250.jpg2025-05-06 14:19 9.2K 
[IMG]share_pattern_march-400x284.jpg2025-05-06 14:19 10K 
[IMG]share_pattern_march-400x380.jpg2025-05-06 14:19 15K 
[IMG]share_pattern_march-480x305.jpg2025-05-06 14:19 11K 
[IMG]share_pattern_march-510x380.jpg2025-05-06 14:19 17K 
[IMG]share_pattern_march.jpg2025-05-06 14:19 17K 
[IMG]shere_pattern_30-6-2014-150x150.jpg2025-05-06 14:19 5.2K 
[IMG]shere_pattern_30-6-2014-300x182.jpg2025-05-06 14:19 7.1K 
[IMG]shere_pattern_30-6-2014-400x250.jpg2025-05-06 14:19 11K 
[IMG]shere_pattern_30-6-2014-400x284.jpg2025-05-06 14:19 12K 
[IMG]shere_pattern_30-6-2014-400x333.jpg2025-05-06 14:19 16K 
[IMG]shere_pattern_30-6-2014-480x292.jpg2025-05-06 14:19 13K 
[IMG]shere_pattern_30-6-2014-510x333.jpg2025-05-06 14:19 17K 
[IMG]shere_pattern_30-6-2014.jpg2025-05-06 14:19 17K 
[IMG]singhal.jpg2025-05-06 14:19 6.5K 
[IMG]subramanian.jpg2025-05-06 14:19 3.6K 
[IMG]sudhir-valia.jpg2025-05-06 14:19 4.1K 
[IMG]ubm.jpg2025-05-06 14:19 5.8K 
[IMG]vivek-chaand-sehgal.jpg2025-05-06 14:19 3.7K 
[ ]votingresultsfor25thagm.pdf2025-05-06 14:19 8.5M 
Apache/2.4.52 (Ubuntu) Server at sunpharma.com Port 80